Document:

EX-10.1

 EXHIBIT 10.1 
 SECURITIES PURCHASE AGREEMENT 
 This SECURITIES
PURCHASE AGREEMENT (the “Agreement”) is dated as of the 9th day of May, 2013 (the “Effective Date”), by and among Institutional Financial Markets, Inc., a Maryland corporation (the
“Company”), and Mead Park Capital Partners LLC, a Delaware limited liability company (“Buyer”) and, solely for purposes of Section 6.3 hereof, Mead Park Holdings, LP, a Delaware limited
partnership (“Mead Park”). 
 RECITALS: 

WHEREAS, Buyer desires to purchase from the Company, and the Company desires to issue and to sell to Buyer, upon the
terms and conditions set forth in this Agreement, (i) an aggregate of One Million Nine Hundred Forty-Nine Thousand One Hundred Sixty-Seven (1,949,167) newly issued shares (each, a “Common Share” and, collectively,
the “Common Shares”) of the Company’s common stock, $0.001 par value per share (“Common Stock”), for a purchase price of Two Dollars ($2.00) per Common Share, representing an aggregate purchase
price of Three Million Eight Hundred Ninety-Eight Thousand Three Hundred Thirty-Four Dollars ($3,898,334) (the “Common Stock Purchase Price”); and (ii) a convertible senior promissory note in the aggregate principal
amount of Five Million Eight Hundred Forty-Seven Thousand Five Hundred and One Dollars ($5,847,501) (the “Note Purchase Price”), in substantially the form attached hereto as Exhibit A (the
“Note”); 
 WHEREAS, the Company and Buyer are executing and delivering this Agreement
in reliance upon an exemption from registration afforded by the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations promulgated thereunder by the U.S. Securities and Exchange Commission
(the “SEC”); 
 WHEREAS, contemporaneously with the execution and delivery of this
Agreement, the parties hereto are executing and delivering the Registration Rights Agreement attached hereto as Exhibit B (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide
certain registration rights to Buyer and to Cohen Bros. (as defined below) under the Securities Act and under applicable state securities Laws; 
 WHEREAS, the Company has approved the shareholder rights plan attached hereto as Exhibit C (the “Shareholder Rights Plan”) to reduce the risk of any limitation of net
operating loss and net capital loss carryforwards and certain other tax benefits under Section 382 of the Internal Revenue Code of 1986, as amended, and the Treasury Regulations promulgated thereunder (the “Code”) and
such plan is effective as of the Effective Date; 
 WHEREAS, contemporaneously with the execution and delivery
of this Agreement, Cohen Bros. and the Company are entering into the following agreements: (i) a securities purchase agreement, pursuant to which Cohen Bros. has agreed to purchase from the Company and the Company has agreed to sell to Cohen
Bros. (A) Eight Hundred Thousand (800,000) shares of Common Stock, for a purchase price of Two Dollars ($2.00) per share, representing an aggregate purchase price of One Million Six Hundred Thousand Dollars ($1,600,000) (the
“Cohen Shares”) and (B) a convertible senior promissory note (the “Cohen Note”) in the aggregate principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000), in the form attached
hereto as Exhibit D (the “Cohen Purchase Agreement”); and (ii) an exchange agreement providing for the exchange of all of the Institutional Financial Markets, Inc. Series D Voting Non-Convertible Preferred Stock
owned by Cohen Bros. for newly issued shares of Institutional Financial Markets, Inc. Series E Voting Non-Convertible Preferred Stock, in the form attached hereto as Exhibit E (the “Exchange Agreement”); 

 WHEREAS, contemporaneously with the execution and delivery of this
Agreement, Daniel G. Cohen and the Company are entering into an amended and restated employment agreement, which is amending and restating the Cohen IFMI Employment Agreement and terminating the Cohen PrinceRidge Employment Agreement (each as
defined below), in the form attached hereto as Exhibit F (the “Amended and Restated Cohen Employment Agreement”); 
 WHEREAS, on or prior to the Effective Date, each member of IFMI, LLC and the board of managers of IFMI, LLC shall have approved, pursuant to written consents provided to Buyer, the amendment to the IFMI
LLC Agreement (as defined below) attached hereto as Exhibit G (“LLC Agreement Amendment”); and 
 WHEREAS, on or prior to the Effective Date, the Company and the Voting Agreement Signatories (as defined below), have entered into and delivered to Buyer voting agreements, each attached hereto as
Exhibit H (collectively, the “Voting Agreements”). 
 NOW, THEREFORE, in
consideration of the premises and the mutual covenants of the parties hereinafter expressed and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally
bound, agree as follows: 
 ARTICLE I 
 RECITALS, EXHIBITS, SCHEDULES 
 The foregoing Recitals are
true and correct and, such Recitals, together with the Schedules and Exhibits referred to therein and referred to hereafter, are hereby incorporated into this Agreement by this reference. 

ARTICLE II 

DEFINITIONS 
 Capitalized terms used in this Agreement but otherwise not defined herein shall have the following meanings: 
 2.1      “Affiliate” means, with respect to a Person, any other Person directly or indirectly controlling, controlled by, or under common control
with, such Person at any time during the period for which the determination of affiliation is being made. For purposes of this definition, the terms “control,” “controlling,” “controlled” and words
of similar import, when used in this context, mean, with respect to any Person, the possession, directly or indirectly, of the power to direct, or cause the direction of, management policies of such Person, whether through the ownership of voting
securities, by contract or otherwise; provided, however, that in no event shall Buyer be deemed to be an Affiliate of the Company for purposes of this Agreement or any of the Transaction Documents. 

  
 2 

 2.2       “Assets”
means all of the properties and assets of the Company or of the Subsidiaries, whether real, personal or mixed, tangible or intangible, wherever located, whether now owned or hereafter acquired. 

2.3       “Board of Directors” means the Board of Directors of the
Company. 
 2.4       “Buyer Fundamental Representations”
means, collectively, the representations and warranties of Buyer contained in Sections 4.1 (Organization; Authority), 4.3 (Investment Purpose), 4.4 (Accredited Buyer Status; Experience of Buyer) and 4.9 (Brokers and Finders). 

2.5       “CCFL” means Cohen & Company Financial Limited
(formerly known as EuroDekania Management LTD) a wholly-owned Subsidiary organized under the laws of the United Kingdom. 
 2.6       “Claims” means any threatened or actual Proceeding, Judgment, settlement, and/or assessment of any nature or kind. 

2.7       “Cohen IFMI Employment Agreement” means the Employment
Agreement, dated February 18, 2010, by and among the Company, IFMI, LLC, and Daniel G. Cohen, as amended by Amendment No. 1, dated December 18, 2012. 

2.8       “Cohen Bros.” means Cohen Bros. Financial, LLC, a
Delaware limited liability company of which Daniel G. Cohen is the sole member. 
 2.9
      “Cohen Conversion Shares” means the shares of Common Stock into which the Cohen Note is convertible. 

2.10     “Cohen PrinceRidge Employment Agreement” means the Executive
Agreement, dated May 31, 2011, by and among PrinceRidge, the Company, IFMI, LLC and Daniel G. Cohen and, solely for purposes of Sections 5.5 and 5.6 thereof, C&Co/PrinceRidge Partners LLC (formerly known as PrinceRidge Partners LLC).

 2.11     “Company Fundamental Representations” means,
collectively, the representations and warranties of the Company contained in Sections 5.1 (Organization and Qualification), 5.2 (Authorization; Enforcement; Validity), 5.3 (Capitalization), 5.5 (No Conflicts; Consents and Approvals), 5.6 (Issuance
of Securities), 5.8 (Absence of Certain Changes), 5.11 (Compliance with Laws), 5.15 (Acknowledgement Regarding Buyer’s Purchase of the Securities) and 5.16 (Brokerage Fees). 

2.12     “Confidentiality Agreement” means the Confidentiality Agreement,
dated March 13, 2012, between the Company and Mead Park Management, LLC, as amended by the Letter Agreement re: Confidentiality Agreement, dated September 26, 2012, and as extended by the Second Letter Agreement re: Confidentiality
Agreement, dated March 12, 2013. 
 2.13     “Consent” means
any consent, approval, order or authorization of, or any declaration, qualification, filing or registration with, or any application or report to, or any waiver by, or any other action (whether similar or dissimilar to any of the foregoing) of, by
or with, any Person, which is necessary in order to take a specified action or actions, in a specified manner and/or to achieve a specific result. 

  
 3 

 2.14     “Contract” means any
written or oral contract, agreement, order or commitment of any nature whatsoever, including any sales order, purchase order, lease, sublease, license agreement, services agreement, loan agreement, mortgage, security agreement, guarantee, management
contract, employment agreement, consulting agreement, partnership agreement, stockholders agreement, buy-sell agreement, option, warrant, debenture, subscription, call or put. 

2.15     “Conversion Shares” means the shares of Common Stock issuable upon
conversion of the Note. 
 2.16     “Convertible IFMI LLC Units”
means units of membership interest in IFMI, LLC that are redeemable for shares of Common Stock or cash, at the option of the Company, pursuant to the IFMI LLC Agreement (other than any units of membership interest held by the Company). 

2.17     “Current Independent Directors” means the members of the Board of
Directors as of the Effective Date who are considered to be independent directors (as determined in accordance with Section 803 of the NYSE MKT’s Company Guide). 

2.18     “Director” means a member of the Board of Directors. 

2.19     “DRS” means the Direct Registration System maintained by the
transfer agent for the Common Stock. 
 2.20     “Encumbrance” means
any lien, security interest, pledge, mortgage, easement, leasehold, assessment, tax, covenant, reservation, conditional sale, prior assignment, or any other encumbrance, claim, burden or charge of any nature whatsoever. 

2.21     “Exchange Act” means the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder. 
 2.22
    “Exclusivity Agreement” means the Letter Agreement, dated as of March 11, 2013, by and between Mead Park and the Company. 

2.23     “GAAP” means generally accepted accounting principles in the United
States of America as in effect from time to time. 
 2.24     “Governmental
Authority” means any foreign, federal, state or local government, or any political subdivision thereof, or any court, agency or other body, organization, group, stock market or exchange exercising any executive, legislative, judicial,
quasi-judicial, regulatory or administrative function of government. 
 2.25
    “IFMI, LLC” means IFMI, LLC, a Delaware limited liability company and a majority owned Subsidiary. 

  
 4 

 2.26     “IFMI LLC Agreement”
means the Amended and Restated Limited Liability Company Agreement of IFMI, LLC, dated as of December 16, 2009 by and among the Company and the Members (as defined therein) that are signatories thereto, as amended. 

2.27     “Judgment” means any order, ruling, writ, injunction, fine,
citation, award, decree, or any other judgment of any nature whatsoever of any Governmental Authority. 
 2.28
    “Knowledge of the Company” or words to that effect means the actual knowledge of any of the following Persons: Daniel G. Cohen, Joseph W. Pooler, Jr., Douglas Listman, Rachael Fink, Stephan Burklin and
James J. McEntee, III; provided, that for purposes of this definition such Persons shall be deemed to have actual knowledge of facts that would be reasonably expected to come to the attention of such Person in performing his or her duties in
accordance with the Company’s or any relevant Subsidiary’s ordinary management practices. 
 2.29
    “Law” means any provision of any law, statute, ordinance, code, constitution, charter, treaty, rule or regulation of any Governmental Authority. 

2.30     “Material Adverse Effect” means any circumstance, event, change,
development, effect or occurrence that, individually or in the aggregate, (i) is or would reasonably be expected to be materially adverse to the Company’s financial position, results of operations, business, condition (financial or
otherwise) or Assets of the Company and its Subsidiaries, taken as a whole or (ii) would materially impair the ability of the Company to perform its obligations under this Agreement or otherwise materially threaten or materially impede the
consummations of the transactions contemplated herein; provided, however, that in the case of clause (i) only, any circumstance, event, change, development, effect or occurrence that results from any of the following shall be disregarded in
determining whether there has been or would be a “Material Adverse Effect” on the Company (except to the extent that such circumstance, event, change, development, effect or occurrence has a disproportionate adverse effect on the Company
and the Subsidiaries relative to other companies engaged in a similar business as the Company): (A) changes, after the Effective Date, in GAAP; (B) changes, after the Effective Date, in Laws or interpretations thereof applicable to the
Company or the Subsidiaries by any Governmental Authority; (C) general changes in the national or world economy or securities markets generally; (D) changes in the price or trading volume of the Common Stock on the Trading Market (but not
the underlying causes of such changes); or (E) the outbreak or escalation of war or hostilities, any occurrence or threats of terrorist acts or any armed hostilities associated therewith or any national or international calamity, disaster or
emergency or escalation thereof. 
 2.31     “Meeting” means any
meeting of the stockholders of the Company at which the election of Directors is to be voted upon, however called (and including any postponement or adjournment of any such meeting) and any written consent of the stockholders of the Company with
respect to the election of Directors. 
 2.32     “Obligation” means
any debt, liability or obligation of any nature whatsoever, whether secured, unsecured, recourse, nonrecourse, liquidated, unliquidated, accrued, absolute, fixed, contingent, ascertained, unascertained, known, unknown or obligations under executory
Contracts. 

  
 5 

 2.33     “Permit” means any
license, permit, approval, waiver, order or authorization granted, issued or approved by any Governmental Authority. 
 2.34     “Person” means any individual, sole proprietorship, joint venture, partnership, company, corporation, association, cooperation, trust, estate,
Governmental Authority, or any other entity of any nature whatsoever. 
 2.35
    “PrinceRidge” means C&Co/PrinceRidge Holdings LP (formerly known as PrinceRidge Holdings LP), an indirect Subsidiary. 

2.36     “Principal” of any Person means, at the time of determination, each
principal, partner or member of such Person, any spouse or child of each principal, partner or member, and any trust for the benefit of each principal, partner or member or each such principal’s, partner’s or member’s spouse or lineal
descendants. 
 2.37     “Proceeding” means any demand, claim, suit,
action, litigation, investigation, audit, study, arbitration, administrative hearing, or any other proceeding of any nature whatsoever. 
 2.38     “Sandler O’Neill” means Sandler O’Neill & Partners, L.P., the independent financial advisor to the Special Committee. 

2.39     “Securities” means, together, the Common Shares and the Note.

 2.40     “Shell Company” means an issuer that meets the
description of a shell company as defined under Rule 144. 
 2.41
    “Significant Subsidiary” means each of the significant subsidiaries (as such term is defined in Rule 1-02(w) of Regulation S-X) of the Company, as set forth in the Company’s SEC Documents.

 2.42     “Special Committee” means the special committee of
independent directors of the Board of Directors formed in connection with the transactions contemplated by this Agreement and the Transaction Documents. 
 2.43     “Subsidiary” means each subsidiary of the Company. 
 2.44     “Tax” means (i) any foreign, federal, state or local income, profits, gross receipts, franchise, sales, use, occupancy, general property, real
property, personal property, intangible property, transfer, excise, accumulated earnings, unemployment compensation, social security, withholding taxes, payroll taxes, or any other tax of any nature whatsoever, (ii) any foreign, federal, state
or local organization fee, qualification fee, annual report fee, filing fee, occupation fee, or assessment, or (iii) any deficiency, interest or penalty imposed with respect to any of the foregoing. 

2.45     “Tax Return” means any tax return, filing, declaration, information
statement or other form or document required to be filed in connection with or with respect to any Tax. 

  
 6 

 2.46     “Trading Market” means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange or the OTC Bulletin Board (or any successors to any of the foregoing). 
 2.47
    “Transaction Documents” means (i) any documents or instruments to be executed by the Company, Cohen Bros., Buyer, Mead Park and IFMI, LLC in connection with this Agreement, including the Note, and
the Registration Rights Agreement; and (ii) the Voting Agreements, together, in each case, with all modifications, amendments, extensions, future advances, renewals, and substitutions thereof and thereto. 

2.48     “Voting Agreement Signatories” means, collectively, Daniel G. Cohen,
Christopher Ricciardi, Stephanie Ricciardi, The Ricciardi Family Foundation, James J. McEntee, III, Joseph W. Pooler, Jr., Doug Listman, Rachael Fink, Walter Beach, Rodney E. Bennett, Thomas P. Costello, G. Steven Dawson, Joseph M. Donovan, Jack
Haraburda, Lance Ullom, Charles W. Wolcott and Neil S. Subin. 
 In addition, the following terms shall have the
respective meanings ascribed to them in the corresponding Sections: 
  

			
	Term	  	Section
	 2013 Annual Meeting of Stockholders
	  	 Section 6.8

	 8-K Filing
	  	 Section 6.6

	 Agreement
	  	 Preamble

	 Amended and Restated Cohen Employment Agreement
	  	 Recitals

	 Articles of Incorporation
	  	 Section 5.1

	 Benefit Plan
	  	 Section 5.18

	 Buyer
	  	 Preamble

	 Buyer Indemnified Parties
	  	 Section 9.1

	 Bylaws
	  	 Section 5.1

	 Closing
	  	 Section 3.2

	 Closing Date
	  	 Section 3.2

	 Code
	  	 Recitals

	 Cohen Note
	  	 Recitals

	 Cohen Purchase Agreement
	  	 Recitals

	 Cohen Shares
	  	 Recitals

	 Common Share(s)
	  	 Recitals

	 Common Stock
	  	 Recitals

	 Common Stock Purchase Price
	  	 Recitals

	 Company
	  	 Preamble

	 Company Indemnified Parties
	  	 Section 9.2

	 Company Proxy Statement
	  	 Section 6.8

	 Effective Date
	  	 Preamble

	 Employees
	  	 Section 5.18

	 ERISA
	  	 Section 5.18

	 ERISA Plans
	  	 Section 5.18

  
 7 

			
	Term	  	Section
	 Exchange Agreement
	  	 Recitals

	 Investment Company Act
	  	 Section 5.17

	 Financial Statements
	  	 Section 5.7

	 LLC Agreement Amendment
	  	 Recitals

	 Listing Application
	  	 Section 6.7

	 Mead Park
	  	 Preamble

	 Minority Board Representative
	  	 Section 6.9(c)i(A)

	 Minority Ownership Interest
	  	 Section 6.9(c)i

	 New Security
	  	 Section 6.10(a)

	 Note
	  	 Recitals

	 Note Purchase Price
	  	 Recitals

	 Pension Plan
	  	 Section 5.18

	 Qualifying Board Representatives
	  	 Section 6.9(b)

	 Qualifying Ownership Interest
	  	 Section 6.9(b)

	 Registration Rights Agreement
	  	 Recitals

	 Rule 144
	  	 Section 5.21

	 Rule 144 Certificate
	  	 Section 6.2(b)ii

	 SEC
	  	 Recitals

	 SEC Documents
	  	 Section 5.7

	 Securities Act
	  	 Recitals

	 Securities Being Sold
	  	 Section 6.2(b)ii

	 Share Reserve
	  	 Section 6.5

	 Shareholder Rights Plan
	  	 Recitals

	 Stockholder Proposal
	  	 Section 6.8

	 Transaction Deadline
	  	 Section 10.1(b)ii

	 Voting Agreements
	  	 Recitals

 ARTICLE III 
 PURCHASE AND SALE OF SECURITIES 
 3.1
      Purchase and Sale of Securities.   Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, on the Closing Date, (i) Buyer agrees to purchase the
Securities; and (ii) the Company agrees to sell and to issue to Buyer the Securities for the aggregate amount of the Common Stock Purchase Price and the Note Purchase Price. 

3.2       Closing.   The closing (the
“Closing”) of the transactions contemplated hereby will occur at the offices of Duane Morris LLP, 30 South 17th Street, Philadelphia, Pennsylvania, commencing at 9:00 a.m. local time on the second (2nd) business day after the satisfaction or waiver of all
conditions in Article VII and Article VIII (other than conditions with respect to actions that the respective parties hereto will take at the Closing), or at such other location and on such other date as the parties mutually determine (the
“Closing Date”). 
 3.3       Form of Payment; Delivery
of Securities.  Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, on the Closing Date, (i) Buyer shall deliver to the Company the Common Stock Purchase Price and the Note Purchase Price, in the
form of wire transfers of immediately available U.S. funds; and (ii) the Company shall deliver to Buyer the Securities, duly executed on behalf of the Company, together with any other documents required to be delivered pursuant to this
Agreement. 

  
 8 

 ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES OF BUYER 
 Buyer represents
and warrants to the Company that: 
 4.1       Organization;
Authority.  Buyer is duly organized, validly existing under the laws of the jurisdiction of its organization with the requisite limited liability company power and authority to enter into and to consummate the transactions contemplated
by this Agreement and by each of the Transaction Documents to which Buyer is a party and otherwise to carry out its obligations hereunder and thereunder. The execution, delivery and performance by Buyer of this Agreement and of each of the
Transaction Documents to which Buyer is a party have been duly authorized by all necessary limited liability company action, on the part of Buyer. Each of this Agreement and the Transaction Documents to which Buyer is a party has been (or upon
delivery will have been) duly executed by Buyer, and, when delivered by Buyer in accordance with the terms hereof and thereof, will constitute the valid and legally binding obligation of Buyer, enforceable against it in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other
equitable principles of general application. 
 4.2       No
Conflicts.    The execution, delivery and performance by Buyer of this Agreement and the Transaction Documents to which Buyer is a party and the consummation by Buyer of the transactions contemplated hereby and thereby will
not (i) result in a violation of the organizational documents of Buyer, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any Contract, indenture or instrument to which Buyer is a party, or (iii) result in a violation of any Law, rule, regulation, order, judgment or decree (including federal and state
securities Laws) applicable to Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material
adverse effect on the ability of Buyer to perform its obligations hereunder. 
 4.3
      Investment Purpose.   Buyer understands that the Securities are not, and the Conversion Shares will not be, registered under the Securities Act or any applicable state securities Laws
(subject to the Registration Rights Agreement). Buyer is acquiring the Securities and, upon exercise of the Note (if applicable), will acquire the Conversion Shares issuable upon exercise thereof, as principal for its own account for investment only
and not with a view to or for the purpose of distributing or reselling such Securities or Conversion Shares (if applicable) or any part thereof in violation of the Securities Act or any applicable state securities Laws. Buyer does not presently have
any agreement, plan or understanding, directly or indirectly, with any Person to distribute or effect any distribution of any of the Securities or the Conversion Shares (if applicable) (or any securities which are derivatives thereof) to or through
any person or entity; Buyer is not a registered broker-dealer under Section 15 of the Exchange Act or an entity engaged in a business that would require it to be so registered as a broker-dealer. 

  
 9 

 4.4       Accredited Buyer Status;
Experience of Buyer.  At the time Buyer was offered the Securities, it was, on each date on which it acquires Securities it will be, and on each date on which it exercises the Note (if applicable) it will be, an “accredited
investor” as defined in Rule 501(a) under the Securities Act. Buyer, either alone or together with its representatives (if any), has such knowledge, sophistication and experience in business and financial matters so as to be capable of
evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Buyer acknowledges that it can bear the economic risk and complete loss of its investment in the
Securities. 
 4.5       Residency.  Buyer has its principal
place of business in the State of New York. 
 4.6       Reliance on
Exemptions.  Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities Laws and that the Company is
relying upon the truth and accuracy of, and Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of Buyer set forth herein in order to determine the availability of such exemptions and the
eligibility of Buyer to acquire the Securities. 
 4.7
      Information.  Buyer and its advisors have been furnished with all materials relating to the business, finances and operations of the Company and information Buyer deemed material to making an
informed investment decision regarding its purchase of the Securities, which have been requested by Buyer. Buyer and its advisors have been afforded with the opportunity to ask questions of the Company and its management. Buyer has sought such
accounting, legal, tax and other professional advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities. 

4.8       Restrictions on Transferability.   Buyer understands that
because the Securities have not have been registered under the Securities Act, Buyer cannot dispose of any or all of the Securities unless such Securities are subsequently registered under the Securities Act or exemptions from registration are
available. Buyer acknowledges and understands that, except as provided in the Registration Rights Agreement, it has no registration rights. By reason of these restrictions, Buyer understands that it may be required to hold the Securities for an
indefinite period of time. Buyer understands that each certificate or other instrument representing the Securities and the Conversion Shares will bear appropriate legends reflecting the foregoing as well as state “blue sky” legends. In
addition, appropriate transfer restrictions will be affixed to any notation in the DRS for any Securities or Conversion Shares. 
 4.9       Brokers and Finders.   Buyer has not employed any Person, or incurred any liability, for any financial advisory, brokerage or finder’s
fee or commission, and no broker or finder has acted directly or indirectly for Buyer, in connection with the transactions contemplated by this Agreement and the Transactions Documents. 

4.10     Independent Investment Decision.   Buyer has evaluated, independently
of the Company, the merits of its decision to purchase the Securities pursuant to this Agreement and the Transaction Documents. Buyer understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the
Buyer in connection with the purchase of the Securities constitutes legal, tax or investment advice. 

  
 10 

 ARTICLE V 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 Except as
set forth and disclosed in the disclosure schedule attached to this Agreement and made a part hereof or as set forth in the SEC Documents (excluding any risk factor disclosures contained in such documents under the heading “Risk Factors”
and any disclosure of risks included in any “forward-looking statements” disclaimer or other statements, in each case, that are predictive or forward-looking in nature), the Company hereby makes the following representations and warranties
to Buyer: 
 5.1        Organization and
Qualification.   The Company is an entity duly incorporated, validly existing and in good standing under the laws of the State of Maryland, with the requisite power and authority to own or lease and use its properties and Assets
and to carry on its business as currently conducted and as currently proposed to be conducted. The Company is not in violation of any of the provisions of the Articles of Incorporation or the Bylaws. The Company is duly qualified to conduct business
and is in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the
case may be, would not have or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, and no Proceeding has been instituted, is pending, or, to the Knowledge of the Company, is threatened in any such
jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. The Company has furnished or made available to Buyer true, complete and correct copies of: (A) the Company’s
Articles of Incorporation, as amended and as in effect on the Effective Date (the “Articles of Incorporation”); and (B) the Company’s Bylaws, as in effect on the Effective Date (the
“Bylaws”). 
 5.2       Authorization; Enforcement;
Validity.  The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and by each of the Transaction Documents to which it is a party and otherwise to
carry out its obligations hereunder and thereunder. The execution, delivery and performance by the Company of this Agreement and of each of the Transaction Documents to which it is a party and the consummation by it of the transactions contemplated
hereby and thereby (including, but not limited to, the issuance, sale and delivery of the Securities and the reservation for issuance and the subsequent issuance of the Conversion Shares upon exercise of the Note) have been duly authorized by all
necessary corporate action on the part of the Company, and, other than the approval by the Company’s stockholders of the Stockholder Proposal, no further corporate action is required by the Company, the Board of Directors or its stockholders in
connection herewith and therewith. Each of this Agreement and the Transaction Documents to which the Company is a party has been (or upon delivery will have been) duly and validly executed by the Company and is, or when delivered in accordance with
the terms hereof will constitute, the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application. The Board of Directors has resolved that the transactions
contemplated by this Agreement and the Transaction Documents are in the best interests of stockholders of the Company. 

  
 11 

 5.3
      Capitalization.   The authorized capital stock of the Company consists of: (a) 100,000,000 shares of Common Stock, of which 12,237,104 shares of Common Stock are issued and outstanding
as of the Effective Date; (b) 10,000,000 shares of Preferred Stock, par value $0.001 per share, all of which are designated as Series C Junior Participating Preferred Stock, none of which are issued or outstanding as of the Effective Date; and
(c) 50,000,000 shares of Preferred Stock, par value $0.001 per share, of which 4,983,557 shares are designated as Series E Voting Non-Convertible Preferred Stock, all of which are issued and outstanding as of the Effective Date. All outstanding
shares of Common Stock and Series E Voting Non-Convertible Preferred Stock have been duly authorized, validly issued and are fully paid and nonassessable. The Common Stock is currently quoted on the NYSE MKT under the trading symbol
“IFMI,” and the Company has maintained all requirements on its part for the continuation of such quotation. No shares of Common Stock are subject to preemptive rights or any other similar rights. Except as contemplated hereby and as set
forth on Schedule 5.3 hereto, as of the Effective Date: (i) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any
shares of capital stock of the Company, or Contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of capital stock of the Company, or options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company; (ii) there are no outstanding debt securities, notes, credit agreements, credit
facilities or other Contracts or instruments evidencing indebtedness of the Company, or by which the Company is or may become bound; (iii) there are no agreements or arrangements under which the Company is obligated to register the sale of any
of its securities under the Securities Act (except pursuant to the Registration Rights Agreement); (iv) there are no financing statements securing any obligations of the Company; (v) there are no securities or instruments containing
anti-dilution or similar provisions that will be triggered by this Agreement or any related agreement or the consummation of the transactions described herein or therein; and (vi) there are no outstanding securities or instruments of the
Company which contain any redemption or similar provisions, and there are no Contracts by which the Company is or may become bound to redeem a security of the Company. Schedule 5.3 attached hereto contains a pro forma beneficial ownership table for
the Company giving effect to the transactions contemplated by this Agreement and the other Transaction Documents. 
 5.4       Subsidiaries.  Except as set forth on Schedule 5.4 hereto, the Company has no other Subsidiaries and all shares of the outstanding capital stock of
each Subsidiary are owned directly or indirectly by the Company. All of such shares so owned by the Company are duly authorized, validly issued and are fully paid and nonassessable, and are owned by it free and clear of any Encumbrance with respect
thereto. Each Significant Subsidiary is an entity duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and has the requisite power and authority to own or lease and use its properties and Assets
and to carry on its business as currently conducted and as currently proposed to be conducted, in each case except as would not reasonably be expected to have a Material Adverse Effect on the Company. Except as set forth on Schedule 5.4 hereto, the
Company does not own beneficially, directly or indirectly, more than five percent (5%) of any class of equity securities or similar interests of any organization, and is not, directly or indirectly, a partner in any partnership or party to any
joint venture. Except as set forth on Schedule 5.4 hereto, no equity security of any Subsidiary is or may be required to be issued by reason of any option, warrant, scrip, right to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital stock of such Subsidiary, and there are no Contracts, commitments, understandings or arrangements by which any Subsidiary is or may become bound to issue additional shares
of its capital stock, or any option, warrant, scrip, right to subscribe to, call or commitment of any character whatsoever relating to, or securities or rights convertible into, any shares of its capital stock. 

  
 12 

 5.5       No Conflicts; Consents and
Approvals.  The execution, delivery and performance of this Agreement and the Transaction Documents, and the consummation of the transactions contemplated hereby and thereby, including the issuance, sale and delivery of any of the
Securities and the Conversion Shares, and compliance by the Company with any provisions of the Transaction Documents will not: (i) constitute or result in a violation of or conflict with the Articles of Incorporation, Bylaws, or any other
organizational or governing documents of Company or any Subsidiary; (ii) constitute or result in a violation of, or a default or breach under (either immediately, upon notice, upon lapse of time, or both), or conflicts with, or gives to any
other Person any rights of termination, amendment, acceleration or cancellation of, any provision of any Contract, indenture or instrument to which Company or any Subsidiary is a party or by which it may be bound, or to which the Company or any
Subsidiary or any of their Assets or properties may be bound (other than immaterial contracts relating to back office operations, systems and facilities or similar matters); (iii) constitute a violation of, or a default or breach under (either
immediately, upon notice, upon lapse of time, or both), or conflicts with, any Judgment; (iv) assuming that, in connection with the transactions contemplated hereby, the parties hereto timely make all of the filings required by applicable state
securities Laws and under the applicable rules and regulations of the Trading Market constitute a violation of, or conflict with, any Law, rule, regulation, order, judgment or decree (including federal and state securities Laws); or (v) result
in the loss or adverse modification of, or the imposition of any fine, penalty or other Encumbrance with respect to, any Permit granted or issued to, or otherwise held by or for the use of, the Company or any Subsidiary or any of the their Assets or
properties; except, in the case of clause (v), for such violations, defaults, breaches, conflicts, losses, modifications or impositions that have not had and would not reasonably be expected to have a Material Adverse Effect. The Company is not in
default or breach (and no event has occurred which with notice or lapse of time or both could put the Company in default or breach) under, and the Company has not taken any action or failed to take any action that would give to any other Person any
rights of termination, amendment, acceleration or cancellation of, any material Contract to which the Company is a party or by which any property or Assets of the Company are bound or affected. Except with respect to the SEC and the Trading Market
and as specifically contemplated by this Agreement or the Transaction Documents, the Company is not required to obtain any Consent of, from, or with any Governmental Authority, or any other Person, and no expiration or termination of any statutory
waiting period is necessary, in order for the Company to execute, deliver or perform any of its obligations under this Agreement and the Transaction Documents in accordance with the terms hereof or thereof, or to issue, sell and deliver the
Securities and the Conversion Shares in accordance with the terms hereof and thereof. All Consents which the Company is required to obtain pursuant to the immediately preceding sentence have been obtained or effected on or prior to the Effective
Date or will be obtained or effected on or prior to Closing or as otherwise required under the rules and regulations of the applicable Governmental Authority. 

  
 13 

 5.6       Issuance of
Securities.  The Securities to be issued pursuant to this Agreement have been duly authorized by all necessary corporate action of the Company and, upon issuance in accordance with the terms hereof, the Common Shares, the Note and the
Conversion Shares, as applicable, shall be duly and validly issued, fully paid and non-assessable, and free from all Encumbrances with respect to the issue thereof, and, assuming the accuracy of the representations and warranties of Buyer set forth
in Article IV above, will be issued in compliance with all applicable United States federal and state securities Laws. 
 5.7       Listing and Maintenance Requirements; SEC Documents; Financial Statements.  The Company’s Common Stock is registered pursuant to
Section 12(b) of the Exchange Act, and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act, nor has the Company received any notification
that the SEC is contemplating terminating such registration. The Company has filed all reports, schedules, forms, statements and other documents, together with any amendments thereto, required to be filed by it with the SEC under the Exchange Act
(all of the foregoing filed within the two (2) years preceding the Effective Date and all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference therein, being hereinafter referred to as
the “SEC Documents”). The Company is current with its filing obligations under the Exchange Act and there are no outstanding comments from the SEC with respect to any report, schedule, form, statement and other document
required to be filed by it with the SEC under the Exchange Act. The Company represents and warrants that true and complete copies of the SEC Documents are available on the SEC’s website (www.sec.gov) at no charge. As of their respective dates,
the SEC Documents complied in all material respects with the applicable requirements of the Exchange Act, and none of the SEC Documents, at the time they were filed with or furnished to the SEC, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. No executive officer of the Company has failed in any
respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act of 2002. To the Knowledge of the Company as of the Effective Date, there are no facts or circumstances that would prevent its current
Chief Executive Officer and Chief Financial Officer from giving the certifications and attestations required pursuant to Rules 13a-14 and 15d-14 under the Exchange Act, without qualification, with respect to the Quarterly Report on Form 10-Q for the
fiscal quarter ended March 31, 2013. As of their respective dates, the financial statements of the Company included in the SEC Documents (collectively, the “Financial Statements”) (i) have been prepared from the
books and records of the Company and the Subsidiaries, (ii) complied in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (iii) have been prepared in
accordance with GAAP, consistently applied during the periods involved and (iv) fairly present in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations
and comprehensive income/loss, changes in equity and cash flows for the periods then ended, subject, in the case of unaudited statements, to the absence of notes and normal year-end audit adjustments. 

  
 14 

 5.8       Absence of Certain
Changes.  Except as otherwise disclosed to Buyer in writing on or prior to the date hereof, since the date upon which the last of the SEC Documents was filed with the SEC, there has been no event or circumstance of any nature
whatsoever that has resulted in, or would reasonably be expected to result in, a Material Adverse Effect. 
 5.9
      Absence of Litigation; No Undisclosed Liabilities.  Except as otherwise disclosed to Buyer in writing on or prior to the date hereof or as would not reasonably be expected to have a Material
Adverse Effect, (i) there is no Proceeding before or by any Governmental Authority or any other Person, pending, or to the Knowledge of the Company, threatened or contemplated by, against or affecting the Company or any Subsidiary, or their
Assets; and (ii) there are no outstanding Judgments against or affecting the Company, any Subsidiary, or their Assets. There are no obligations that are not appropriately reflected or reserved against in the financial statements described in
Section 5.7 to the extent required to be so reflected or reserved against in accordance with GAAP, except for (i) liabilities that have arisen since December 31, 2012 in the ordinary course of business consistent with past practice
and (ii) liabilities that have not had and would not reasonably be expected to have a Material Adverse Effect. 
 5.10     Title to Assets.  Except as set forth on Schedule 5.10 hereto, the Company or a Significant Subsidiary has good and marketable title to, or a valid leasehold
interest in, all of its Assets which are material to the business and operations of the Company and the Significant Subsidiaries as presently conducted, free and clear of all Encumbrances or restrictions on the transfer or use of same. Except as
would not have a Material Adverse Effect, the Company’s Assets are in good operating condition and repair, ordinary wear and tear excepted. 
 5.11     Compliance with Laws.  The Company and the Subsidiaries (i) are in material compliance with all applicable Laws and Judgments; (ii) to the Knowledge
of the Company, have all material Permits and such Permits are in full force and effect and no material suspension or cancellation of any of them is threatened; and (iii) to the Knowledge of the Company, are not under investigation with respect
to, and have not been threatened to be charged with or given notice of, any material violation of all applicable Laws and Judgments. 
 5.12     No Directed Selling Efforts or General Solicitation.  Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has
conducted any “general solicitation” or “general advertising” (as those terms are used in Regulation D promulgated under the Securities Act) in connection with the offer or sale of any of the Securities. 

5.13     Tax Matters.  The Company and each of its Affiliates has made and timely
filed all United States federal income Tax Returns and all foreign income Tax Returns and all other material Tax Returns required to be filed by it, and each such Tax Return has been prepared in material compliance with all applicable Laws, and all
such Tax Returns are true and accurate in all material respects. Except and only to the extent that the Company or any of its Affiliates, as the case may be, has set aside on its books provisions reasonably adequate for the payment of all unpaid and
unreported Taxes, the Company and each of its Affiliates has timely paid all Taxes shown or determined to be due on such Tax Returns, except those being contested in good faith, and the Company and each of its Affiliates has set aside on its books
provision reasonably adequate for the payment of all Taxes for periods subsequent to the periods to which such Tax Returns apply. There are no unpaid Taxes of the Company or any of its Affiliates in any material amount claimed to be due by the
taxing authority of any jurisdiction, and, to the Knowledge of the Company, no basis for any such claim. The Company and each of its Affiliates has withheld and paid all Taxes to the appropriate Governmental Authority required to have been withheld
and paid in connection with amounts paid or owing to any Person. There is no Proceeding or Claim for refund now in progress, pending or threatened against or with respect to the Company or any of its Affiliates, in each case, regarding Taxes.
Neither the Company nor any of its Affiliates has waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency, in each case, that is still in effect, or has pending a
request for any such extension or waiver. Neither the Company nor any of its Affiliates has entered into any “listed transaction” within the meaning of Treasury Regulations section 1.6011-4(b)(2). Neither the Company nor any of its
Affiliates has liability for the Taxes of any person other than the Company or any of its Affiliates under Treasury Regulations section 1.1502-6 (or any similar provision of state, local or foreign law). Neither the Company nor any of its Affiliates
is party to, bound by or has any obligation under any Tax allocation, Tax sharing, Tax indemnity or similar agreement, arrangement or understanding (other than any agreement, arrangement or understanding solely among the Company and its Affiliates).
Neither the Company nor any of its Affiliates is currently subject to a section 382 limitation, as defined in section 382 of the Code, with respect to any of its Tax attributes. The representation made in the previous sentence will be true
immediately after the end of the Closing Date. The aggregate amount of the net operating loss carryovers for United States federal income tax purposes of the Company and its Affiliates as of December 31, 2011 equals or exceeds $88,830,601 and
as of December 31, 2012, as currently estimated in good faith by the Company (but subject to future adjustment), equals or exceeds $86,051,682, and Schedule 5.13 attached hereto sets forth the dates on which such net operating loss
carryforwards expire. The aggregate amount of the net capital loss carryovers for United States federal income tax purposes of the Company and its Affiliates as of December 31, 2011 equals or exceeds $41,251,297 and as of December 31,
2012, as currently estimated in good faith by the Company (but subject to future adjustment), equals or exceeds $58,892,311, and Schedule 5.13 attached hereto sets forth the dates on which such net capital loss carryforwards expire. 

  
 15 

 5.14     Internal Accounting
Controls.  The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to Assets is permitted only in accordance with management’s general
or specific authorization; and (iv) the recorded accountability for Assets is compared with the existing Assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company (A) has implemented and
maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that material information relating to the Company, including its consolidated Subsidiaries, is made known to the Chief Executive Officer and
the Chief Financial Officer of the Company by others within those entities, and (B) has disclosed, based on its most recent evaluation prior to the date of this Agreement, to the Company’s outside auditors and the audit committee of the
Board of Directors (x) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that are reasonably likely to adversely
affect the Company’s ability to record, process, summarize and report financial information, and (y) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal
controls over financial reporting. Since December 31, 2010, (i) neither the Company nor any Subsidiary nor, to the Knowledge of the Company, any director, officer, employee, auditor, accountant or representative of the Company or any
Subsidiary has received, or otherwise had or obtained knowledge of, any complaint, allegation, assertion or claim that the Company or any Subsidiary has engaged in questionable accounting or auditing practices, and (ii) no attorney representing
the Company or any Subsidiary, whether or not employed by the Company or any Subsidiary, has reported evidence of a material violation of securities laws, breach of fiduciary duty or similar violation by the Company or any of its officers,
directors, employees or agents to the Board of Directors or any committee thereof or to any director or officer of the Company. 

  
 16 

 5.15     Acknowledgment Regarding Buyer’s
Purchase of the Securities.  The Company acknowledges and agrees that Buyer is acting solely in the capacity of an “arm’s length” purchaser with respect to this Agreement and the transactions contemplated hereby. The
Company further acknowledges that Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any advice given by Buyer or any of its
representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to Buyer’s purchase of the Securities. The Company further represents to Buyer that the Company’s decision to enter
into this Agreement has been based solely on the independent evaluation by the Company and its representatives. 

5.16     Brokerage Fees.  There is no Person acting on behalf of the Company as
placement agent in connection with the transactions contemplated hereby, and, other than the Special Committee’s retention of Sandler O’Neill, there is no Person acting on behalf of the Company who is entitled to or has any claim for any
financial advisory, brokerage or finder’s fee or commission in connection with the execution of this Agreement or the transactions contemplated hereby. 
 5.17     Investment Company.  The Company is not an “investment company” as defined under the Investment Company Act of 1940, as amended (the
“Investment Company Act”), and the Company does not sponsor any person that is such an investment company. 

  
 17 

 5.18     Employee Matters.  All benefit
and compensation plans, contracts, policies, programs or arrangements covering current or former employees, Directors and consultants of the Company and its Subsidiaries (the “Employees”), including, but not limited to,
“employee benefit plans” within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and employment, consulting, retirement, pension, severance, termination,
change in control, vacation, deferred compensation, stock option, stock purchase, stock appreciation rights, equity based, incentive, bonus, profit sharing, insurance, medical, welfare, fringe or other benefit plans, contracts, policies, programs or
arrangements (the “Benefit Plans”) are listed in this Schedule 5.18 attached hereto, and each Benefit Plan which has received a favorable opinion letter from the Internal Revenue Service National Office, including any master
or prototype plan, has been separately identified. All Benefit Plans are in substantial compliance with ERISA, the Code and other applicable laws. Each Benefit Plan which is subject to ERISA (the “ERISA Plans”) that is an
“employee pension benefit plan” within the meaning of Section 3(2) of ERISA (“Pension Plan”) and that is intended to be qualified under Section 401(a) of the Code, has received a favorable determination
letter from the Internal Revenue Service and, to the Knowledge of the Company, there are no circumstances likely to result in revocation of any such favorable determination letter or the loss of the qualification of such Pension Plan under
Section 401(a) of the Code. Neither the Company nor any Subsidiary has engaged in a transaction with respect to any ERISA Plan that, assuming the taxable period of such transaction expired as of the Effective Date, could subject the Company or
any Subsidiary to a tax or penalty imposed by either Section 4975 of the Code or Section 502(i) of ERISA in an amount which would be material. Neither the Company nor any of the Subsidiaries has incurred or reasonably expects to incur a
material tax or penalty imposed by Section 4980F of the Code or Section 502 of ERISA. Neither the Company, any Subsidiary nor any entity which is considered one employer with the Company under Section 4001 of ERISA or Section 414
of the Code (x) maintains or contributes to or has within the past six years maintained or contributed to a Pension Plan that is subject to Subtitles C or D of Title IV of ERISA or (y) maintains or has an obligation to contribute to or has
within the past six years maintained or had an obligation to contribute to a multiemployer plan, as defined in Section 3(37) of ERISA. All contributions required to be made under each Benefit Plan, as of the Effective Date, have been timely
made and all obligations in respect of each Benefit Plan have been properly accrued and reflected in the Financial Statements. As of the Effective Date, there is no material pending or, to the Knowledge of the Company threatened, litigation relating
to the Benefit Plans. Neither the Company nor any Subsidiary has any obligations for retiree health and life benefits under any Benefit Plan or collective bargaining agreement. The Company or its Subsidiaries may amend or terminate any such retiree
health and life plan at any time without incurring any liability thereunder other than in respect of claims incurred prior to such amendment or termination. There has been no amendment to, announcement by the Company or any Subsidiary relating to,
or change in participation or coverage under, any Benefit Plan which would increase materially the expense of maintaining such plan above the level of the expense incurred therefor for the most recent fiscal year. None of the transactions
contemplated by this Agreement or the other Transaction Documents, individually or in the aggregate, (i) constitute a “change in control” or “change of control” (or phrases of similar import) within the meaning of any
Benefit Plan, (ii) result in any payment or benefit (including severance, unemployment compensation, “excess parachute payment” (within the meaning of Section 280G of the Code), forgiveness of indebtedness or otherwise) becoming
due to any Employee, the Directors or any consultant of the Company or any Subsidiary under any Benefit Plan, (iii) result in payments under any of the Benefit Plans which would not be deductible under Section 162(m) of the Code,
(iv) increase any compensation or benefits otherwise payable under any Benefit Plan, (v) result in any acceleration of the time of payment or vesting of any such benefits, (vi) require the funding or increase in the funding of any
such benefits, or (vii) result in any limitation on the right of the Company or any Subsidiary to amend, merge, terminate or receive a reversion of assets from any Benefit Plan or related trust. 

5.19     Risk Management; Derivatives.  The Company and the Significant Subsidiaries
have in place risk management policies and procedures designed to protect against material risks of the type and in amounts reasonably expected to be incurred by Persons of similar size and in similar lines of business as the Company and the
Significant Subsidiaries. 

  
 18 

 5.20       Foreign Corrupt Practices and
International Trade Sanctions.   To the Knowledge of the Company, neither the Company nor any Subsidiary, nor any of their respective directors, officers, agents, employees or any other persons acting on their behalf (i) has
violated the Foreign Corrupt Practices Act, 15 U.S.C. § 78dd-1 et seq., as amended, or any other similar applicable foreign, federal, or state legal requirement; (ii) has made or provided, or caused to be made or provided, directly or
indirectly, any payment or thing of value to a foreign official, foreign political party, candidate for office or any other person knowing that the person shall pay or offer to pay the foreign official, party or candidate, for the purpose of
influencing a decision, inducing an official to violate their lawful duty, securing any improper advantage, or inducing a foreign official to use their influence to affect a governmental decision; (iii) has paid, accepted or received any
unlawful contributions, payments, expenditures or gifts; (iv) has violated or operated in noncompliance with any export restrictions, money laundering law, anti-terrorism law or regulation, anti-boycott regulations or embargo regulations; or
(v) is currently subject to any United States sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department. 
 5.21       Rule 144.   With a view to making available to Buyer the benefits of Rule 144 promulgated under the Securities Act (“Rule
144”), or any similar rule or regulation of the SEC that may at any time permit Buyer to sell any of the Securities to the public without registration, the Company represents and warrants that: (i) the Company is, and has been for
a period of at least ninety (90) days immediately preceding the Effective Date, subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; (ii) the Company has filed all required reports under Section 13 or
15(d) of the Exchange Act, as applicable, during the twelve (12) months preceding the Closing Date (or for such shorter period that the Company was required to file such reports); and (iii) the Company is not and has not been an issuer
defined as a Shell Company. 
 Buyer acknowledges and agrees that the Company makes no representations or
warranties whatsoever, express or implied, except for those specifically set forth in this Article V, in any certificate delivered hereto or in any other Transaction Document. 
 ARTICLE VI 
 COVENANTS 

6.1         Use of Proceeds.   The proceeds from the purchase
and sale of the Securities shall be used by the Company for general corporate purposes. 
 6.2
       Affirmative Covenants of the Company.   Following the Closing, for so long as Buyer, Mead Park and its or their controlled Affiliates and Principals collectively own ten percent
(10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock), unless waived in writing by Buyer: 

(a)       Reporting Status; Listing.   The Company shall (i) file
all reports required to be filed under the Securities Act, under the Exchange Act, under any federal or state securities Laws and regulations applicable to the Company, and under the rules and regulations of the Trading Market; and (ii) comply
in all material respects with the Company’s required reporting, filing and other obligations under the Bylaws or rules of the Trading Market. 

  
 19 

 (b)        Rule 144. The
Company shall: 
   i.          use its reasonable
best efforts to make, keep and ensure that adequate current public information with respect to the Company, as required in accordance with Rule 144, is publicly available; 

 ii.          furnish to Buyer, promptly upon reasonable request, such
statements, reports, documents or other information as may be reasonably requested by Buyer to permit Buyer to sell any of the Securities or Conversion Shares pursuant to Rule 144 without limitation or restriction; 

iii.           promptly, at the request of Buyer, give the
Company’s transfer agent instructions to the effect that, upon the transfer agent’s receipt from Buyer of a certificate (a “Rule 144 Certificate”) certifying the eligibility for sale under Rule 144 of any portion of
the Securities or Conversion Shares which Buyer proposes to sell (the “Securities Being Sold”), and receipt by the transfer agent of a “Rule 144 Opinion” from the Company or its counsel (or from Buyer and its
counsel), the transfer agent is to effect the transfer of the Securities Being Sold and issue to such transferee(s) thereof the transferred Securities Being Sold. If the transfer agent requires any additional documentation in connection with any
proposed transfer by Buyer of any Securities Being Sold, then the Company shall promptly deliver or cause to be delivered to the transfer agent or to any other Person, all such additional documentation as may be necessary to effectuate the transfer
of the Securities Being Sold and the issuance of an unlegended certificate to any transferee thereof, all at the Company’s expense; and 
 iv.          take such further action as Buyer may reasonably request, all to the extent required from time to time to enable Buyer to sell the Securities or
the Conversion Shares without registration under the Securities Act. 
 (c)
      Access to Books and Records.   The Company shall afford to Buyer and its representatives (including officers and employees of Buyer, and counsel, accountants and other professionals retained by
Buyer), during normal business hours and upon reasonable notice to the Company, such access to the Company’s books, records, properties and personnel and to such other information as Buyer may reasonably request; provided, however, that the
Company may withhold such access to Buyer or any such representative in the event that Buyer or such representative shall fail to execute a confidentiality agreement in a form reasonably satisfactory to the Company. 

(d)       Efforts.   The Company shall use reasonable best efforts to
prepare and file all necessary documentation, to effect all necessary applications, notices, petitions, filings and other documents, and to obtain all necessary Consents or Permits, or any exemption by, all third parties and Governmental
Authorities, and expiration or termination of any applicable waiting periods, necessary or advisable to consummate the transactions contemplated by this Agreement and the other Transaction Documents and to perform covenants contemplated by this
Agreement and the other Transaction Documents. 

  
 20 

 6.3      Affirmative Covenants of Mead Park.
  Following the Closing, for so long as Buyer, Mead Park and its or their controlled Affiliates and Principals collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all
Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock), unless waived in writing by the Company, Mead Park shall use its reasonable best efforts to: 

(a)       provide the Company with access to information regarding the funding
relationships of Mead Park and its Affiliates; 
 (b)       assist the Company in
establishing business relationships with credit trading desks at other institutions; 
 (c)
      source new corporate medium-term notes and new annuities for distribution through the Company’s distribution channels; 

(d)       assist the Company with sourcing external personnel to expand key business lines
within the Company; and 
 (e)       introduce the Company to potential sources
of capital. 
 In addition, following the Closing, for so long as Buyer, Mead Park and its or their controlled
Affiliates and Principals collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock), Mead
Park and its Affiliates shall, to the extent commercially practicable, offer PrinceRidge the opportunity to serve as a co-manager for the placement of securities in connection with collateralized loan obligation (CLO) products and other similar
securitization transactions sponsored and/or managed by Mead Park or its controlled Affiliates, on commercially reasonable and arms’ length terms. 
 6.4      Fees and Expenses.   Each party shall bear its own expenses in connection with the transactions contemplated by this Agreement and the Transaction
Documents; provided, however, that in the event that Buyer terminates this Agreement under Section 10.1(b)i or Section 10.1(e)(i) or the Company terminates this Agreement under Section 10.1(f)(ii), the Company will reimburse Buyer for
all out-of-pocket expenses incurred by Buyer and its Affiliates in connection with due diligence, the negotiation and preparation of this Agreement, the Transaction Documents and the undertaking of the transactions contemplated herein and therein
(including fees and expenses of counsel), up to an aggregate maximum amount of Three Hundred Thousand Dollars ($300,000). 
 6.5      Reservation of Shares.   The Company shall, at all times, have authorized and reserved for the purpose of issuance, such number of shares of Common Stock
as shall be necessary for the issuance of all of the Conversion Shares upon conversion of the Note (collectively, the “Share Reserve”). If at any time the Share Reserve is insufficient, then the Company shall, as soon as
reasonably practicable, take all required measures to implement an increase of the Share Reserve accordingly. If the Company does not have sufficient authorized and unissued shares of Common Stock available to increase the Share Reserve, then the
Company shall call and hold a special meeting of the stockholders of the Company within ninety (90) business days of such occurrence, for the purpose of increasing the number of shares of Common Stock authorized, and, at any such special
meeting, the Company’s management shall recommend to the stockholders to vote in favor of increasing the number of shares of Common Stock authorized. 

  
 21 

 6.6      Disclosure of Transactions and
Other Material Information.  The Company shall, on or before 8:30 a.m., New York City time, on the first (1st) trading day after the date of this Agreement, issue a press release disclosing the material terms of the
transactions contemplated by this Agreement and the Transaction Documents. On or before 5:30 p.m., New York City time, on the second (2nd) business day after the date of this Agreement, the Company shall file a Current Report on Form 8-K describing
all the material terms of the transactions contemplated by this Agreement and by the Transaction Documents in the form required by the Exchange Act (the “8-K Filing”). None of the Company, its Subsidiaries, or Buyer shall
issue any press releases or any other public statements with respect to the transactions contemplated by this Agreement or by the Transaction Documents without the express written consent of all of the other parties to this Agreement (such consent
not to be unreasonably withheld or delayed); provided, however, that the Company shall be entitled, without the prior approval of Buyer, to file the 8-K Filing or other public disclosure as is required by applicable Law and regulations, subject to
providing Buyer with reasonable opportunity to comment thereon. Notwithstanding the foregoing, the Company shall not publicly disclose the name of Buyer or any of its Affiliates, or include the name of Buyer or any of its Affiliates in any filing
with the SEC or any regulatory agency or Trading Market, without the prior consent of Buyer (such consent not to be unreasonably withheld or delayed), except: (a) as required by federal securities Laws in connection with (x) the 8-K
Filing, (y) any registration statement contemplated by the Registration Rights Agreement, or (z) the filing of this Agreement and the final Transaction Documents with the SEC; and (b) to the extent that such disclosure is required by
Law or Trading Market rules and regulations, in which case the Company shall provide Buyer with prior notice of such disclosure permitted under this clause (b). 

6.7      NYSE MKT Listing Application.  Following the Effective Date and
prior to the Closing, the Company shall prepare and file with the NYSE MKT an Additional Listing Application (the “Listing Application”) relating to the Common Shares and the Conversion Shares. 

  
 22 

 6.8      Stockholder Meeting and Company
Proxy Statement.  As promptly as reasonably possible following the Effective Date, but in any event within forty-five (45) days of the Effective Date, the Company shall call a meeting of its stockholders (the “2013
Annual Meeting of Stockholders”) to vote on, among other things, proposals (collectively, the “Stockholder Proposal”) regarding the issuance of the Common Shares, the Conversion Shares, the Cohen Shares and the
Cohen Conversion Shares for purposes of Sections 711 and 713 of the NYSE MKT’s Company Guide, as applicable. The Board of Directors shall recommend to the Company’s stockholders that such stockholders approve the Stockholder Proposal, and
shall not modify or withdraw such resolution. In connection with the 2013 Annual Meeting of Stockholders, the Company shall promptly prepare and file with the SEC a Definitive Proxy Statement on Schedule 14A pursuant to Section 14(a) of the
Exchange Act (the “Company Proxy Statement”), shall use its reasonable best efforts to solicit proxies for such stockholder approval and shall use its reasonable best efforts to respond to any comments of the SEC or its staff
and to cause a definitive proxy statement related the 2013 Annual Meeting of Stockholders to be mailed to the Company’s stockholders promptly after clearance by the SEC. The Company shall notify Buyer promptly of the receipt of any comments
from the SEC or its staff with respect to the Company Proxy Statement and of any request by the SEC or its staff for amendments or supplements to such proxy statement or for additional information and shall supply Buyer with copies of all
correspondence between the Company or any of its representatives, on the one hand, and the SEC or its staff, on the other hand, with respect to such proxy statement. If at any time prior to the 2013 Annual Meeting of Stockholders there shall occur
any event that is required to be set forth in an amendment or supplement to the Company Proxy Statement, the Company shall promptly prepare and mail to its stockholders such an amendment or supplement. The Company agrees promptly to correct any
information provided by it or on its behalf for use in the Company Proxy Statement if and to the extent that such information shall have become false or misleading in any material respect, and the Company shall promptly prepare and mail to its
stockholders an amendment or supplement to correct such information to the extent required by applicable Laws. The Company shall consult with Buyer prior to mailing the Company Proxy Statement, or any amendment or supplement thereto, and provide
Buyer with reasonable opportunity to comment thereon. The Board of Directors’ recommendation described in this Section 6.8 shall be included in the Company Proxy Statement. 

6.9      Board Representatives; Chairman of the Board. 

(a)      2013 Annual Meeting of Stockholders.  The Board of Directors
shall (i) nominate Christopher Ricciardi and Jack DiMaio for election to the Board of Directors at the 2013 Annual Meeting of Stockholders; (ii) recommend to the Company’s stockholders the election of Messrs. Ricciardi and DiMaio at
such meeting; and (iii) solicit proxies for Messrs. Ricciardi and DiMaio in connection with such meeting to the same extent as it does for any of its other nominees to the Board of Directors. 

(b)      Qualifying Board Representatives. 

i.          Following the Closing, if Buyer, Mead Park and its or
their controlled Affiliates and Principals collectively own fifteen percent (15%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and Convertible IFMI LLC Units as outstanding shares of
the Common Stock) (a “Qualifying Ownership Interest”) as of the record date of a Meeting, then: 
 (A)     Buyer shall be entitled to designate two (2) individuals (the “Qualifying Board Representatives”) to stand for election to the Board of
Directors at such Meeting; provided, however, that such Qualifying Board Representatives shall have satisfied all of the requirements applicable to the Directors under applicable Law, the Articles of Incorporation, the Bylaws and any customary
director qualification standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing; and 
 (B)     the Board of Directors shall (i) nominate such Qualifying Board Representatives for election to the Board of Directors at such Meeting; (ii) recommend to the
Company’s stockholders the election of the Qualified Board Representatives at such Meeting; and (iii) solicit proxies for such Qualifying Board Representatives in connection with such Meeting to the same extent as it does for any of its
other nominees to the Board of Directors. 

  
 23 

 ii.         Upon any
Qualifying Board Representative’s death, resignation, retirement, disqualification or removal from office as a Director (including by failure to elect or re-elect), if there is a vacancy on the Board of Directors as a result of such occurrence,
then: 
 (A)     Buyer shall have the right to designate the successor for such
Qualifying Board Representative; provided, however, that such successor shall have satisfied all of the requirements applicable to the Directors under applicable Law, the Articles of Incorporation, the Bylaws and any customary director qualification
standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing; and 
 (B)     the Board of Directors take all necessary actions to fill the vacancy resulting therefrom with such successor. 

(c)     Minority Board Representative. 

i.          Following the Closing, if Buyer, Mead Park and its or
their controlled Affiliates and Principals collectively own less than a Qualifying Ownership Interest but at least ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and
Convertible IFMI LLC Units as outstanding shares of the Common Stock) (a “Minority Ownership Interest”) as of the record date of a Meeting, then: 

(A)    Buyer shall be entitled to designate one (1) individual (the “Minority Board
Representative”) to stand for election to the Board of Directors at such Meeting; provided, however, that such Minority Board Representative shall have satisfied all of the requirements applicable to the Directors under applicable Law,
the Articles of Incorporation, the Bylaws and any customary director qualification standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing; and 

(B)    the Board of Directors shall (i) nominate such Minority Board Representative for
election to the Board of Directors at such Meeting; (ii) recommend to the Company’s stockholders the election of the Minority Board Representative at such Meeting; and (iii) solicit proxies for such Minority Board Representative in
connection with such Meeting to the same extent as it does for any of its other nominees to the Board of Directors. 
 ii.        Upon any Minority Board Representative’s death, resignation, retirement, disqualification or removal from office as a Director (including by failure
to elect or re-elect), if there is a vacancy on the Board of Directors as a result of such occurrence, then: 

(A)    Buyer shall have the right to designate the successor for such Minority Board Representative;
provided, however, that such successor shall have satisfied all of the requirements applicable to the Directors under applicable Law, the Articles of Incorporation, the Bylaws and any customary director qualification standards in effect as of the
Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing; and 

  
 24 

 (B)     the Board of Directors take all necessary
actions to fill the vacancy resulting therefrom with such successor. 

(d)     Removal of Board Representatives.  Notwithstanding any other provision
of this Agreement, if Buyer, Mead Park and its or their controlled Affiliates and Principals shall collectively own less than a Qualifying Ownership Interest but continue to collectively own a Minority Ownership Interest, then (i) the terms and
conditions set forth in Section 6.9(b) shall be null and void; and (ii) if so requested by the Board of Directors (in its sole discretion), Buyer shall cause one (1) of the Qualifying Board Representatives (or its successor designated
by Buyer pursuant to Section 6.9(b)) of Buyer’s choosing to resign from his or her position as Director. Notwithstanding any other provision of this Agreement, if Buyer, Mead Park and its or their controlled Affiliates and Principals
collectively own less than a Qualifying Ownership Interest or a Minority Ownership Interest, then (A) the terms and conditions set forth in Section 6.9(b) and Section 6.9(c) shall be null and void; and (B) if so requested by the
Board of Directors (in its sole discretion), Buyer shall cause any Qualifying Board Representatives, Minority Board Representative, or any of their respective successors designated by Buyer pursuant to Section 6.9(b) and/or Section 6.9(c),
to resign from his or her position as Director. 

(e)     Chairman.  No later than the Closing Date, and thereafter for so long
as Buyer, Mead Park and its or their controlled Affiliates and Principals collectively own a Minority Ownership Interest and Jack DiMaio is a Director and agrees to act as Chairman of the Board of Directors, the Company shall cause Jack DiMaio to be
elected and appointed as the Chairman of the Board of Directors subject to his satisfaction of all of the requirements applicable to the Chairman position under applicable Law, the Articles of Incorporation, the Bylaws and any customary chairman
qualification standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing. For so long as Buyer, Mead Park and its or their controlled Affiliates and Principals collectively own a
Minority Ownership Interest, and both (i) Jack DiMaio is no longer Chairman of the Board of Directors due to his death, disqualification or removal from office as Director and (ii) Christopher Ricciardi is a Director and agrees to act as
Chairman of the Board of Directors, then the Company shall cause Christopher Ricciardi to be elected and appointed as the Chairman of the Board of Directors subject to satisfaction of all of the requirements applicable to the Chairman position under
applicable Law, the Articles of Incorporation, the Bylaws and any customary chairman qualification standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing. In all other situations
(including in the event Mr. DiMaio resigns or retires from his positions as Chairman of the Board of Directors), the Chairman of the Board of Directors shall be elected and appointed pursuant to the Bylaws. 

  
 25 

 6.10    Gross-Up Rights. 

(a)      Sale of New Securities.  After the Closing, for so long as
Buyer, Mead Park and its or their controlled Affiliates and Principals collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and Convertible IFMI LLC Units as
outstanding shares of the Common Stock) (before giving effect to any issuances triggering provisions of this Section 6.10), at any time that the Company or IFMI, LLC makes any public or nonpublic offering or sale of any equity (including the
Common Stock, or any preferred stock or restricted stock), or any securities, options or debt that is convertible or exchangeable into equity (including Convertible IFMI LLC Units) or that includes an equity component (such as, an “equity”
kicker) (including any hybrid security) (any such security, a “New Security”) other than (i) pursuant to the granting or exercise of employee stock options or other stock incentives pursuant to the Company’s stock
incentive plans approved by the Board of Directors (so long as the authorized awards under the Company’s stock incentive plans represent less than ten percent (10%) of the outstanding shares of the Company’s capital stock) or the
issuance of capital stock pursuant to any employee stock purchase plan of the Company approved by the Board of Directors or similar plan where stock is being issued or offered to a trust, other entity or otherwise, for the benefit of any employees,
officers or directors of the Company, in each case, in the ordinary course of providing incentive compensation, (ii) issuances of capital stock as full or partial consideration for a merger, acquisition, joint venture, strategic alliance,
license agreement or other similar nonfinancing transaction, (iii) issuances of shares of the Common Stock upon the conversion or exercise of any convertible preferred stock or notes outstanding as of the Effective Date or issued pursuant to
the Transaction Documents, in each case, in accordance with the terms thereof as of the Effective Date); (iv) issuances of rights, stock or other property pursuant to the Shareholder Rights Plan; or (v) issuances of Convertible IFMI LLC
Units pursuant to Section 6.10(x) or (y) of the IFMI LLC Agreement, Buyer shall be afforded the opportunity to acquire from the Company and/or IFMI, LLC for the same price (net of any underwriting discounts or sales commissions) and on the
same terms as New Securities are proposed to be offered to others, up to the amount of New Securities in the aggregate required to enable it to maintain its proportionate equivalent interest in the Company immediately prior to any such issuance of
New Securities (counting for such purposes all Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock). 
 (b)      Notice.  In the event the Company and/or IFMI, LLC proposes to offer or sell New Securities that are subject to Buyer’s rights under
Section 6.10(a), the Company and/or IFMI, LLC (as applicable) shall give Buyer written notice of its intention, describing the price (or range of prices), anticipated amount of securities, timing and other terms upon which the Company and/or
IFMI, LLC proposes to offer the same (including, in the case of a registered public offering and to the extent possible, a copy of the prospectus included in the registration statement filed with respect to such offering), no later than five
(5) business days, as the case may be, after the initial filing of a registration statement with the SEC with respect to an underwritten public offering, after the commencement of marketing with respect to a Rule 144A offering or after the
Company and/or IFMI, LLC proposes to pursue any other offering. Buyer shall then have ten (10) business days from the date of receipt of such a notice to notify the Company and/or IFMI, LLC (as applicable) in writing that it intends to exercise
its rights provided in this Section 6.10 and as to the amount of New Securities Buyer desires to purchase, up to the maximum amount calculated pursuant to Section 6.10(a). Such notice shall constitute a nonbinding indication of interest of
Buyer to purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s and/or IFMI, LLC’s notice to it. The failure of Buyer to respond within such ten (10) business day period shall be
deemed to be a waiver of Buyer’s rights under this Section 6.10 only with respect to the offering described in the applicable notice. The Company shall cause IFMI, LLC to comply with this Section 6.10. 

  
 26 

 6.11    Redemption
Transactions.  Following the Closing, for so long as Buyer, Mead Park and its or their controlled Affiliates and Principals collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for
such purposes all Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock), the Company shall not redeem, recapitalize or repurchase any shares of capital stock of the Company, or rights, options or warrants to
purchase shares of capital stock of the Company, or securities of any type whatsoever that are, or may become, convertible into or exchangeable into or exercisable for capital stock of the Company (except with respect to the Conversion Shares)
unless Buyer is given the right to participate in such redemption, recapitalization, or repurchase in a pro rata manner. 
 6.12    Additional Covenants Prior to Closing.  Prior to the earlier of the Closing Date and the termination of this Agreement pursuant to Section 10.1, except as
expressly provided in this Agreement or as otherwise consented to in writing in advance by Buyer: 

(a)      The Company shall promptly provide Buyer with written notice of the occurrence of
any circumstance, event, change, development or effect occurring after the date hereof and relating to the Company or any Subsidiary of which the Company has Knowledge and which constitutes a Material Adverse Effect or otherwise causes or renders
any of the representations and warranties of the Company or any Subsidiary, as applicable, set forth in this Agreement to be inaccurate. 
 (b)      The Company shall not agree to any amendment, waiver or modification of the Transaction Documents to which Buyer is not a party. 

(c)      The Company will not modify, in any manner, the limited liability company
agreement of IFMI, LLC, other than by the effectiveness of the LLC Agreement Amendment, which amendment shall not be modified in any manner. 
 (d)      The Company shall and shall cause the Subsidiaries to take all actions necessary to ensure that none of the transactions contemplated by this Agreement or the other
Transaction Documents, individually or in the aggregate, shall give rise to a “change in control” or “change of control,” the acceleration of any right, or result in any additional rights, under any Benefit Plan. 

(e)      The Company shall, and shall cause each Subsidiary to conduct its and their
businesses only in the ordinary course of business consistent with past practice and shall use reasonable best efforts to maintain and preserve its and each Subsidiary’s business (including its business organization, Assets, goodwill and
insurance coverage) and preserve business relationships with customers, strategic partners and others having business dealings with it. 
 (f)      Except as required pursuant to any existing written, binding agreements in effect prior to the date of this Agreement, the Company shall not, and shall cause each
Subsidiary to not, take any of the following actions: 

i.          other than in the ordinary course of business, incur any
indebtedness for borrowed money, assume, guarantee, endorse or otherwise as an accommodation become responsible for the obligations of any other Person or incur any indebtedness of the Company that would be senior in right of payment or any other
respect to the Note; 

  
 27 

 ii.          (A) adjust,
split, combine or reclassify any capital stock of the Company; (B) make, declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase or otherwise acquire, any shares of capital stock or any
securities or obligations convertible into or exchangeable for any shares of the capital stock (except dividends paid by any Subsidiary to the Company or any of the Company’s other wholly-owned Subsidiaries and regular quarterly dividends in an
amount not to exceed $0.02 per share); (C) grant any stock options, stock appreciation rights, performance shares, restricted stock units, restricted shares or other equity-based awards or interests, or grant any Person any right to acquire any
shares of capital stock; or (D) issue, sell or otherwise permit to become outstanding any additional shares of capital stock or securities convertible or exchangeable into, or exercisable for, any shares of its capital stock or any options,
warrants, or other rights of any kind to acquire any shares of capital stock, except pursuant to the exercise of stock options or the settlement of equity compensation awards outstanding as of the Effective Date in accordance with their terms or as
otherwise permitted by this Agreement; 
 iii.          sell,
transfer, mortgage, encumber or otherwise dispose of any of its material properties or Assets to any Person other than a wholly-owned Subsidiary, or cancel, release or assign any indebtedness to any such Person or any Claims held by any such Person,
in each case other than in the ordinary course of business or pursuant to contracts or agreements in force at the date of this Agreement; 
 iv.          except for transactions in the ordinary course of business or pursuant to Contracts or agreements in force at the date of this Agreement or
permitted by this Agreement, make any material investment either by purchase of stock or securities, contributions to capital, property transfers, or purchase of any property or non-investment assets of any other Person other than a wholly-owned
Subsidiary or make any capital expenditure in excess of Two Hundred Thousand Dollars ($200,000); 

v.          except for transactions in the ordinary course of
business, terminate, materially amend, or waive any material provision of, any material Contract, as the case may be, or make any change in any instrument or agreement governing the terms of any of its securities, or material Contract, other than
normal renewals of Contracts without material adverse changes of terms, or enter into any material Contract; 

  
 28 

 vi.          except as
required under applicable law or the terms of any Benefit Plan existing as of the Effective Date, as applicable, (A) enter into, adopt or terminate any employee benefit or compensation plan, program, policy or arrangement for the benefit or
welfare of any current or former employee, officer, director or consultant, (B) amend (whether in writing or through the interpretation of) any employee benefit or compensation plan, program, policy or arrangement for the benefit or welfare of
any current or former employee, officer, director or consultant, (C) materially increase the compensation or benefits payable to any current or former employee, officer, director or consultant (other than in connection with a promotion or
change in responsibilities), (D) pay or award, or commit to pay or award, any bonuses or incentive compensation other than in the ordinary course consistent with past practice, (E) grant or accelerate the vesting of any equity-based awards
or other compensation, (F) enter into any new, or amend any existing, employment, severance, change in control, retention, bonus guarantee, collective bargaining agreement or similar agreement or arrangement, (G) fund any rabbi trust or
similar arrangement, (H) terminate the employment or services of any officer or any employee whose target annual compensation is greater than One Hundred Thousand Dollars ($100,000), other than for cause, or (I) hire any officer, employee,
independent contractor or consultant who has target annual compensation (excluding targeted annual compensation based on commission) greater than One Hundred Thousand Dollars ($100,000); 

vii.          settle any material Claim, except in the ordinary course
of business or for settlement of a Claim that is settled in an amount and for consideration not in excess of Five Hundred Thousand Dollars ($500,000) and that would not impose any material restriction on the business of the Company or any
Subsidiary; 
 viii.         amend its organizational documents or
its bylaws or comparable governing documents; 

 ix.          other than in prior consultation with Buyer,
materially restructure or materially change its investment securities or derivatives portfolio or its interest rate exposure, through purchases, sales or otherwise, or the manner in which the portfolio is classified or reported or purchase any
security rated below investment grade other than in the ordinary course of business within the capital limits currently in use by the Company; 
   x.         enter into any new line of business; 
  xi.         take any action that, or fail to take any action the failure of which to be taken, could reasonably be expected to prevent or materially
delay the consummation of the transactions contemplated in this Agreement and the Transaction Documents; or 

xii.         take, offer, propose or authorize any of, or commit or agree
to take any of, the foregoing. 
 6.13    Efforts.  Each of the parties
hereto agrees to use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary to consummate and make effective as promptly as practicable the transactions contemplated hereby and
under the other Transaction Documents and to cooperate with the other parties in connection with the foregoing. Without limiting the generality of the foregoing, the Company shall use its reasonable best efforts to (i) obtain any required
approvals or consents as promptly as practicable, (ii) to lift or rescind as promptly as practicable any injunction or restraining order or other order adversely affecting the ability of the parties hereto to consummate the transactions
contemplated hereby, (iii) to effect all necessary registrations and filings, if any, and (iv) to fulfill all of the conditions to the obligations of the parties to consummate the transactions contemplated by this Agreement set forth in
Article VIII. Without limiting the generality of the foregoing, Buyer shall use its reasonable best efforts to fulfill all of the conditions to the obligations of the parties to consummate the transactions contemplated by this Agreement set forth in
Sections 7.1 and 7.4. 

  
 29 

 ARTICLE VII 
 CONDITIONS PRECEDENT TO THE COMPANY’S OBLIGATIONS TO SELL 
 The obligation of the Company hereunder to issue and to sell the Securities to Buyer at the Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions,
provided that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion: 
 7.1      Buyer’s Execution of Transaction Documents.   Buyer shall have executed the Transaction Documents that require Buyer’s execution, and
delivered such Transaction Documents to the Company. 
 7.2      NYSE MKT
Approval of the Listing of the Common Shares, the Conversion Shares, the Cohen Shares and the Cohen Conversion Shares.    Pursuant to the Listing Application, the Common Shares, the Conversion Shares, the Cohen Shares and the
Cohen Conversion Shares shall have been approved for listing on the NYSE MKT by the NYSE MKT. 

7.3      Company Stockholder Approval of Contemplated
Transactions.   In connection with the Company Proxy Statement, the Company’s stockholders shall have approved the issuance of the Common Shares, the Conversion Shares, the Cohen Shares and the Cohen Conversion Shares.

 7.4      Accuracy of Buyer’s Representations; Compliance with
Covenants.     The representations and warranties of Buyer other than the Buyer Fundamental Representations shall be true and correct in all material respects (except to the extent that any of such representations and
warranties are already qualified as to materiality in Article IV above, in which case, such representations and warranties shall be true and correct in all respects without further qualification) as of the date when made and as of the Closing Date
as though made at that time (except for representations and warranties that speak as of a specific date), the Buyer Fundamental Representations shall be true and correct in all respects (except for de minimis failures) and Buyer shall have
performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by Buyer at or prior to the Closing Date. 

ARTICLE VIII 

CONDITIONS PRECEDENT TO BUYER’S OBLIGATIONS TO PURCHASE 

The obligation of Buyer hereunder to purchase the Securities at the Closing is subject to the satisfaction, at or before
the Closing Date, of each of the following conditions (which conditions shall be deemed satisfied upon the occurrence of the Closing), provided that these conditions are for Buyer’s sole benefit and may be waived by Buyer at any time in its
sole discretion: 
 8.1      Company Execution of the Transaction
Documents.   The Company shall have executed and delivered the Transaction Documents that require the Company’s execution and delivered such Transaction Documents to Buyer and all such Transaction Documents shall have been
fully executed by all other parties thereto (other than Buyer) and remain in full force and effect. 

  
 30 

 8.2      NYSE MKT Approval of the Listing
of the Common Shares, the Conversion Shares, the Cohen Shares and the Cohen Conversion Shares.    Pursuant to the Listing Application, the Common Shares, the Conversion Shares, the Cohen Shares and the Cohen Conversion Shares
shall have been approved for listing on the NYSE MKT by the NYSE MKT. 

8.3      Company Stockholder Approval of Contemplated
Transactions.   In connection with the Company Proxy Statement, the Company’s stockholders shall have approved the issuance of the Common Shares, the Conversion Shares, the Cohen Shares and the Cohen Conversion Shares.

 8.4      Composition of the Board of Directors.  The Board of
Directors shall consist of Daniel G. Cohen, Jack DiMaio, Christopher Ricciardi, and five (5) of the Current Independent Directors. In addition, Jack DiMaio shall be Chairman of the Board of Directors, and Daniel G. Cohen shall be Vice-Chairman
of the Board of Directors and President of the Company’s European operations, including the President of CCFL. 
 8.5      Employment Agreements.  The Cohen IFMI Employment Agreement shall have been amended and restated and the Cohen PrinceRidge Employment Agreement
shall have been terminated, in each case, as provided in the Amended and Restated Cohen Employment Agreement, which shall be in full force and effect as of the Closing. 

8.6      Cohen Purchase Agreement.   The Cohen Purchase Agreement
shall remain in effect and, simultaneous with the Closing, Cohen Bros. shall purchase from the Company and the Company shall sell to Cohen Bros. (i) the Cohen Shares, for a purchase price of Two Dollars ($2.00) per share, representing an
aggregate purchase price of One Million Six Hundred Thousand Dollars ($1,600,000); and (ii) the Cohen Note in the aggregate principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000), pursuant to the Cohen Purchase Agreement.

 8.7      Accuracy of Company’s Representations; Compliance with
Covenants.   The representations and warranties of the Company other than the Company Fundamental Representations and the representations set forth in Section 5.13 (Tax Matters) shall be true and correct in all material
respects (except to the extent that any of such representations and warranties are already qualified as to materiality in Article V above, in which case, such representations and warranties shall be true and correct in all respects without further
qualification) as of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date, in which case they shall be true and correct in all material respects as of
such specified date), the Company Fundamental Representations and the representations set forth in Section 5.13 (Tax Matters) shall be true and correct in all respects (except for de minimis failures) and, with respect to any matter disclosed
to Buyer in writing in response to a representation set forth Article V, there shall have been no materially adverse developments that would reasonably be expected to result in a Material Adverse Effect in connection with any such matter. The
Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date.

  
 31 

 8.8      Closing
Certificates.  The Company shall have executed and delivered to Buyer a closing certificate in substance and form reasonably required by Buyer, which closing certificate shall include and attach as exhibits: (i) a true copy of a
certificate of good standing evidencing the formation and good standing of the Company, from the State of Maryland Department of Assessments and Taxation, as of a date within thirty (30) days of the Closing Date; (ii) the Articles of
Incorporation; (iii) the Bylaws; and (iv) copies of the resolutions of the of the Company, consistent with Section 5.2, as adopted by the Board of Directors in a form reasonably acceptable to Buyer, and a senior executive officer of
the Company shall have executed and delivered to Buyer a closing certificate, dated as of the Closing Date, certifying to the effect that the conditions set forth in Section 8.7 have been satisfied. 

8.9      Opinion.  Buyer shall have received from outside counsel to the
Company, a written opinion dated as of the Closing Date that addresses (i) the due incorporation of the Company, (ii) the due authorization and valid issuance of the Common Shares and (iii) the due authorization, execution and
delivery of this Agreement and the Transaction Documents and shall also have received a 10b-5 letter in form and substance reasonably satisfactory to Buyer. 
 8.10    Tax Benefits.  Since the date of this Agreement, (i) there shall have been no material change to any rules under Sections 382, 383 or 384 of the Code that
adversely affect the application of Sections 382, 383 or 384 of the Code to any net operating losses, unrealized built-in losses or other tax attributes of the Company and any Affiliate (if relevant) that exist on or after the Closing Date; and
(ii) an Ownership Change (as defined by Section 382(g) of the Code), in Buyer’s reasonable judgment, has not occurred and will not occur as a result of the transactions contemplated herein. The Shareholder Rights Plan shall be in
effect and shall have been in continuous effect since the Effective Date, with the distribution of preferred stock purchase rights occurring promptly thereafter. 

8.11    Articles Supplementary; Designation and Issuance of Series E Voting Non-Convertible
Preferred Stock.  Articles supplementary to the Company’s Articles of Incorporation that provide for the designation of the Series E Voting Non-Convertible Preferred Stock shall have been filed with the State of Maryland
Department of Assessments and Taxation and shall be effective. In accordance with the terms and provisions of the Exchange Agreement, any and all outstanding shares of Series D Voting Non-Convertible Preferred Stock shall have been exchanged into
outstanding shares of Series E Voting Non-Convertible Preferred Stock, which series shall be perpetual, and all such shares of Series E Voting Non-Convertible Preferred Stock shall have been duly authorized, validly issued and shall be fully paid
and nonassessable. 
 8.12    Amendment to IFMI LLC Agreement.  The LLC
Agreement Amendment shall be effective. 

  
 32 

 8.13    No Injunctions.  No provision
of any applicable Law and no Judgment shall prohibit the Closing or shall prohibit or restrict Buyer or its Affiliates from owning, voting, converting or exercising any Securities or Conversion Shares in accordance with the terms thereof and no
Proceeding shall have been commenced by a Governmental Authority seeking to effect any of the foregoing. 
 ARTICLE IX

 INDEMNIFICATION 
 9.1      Company’s Obligation to Indemnify.  The Company hereby agrees to defend, indemnify and hold harmless Buyer and Buyer’s Affiliates and
subsidiaries, and its respective directors, officers, partners, employees, agents and representatives, and any Person who controls Buyer, and the successors and assigns of each of the foregoing (collectively, the “Buyer Indemnified
Parties”), to the fullest extent lawful, from and against any and all Claims made, brought or asserted against the Buyer Indemnified Parties, or any one of them, and the Company hereby agrees to pay or reimburse the Buyer Indemnified
Parties for any and all amounts arising out of Claims payable by any of the Buyer Indemnified Parties to any Person, as well as reasonable attorneys’ and paralegals’ fees and expenses, court costs, settlement amounts, costs of
investigation and other similar costs, as a result of, or arising out of, or relating to: (i) any misrepresentation or breach of any representation or warranty made by the Company in this Agreement, the Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby; or (ii) any breach of any covenant, agreement or Obligation of the Company contained in this Agreement, the Transaction Documents or any other certificate, instrument or
document contemplated hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Claims covered
hereby, which is permissible under applicable Law. The Company will not be liable to Buyer under this indemnity: (x) for any settlement by Buyer in connection with any Claim effected without the Company’s prior written consent, which
consent shall not be unreasonably withheld, conditioned or delayed; or (y) to the extent that a Claim is attributable to Buyer’s breach of any of the representations, warranties, covenants or agreements made by Buyer in this Agreement, the
Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby. Notwithstanding anything to the contrary contained in this Section 9.1 or anywhere else in this Agreement or in the Transaction Documents,
the aggregate amount of indemnification which may be sought, claimed and/or recovered by the Buyer Indemnified Parties (collectively) from the Company pursuant to this Section 9.1 relating to a breach of a representation or warranty by the
Company (other than a breach of the Company Fundamental Representations, excluding the representation and warranty of the Company set forth in clause (ii) of Section 5.5) shall not, under any circumstances, exceed Ten Million Dollars
($10,000,000). 

  
 33 

 9.2      Buyer’s Obligation to
Indemnify.  Buyer agrees to defend, indemnify and hold harmless the Company and each of the Company’s Affiliates and Subsidiaries, and their respective directors, officers, partners, employees, agents and representatives, and the
successors and assigns of each of the foregoing (collectively, the “Company Indemnified Parties”), to the fullest extent lawful, from and against any and all Claims made, brought or asserted against the Company Indemnified
Parties, or any one of them, and Buyer hereby agrees to pay or reimburse the Company Indemnified Parties for any and all amounts arising out of Claims payable by any of the Company Indemnified Parties to any Person, as well as reasonable
attorneys’ and paralegals’ fees and expenses, court costs, settlement amounts, costs of investigation and other similar costs, as a result of, or arising out of, or relating to: (i) any misrepresentation or breach of any
representation or warranty made by Buyer in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby or (ii) any breach of any covenant, agreement or Obligation of Buyer contained
in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby. To the extent that the foregoing undertaking by Buyer may be unenforceable for any reason, Buyer shall make the maximum
contribution to the payment and satisfaction of each of the Claims covered hereby, which is permissible under applicable Law. Buyer will not be liable to the Company under this indemnity: (x) for any settlement by the Company in connection with
any Claim effected without Buyer’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed; or (y) to the extent that a Claim is attributable to the Company’s breach of any of the
representations, warranties, covenants or agreements made by the Company in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby. Notwithstanding anything to the contrary contained
in this Section 9.2 or anywhere else in this Agreement or in the Transaction Documents, the aggregate amount of indemnification which may be sought, claimed and/or recovered by the Company Indemnified Parties (collectively) from Buyer pursuant
to this Section 9.2 relating to a breach of representation or warranty made by Buyer (other than a breach of the Buyer Fundamental Representations) shall not, under any circumstances, exceed Three Hundred Thousand Dollars ($300,000).

 ARTICLE X 
 TERMINATION 
 10.1    Termination
Events.  This Agreement may be terminated at any time prior to the Closing: 

(a)     by the written consent of the Company and Buyer. 

(b)     by Buyer with written notice to the Company if: 

 i.     a material breach of this Agreement has been committed by the Company and such
material breach has not been (i) waived in writing by Buyer, or (ii) cured by the Company to the reasonable satisfaction of Buyer within fifteen (15) days following the Company’s receipt of written notice of such material breach
from Buyer; or 
 ii.     the Closing shall not have occurred on or before
September 30, 2013 (the “Transaction Deadline”), unless such failure shall be due to the failure of Buyer to perform or comply with any of the covenants, agreements or conditions hereof to be performed or complied with
by Buyer prior to the Closing. 
 (c)      by the Company with written notice to
Buyer if: 
 i.     a material breach of this Agreement has been committed by Buyer
and such material breach has not been (i) waived in writing by the Company, or (ii) cured by Buyer to the reasonable satisfaction of the Company within fifteen (15) days following Buyer’s receipt of written notice of such
material breach from the Company; or 

  
 34 

 ii.     the Closing shall not have occurred on or
before the Transaction Deadline, unless such failure shall be due to the failure of the Company to perform or comply with any of the covenants, agreements or conditions hereof to be performed or complied with by the Company prior to the Closing.

 (d)      by Buyer or the Company in the event that there shall be (i) any
Law that makes the consummation of the transactions contemplated by this Agreement illegal or otherwise prohibited, or (ii) any Judgment restraining, enjoining or prohibiting any of the transactions contemplated by this Agreement and such
Judgment shall have become final and non-appealable. 
 (e)      (i) by Buyer, if
any of the conditions to Closing set forth in Sections 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.11, or 8.12 are not capable of being satisfied on or before the Transaction Deadline, provided, in each case, that Buyer is not the reason that such condition is
not capable of being satisfied, or (ii) by Buyer, if any of the conditions to Closing set forth in Sections 8.10 or 8.13 are not capable of being satisfied on or before the Transaction Deadline, provided, in each case, that Buyer is not the
reason that such condition is not capable of being satisfied. 
 (f)      (i) by
the Company, if any of the conditions to Closing set forth in Article VII (other than Sections 7.2 , 7.3 and 7.4) are not capable of being satisfied on or before the Transaction Deadline, or (ii) by the Company, if any of the conditions to
Closing set forth in Sections 7.2 and 7.3 are not capable of being satisfied on or before the Transaction Deadline, provided, in each case, that the Company is not the reason that such condition is not capable of being satisfied. 

10.2    Effect of Termination.  If this Agreement is terminated pursuant to this
Article X, then all further obligations of the parties under or pursuant to this Agreement and under or pursuant to the Transaction Documents (other than Section 6.4, if applicable) shall terminate without further liability of any party to the
other parties; provided that nothing herein shall relieve any party from liability for willful breach of this Agreement of breach of this Agreement prior to any termination thereof. 

ARTICLE XI 

MISCELLANEOUS 
 11.1    Interpretation.  In this Agreement, unless the express context otherwise requires: (i) the words “herein,” “hereof” and
“hereunder” and words of similar import refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) references to the words “Article” or “Section” refer to the respective Articles
and Sections of this Agreement, and references to “Exhibit” or “Schedule” refer to the respective Exhibits and Schedules annexed hereto; (iii) references to a “party” mean a party to this Agreement and include
references to such party’s permitted successors and permitted assigns; (iv) references to a “third party” mean a Person not a party to this Agreement; (v) the terms “dollars” and “$” mean U.S. dollars;
(vi) wherever the word “include,” “includes” or “including” is used in this Agreement, it will be deemed to be followed by the words “without limitation.” 

  
 35 

 11.2    Notices.  All notices of
request, demand and other communications hereunder shall be addressed to the parties as follows: 
  

			
	 If to the Company:
	  	 Institutional Financial Markets, Inc.
 Cira Centre
 2929 Arch Street, 17th Floor

Philadelphia, Pennsylvania 19104
 Attn: Joseph W. Pooler, Jr.
 Facsimile: (215) 701-8280

E-mail: jpooler@ifmi.com
  

and to:
  

		  	 Institutional Financial Markets, Inc.
 1633 Broadway, 28th Floor
 New York, New York 10019

Attn: Rachael Fink

Facsimile: (866) 543-2907
 E-mail: rfink@ifmi.com

	  
 With a copy to:
	  	  
 Duane Morris LLP

430 South 17th Street
 Philadelphia, Pennsylvania 19103
 Attn: Darrick M. Mix

Facsimile: (215) 239-4958
 Email: dmix@duanemorris.com

	  
 If to Buyer:
	  	  
 Mead Park Capital Partners LLC

c/o Mead Park Holdings LP
 126 East 56th Street, 19th Floor
 New York, New York 10022

Attn: Christopher Ricciardi
 Facsimile: (212) 432-4770
 Email: cricciardi@meadpark.com

 
 and to:

 
 Mead Park Capital Partners LLC

c/o Mead Park Holdings LP
 126 East 56th Street, 19th Floor
 New York, New York 10022

Attn: Dennis J. Crilly
 Facsimile: (212) 432-4770
 Email:
dcrilly@meadpark.com

  
 36 

			
	 With a copy to:
	  	 Sullivan & Cromwell LLP
 125 Broad Street
 New York, New York 10022

Attn: Mitchell Eitel
 Facsimile: (212) 558-3588
 Email: eitelm@sullcrom.com

 

	 If to Mead Park:
	  	 Mead Park Holdings LP
 126 East 56th Street, 19th Floor
 New York, NY 10022

Attn: Dennis Crilly
 Facsimile: (212) 432-4770
 Email: dcrilly@meadpark.com

 

	 With a copy to:
	  	 Sullivan & Cromwell LLP
 125 Broad Street
 New York, New York 10022

Attn: Mitchell Eitel
 Facsimile: (212) 558-3588
 Email: eitelm@sullcrom.com

 unless the address is changed by the party by like notice given to the other parties. Notice shall be in
writing and shall be deemed delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and properly addressed to the address above, then three (3) business days after deposit of same in a regularly maintained
U.S. Mail receptacle; or (ii) if mailed by Federal Express (FedEx), the United Parcel Service (UPS), or another nationally recognized overnight courier service, next business morning delivery, then one (1) business day after deposit of
same in a regularly maintained receptacle of such overnight courier; or (iii) if hand delivered, then upon hand delivery thereof to the address indicated on or prior to 5:00 p.m., New York City time, on a business day. Any notice hand delivered
after 5:00 p.m. New York City time, shall be deemed delivered on the following business day. Notwithstanding the foregoing, notices, consents, waivers or other communications referred to in this Agreement may be sent by facsimile, e-mail, or other
method of delivery, but shall be deemed to have been delivered only when the sending party has confirmed (by reply e-mail or some other form of written confirmation from the receiving party) that the notice has been received by the other party.

 11.3    Entire Agreement.  This Agreement and (i) the Exhibits and
Schedules attached hereto, (ii) the documents delivered pursuant hereto, including the Transaction Documents, (iii) the Confidentiality Agreement, and (iv) the Exclusivity Agreement, collectively, set forth all the promises,
covenants, agreements, conditions and understandings between the parties hereto with respect to the subject matter hereof and thereof, and supersede all prior and contemporaneous agreements, understandings, inducements or conditions, expressed or
implied, oral or written. 
 11.4    Assignment.  No party hereto may sell
or assign this Agreement or any of the Transaction Documents, or any portion thereof or any rights thereunder, either voluntarily or by operation of law, nor delegate any of their respective duties or obligations hereunder or thereunder, without the
prior written consent of all of the other parties to this Agreement, except that Buyer shall be permitted to assign its rights or obligations hereunder to Mead Park and Buyer’s and Mead Park’s controlled Affiliates and Principals (any such
transferee shall be included in the term “Buyer”); provided, that no such assignment shall relieve Buyer of any of its obligations under this Agreement. 

  
 37 

 11.5    Binding Effect.  This Agreement
shall be binding upon the parties hereto, their respective successors and permitted assigns. 

11.6    Amendment.  The parties hereby irrevocably agree that no attempted
amendment, modification, or change of this Agreement shall be valid and effective, unless the parties shall unanimously agree in writing to such amendment, modification or change. 

11.7    No Waiver.  No failure or delay by any party in exercising any right, power
or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any provision of this
Agreement shall be effective, unless it is in writing and signed by the party against whom it is asserted, and any such written waiver shall only be applicable to the specific instance to which it relates and shall not be deemed to be a continuing
or future waiver. 
 11.8    Gender and Use of Singular and Plural.  All
pronouns shall be deemed to refer to the masculine, feminine, neuter, singular or plural, as the identity of the party or parties or their personal representatives, successors and assigns may require. 

11.9    Execution.  This Agreement may be executed in one or more counterparts, all
of which taken together shall be deemed and considered one and the same Agreement, and the same shall become effective when counterparts have been signed by each party and each party has delivered its signed counterpart to the other party. In the
event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format file or other similar format file, such signature shall be deemed an original for all purposes and shall create a valid and binding
obligation of the party executing same with the same force and effect as if such facsimile or “.pdf” signature page was an original thereof. 
 11.10  Headings.   The article and section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or
interpretation of the Agreement. 
 11.11  Governing Law.   This Agreement shall
be construed in accordance with the laws of the State of New York, without regard to the principles of conflicts of laws that would result in the application of the laws of another jurisdiction. The parties further agree that any action between them
shall be heard in New York City, New York, and expressly consent to the jurisdiction and venue of the state and federal courts sitting in New York City, New York, for the adjudication of any civil action asserted pursuant to this Agreement.

 11.12  Further Assurances.   The parties hereto will execute and deliver such
further instruments and do such further acts and things as may be reasonably required to carry out the intent and purposes of this Agreement and the other Transaction Documents. 

  
 38 

 11.13  Survival.  The covenants and agreements
made by the Company and Buyer herein shall survive for the duration of any statutes of limitations applicable thereto or until, by their respective terms, they are no longer operative. The representations and warranties made by the Company and Buyer
herein shall survive for a period of eighteen (18) months following the Closing Date, provided, however, that the Company Fundamental Representations and Buyer Fundamental Representations shall survive for a period of three (3) years
following the Closing Date. Notwithstanding the foregoing in this Section 11.13, the representations and warranties contained in Section 5.13 (Tax Matters) shall survive until the expiration of the statute of limitation applicable thereto.

 11.14  Time is of the Essence.  The parties hereby agree that time is of the
essence with respect to performance of each of the parties’ obligations under this Agreement. The parties agree that in the event that any date on which performance is to occur falls on a Saturday, Sunday or state or national holiday, then the
time for such performance shall be extended until the next business day thereafter occurring. 

11.15  Joint Preparation.  The preparation of this Agreement has been a joint effort of the
parties and the resulting documents shall not, solely as a matter of judicial construction, be construed more severely against one of the parties than the other. 

11.16  Severability.  If any provision of this Agreement is held to be invalid or
unenforceable in any respect, then the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable
provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 11.17  No Third Party Beneficiaries.  This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person, except that the provisions of Article IX are intended for the benefit of the Persons referred to in that Article. 

11.18  WAIVER OF JURY TRIAL.   EACH OF BUYER AND THE COMPANY, AFTER CONSULTING OR HAVING
HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL, KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES, IRREVOCABLY, THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR
ANY OTHER TRANSACTION DOCUMENT OR ANY OTHER AGREEMENT EXECUTED OR CONTEMPLATED TO BE EXECUTED IN CONJUNCTION WITH THIS AGREEMENT, OR ANY COURSE OF CONDUCT OR COURSE OF DEALING IN WHICH BUYER AND THE COMPANY ARE ADVERSE PARTIES. THIS PROVISION IS A
MATERIAL INDUCEMENT FOR BUYER TO PURCHASE THE SECURITIES. 
 [SIGNATURES ON THE FOLLOWING PAGE] 

  
 39 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
executed as of the date and year first set forth above. 
  

							
		 	COMPANY:	 	
		
		 	INSTITUTIONAL FINANCIAL MARKETS, INC.
			
		 	By:       /s/ Joseph W. Pooler, Jr.            
            	 	
		 	Name:	 	Joseph W. Pooler, Jr.	 	
		 	Title:	 	Executive Vice President, Chief Financial Officer and Treasurer	 	
			
		 	BUYER:	 	
		
		 	MEAD PARK CAPITAL PARTNERS LLC
		
		 	 By:  Mead Park Advisors LLC, its investment adviser

			
		 	
By:       /s/ Christopher Ricciardi                
        
	 	
		 	Name:	 	Christopher Ricciardi	 	
		 	Title:	 	Authorized Officer	 	
		
		 	 MEAD PARK, solely for purposes of Section 6.3:

			
		 	MEAD PARK HOLDINGS, LP	 	
			
		 	By:       /s/ Christopher Ricciardi             
           	 	
		 	Name:	 	Christopher Ricciardi	 	
		 	Title:	 	Authorized Officer	 	

  
 [Signature
page to Securities Purchase Agreement] 

 DISCLOSURE SCHEDULES 

TO 

SECURITIES PURCHASE AGREEMENT 
 May 9, 2013 
 These Schedules relate to that certain
Securities Purchase Agreement (the “Securities Purchase Agreement”), dated May 9, 2013, by and among Institutional Financial Markets, Inc., a Maryland corporation (“IFMI, Inc.” or the
“Company”), and Mead Park Capital Partners LLC, a Delaware limited liability company (“Buyer”) and, solely for purposes of Section 6.3 thereof, Mead Park Holdings, LP. 

Section and subsection references in these Schedules are references to the corresponding sections and subsections of the
Securities Purchase Agreement and are inserted solely for the sake of convenience. All capitalized terms not otherwise defined shall have the meanings ascribed to them in the Securities Purchase Agreement. Any matter disclosed in any section of
these Schedules shall be deemed disclosed in all other sections of the Schedules to the extent that such disclosure is reasonably apparent to be applicable to such other sections, notwithstanding the reference to a particular section or subsection.

 To the extent that any representation or warranty contained in the Securities Purchase Agreement is limited
or qualified by the materiality of the matters to which the representation or warranty is given, the inclusion of any matter in these Schedules does not constitute a determination by Buyer or the Company that such matters are material. Nor in such
cases where a representation or warranty is limited or qualified by the materiality of the matters to which the representation or warranty is given shall the disclosure of any matter in these Schedules imply that any other undisclosed matter having
a greater value or significance is material. 
 The inclusion in these Schedules of any matter or document shall
not constitute any representation, warranty or undertaking not expressly set forth in the Securities Purchase Agreement nor shall such disclosure be taken as extending the scope of any such representations or warranties. Nothing in these Schedules
constitutes an admission of liability or obligation of Buyer or the Company to any third party, or any admission against Buyer or the Company or the interest of Buyer or the Company. 

  
 1 

 SCHEDULE 5.3 
 CAPITALIZATION 
 (i) 
 RESTRICTED IFMI, INC. COMMON STOCK 
  

							
	Recipient	  	 Vesting
 Date
	  	 Amount of
Shares or

Units
	  	Entity           
	 Beach, Walter
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 Bennett, Rodney
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 Brahney, Tom
	  	1/13/2014	  	22,523	  	IFMI, Inc.
				
	 Burklin, Stephan
	  	1/13/2014	  	16,216	  	IFMI, Inc.
				
	 Caton, Cameron
	  	1/13/2014	  	22,523	  	IFMI, Inc.
				
	 Cohen, Daniel G.
	  	 100,000         -
 12/31/2013;
 100,000         -

12/31/2014
	  	200,000	  	IFMI, Inc.
				
	 Costello, Thomas
	  	3/4/2014	  	19,231	  	IFMI, Inc.
	  
  
 Curcio, Vincent
	  	  
  

1/13/2014
	  	  
  

22,523
	  	  
  

IFMI, Inc.

				
	 Dawson, G. Steven
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 DiGennaro, Daniel
	  	1/13/2014	  	6,757	  	IFMI, Inc.
				
	 Donovan, Joseph
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 Haraburda, Jack
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 Hatton, John
	  	1/13/2014	  	45,045	  	IFMI, Inc.
				
	 House, David
	  	1/13/2014	  	22,523	  	IFMI, Inc.
				
	 Jacobs, Michael
	  	1/13/2014	  	17,568	  	IFMI, Inc.
				
	 Listman, Doug
	  	09/30/2013	  	30,000	  	IFMI, Inc.
				
	 Lukas, JoAnn
	  	1/13/2014	  	4,505	  	IFMI, Inc.
				
	 Pooler, Joseph
	  	 32,500         -
 12/31/2013;
 17,500         -

12/31/2014
	  	50,000	  	IFMI, Inc.
				
	 Powell, James
	  	6/30/2013	  	52,788	  	IFMI, Inc.
				
	 Quijano-Martinez,

Lizette
	  	1/13/2014	  	33,784	  	IFMI, Inc.

  
 2 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

							
	Recipient	  	 Vesting
 Date
	  	 Amount of
Shares or

Units
	  	Entity           
	 Subin, Neil
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 Tessar, John
	  	12/31/2014	  	32,258	  	IFMI, Inc.
				
	 Ullom, Lance
	  	3/4/2014	  	19,231	  	IFMI, Inc.
				
	 Wolcott, Charles
	  	3/4/2014	  	19,231	  	IFMI, Inc.
		  		  	  
	  	
				
	 TOTAL:
	  		  	752,092	  	
		  		  	  
	  	

 RESTRICTED IFMI , LLC AND IFMI, INC. UNITS 

 

							
	Recipient	  	 Vesting
 Date
	  	 Amount of
 Shares or
 Units
	  	Entity
	 Burklin, Stephan
	  	1/13/2014	  	9,938	  	IFMI, LLC
				
	 Butkevits, Vince
	  	1/13/2014	  	74,536	  	IFMI, LLC
				
	 DiGennaro, Daniel
	  	1/13/2014	  	9,938	  	IFMI, LLC
				
	 Ferry, James
	  	1/13/2014	  	74,536	  	IFMI, LLC
				
	 Jacobs, Michael
	  	1/13/2014	  	5,591	  	IFMI, LLC
				
	 Lukas, JoAnn
	  	1/13/2014	  	6,212	  	IFMI, LLC
				
	 Weaver, Daniel
	  	1/13/2014	  	5,591	  	IFMI, LLC
				
	 Hohns, Andrew
	  	Variable; based on performance thresholds	  	500,000	  	IFMI, Inc.
				
	 Vernhes, Paul
	  	3/31/2014	  	132,450	  	IFMI, Inc.
		  		  	  
	  	
	 TOTAL:
	  		  	818,792	  	
		  		  	  
	  	

  
 3 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

 VESTED IFMI, LLC UNITS 

 

							
	Recipient	  	 Vesting
 Date
	    	 Amount of
 Shares or
 Units
	  	Entity               
	 Cohen, Daniel G.
  
	  	 N/A
  
	    	 4,983,557   

 
	  	 IFMI, LLC
  

	 Koster, Linda

 
	  	 N/A
  
	    	 72,088   

 
	  	 IFMI, LLC
  

	 Ricciardi, Christopher

 
	  	 N/A
  
	    	 223,520   

 
	  	 IFMI, LLC
  

	 Ricciardi, Stephanie

 
	  	 N/A
  
	    	 44,925   

 
	  	 IFMI, LLC
  

		  		    	  
	  	
	 TOTAL:
	  		    	5,324,090   	  	
		  		    	  
	  	

 UNVESTED RESTRICTED PRINCERIDGE UNITS 

 

							
	Recipient	  	 Vesting
 Date
	    	 Amount of
 Shares or
 Units
	  	Entity               
	 Holmes, James

 
	  	 2/28/2014
  
	    	 234   
  
	  	 PrinceRidge
  

	 Pelletier, Renault

 
	  	 2/28/2014
  
	    	 335   
  
	  	 PrinceRidge
  

	 Teng, Sophia

 
	  	 2/28/2014
  
	    	 167   
  
	  	 PrinceRidge
  

		  		    	  
	  	
	 TOTAL:
	  		    	736   	  	
		  		    	  
	  	

 Other Securities / Instruments with Redemptive Features 

The PrinceRidge units not owned by IFMI, LLC; ($532,527 as of March 31, 2013) are subject to redemption by PrinceRidge upon the
withdrawal of limited partners. 
 (ii) 
 Outstanding Debt Securities 
  

	 	1.	$28,125,000 of outstanding par value of junior subordinated notes - Alesco Capital Trust I; 

	 	2.	$20,000,000 of outstanding par value of junior subordinated notes - Sunset Financial Statutory Trust I; and 

	 	3.	$8,121,000 of outstanding par value of 10.50% Contingent Convertible Senior Notes Due 2027 (convertible into common shares at approximately $116.37 per share).

  
 4 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

 Pro Forma Beneficial Ownership Table 

 

																																													
	 	 	IFMI, Inc. Common Stock	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	   Common Stock   	 	 	    Restricted    
Stock	 	 	    Total    	 	 	Series E
   Voting Non-   
Convertible
Preferred
Stock	 	 	   Total   
   Voting   	 	 	Securities
Purchase
   Agreement   	 	 	Pro Forma
without
   Converts   	 	 	   Percentage   	 	 	    Convertible    
Debt (2)	 	 	Pro Forma
Assuming
    Conversion    	 	 	   Percentage   	 
												
	 Cohen, Daniel G.
	 	 	503,142	  	 	 	200,000	  	 	 	703,142	  	 	 	4,983,557	  	 	 	5,686,699	  	 	 	800,000	  	 	 	6,486,699	  	 	 	32.5% 	  	 	 	800,000	  	 	 	7,286,699	  	 	 	32.1% 	  
												
	 Mead Park
	 	 	–	  	 	 	–	  	 	 	–	  	 	 	–	  	 	 	–	  	 	 	1,949,167	  	 	 	1,949,167	  	 	 	9.8% 	  	 	 	1,949,167	  	 	 	3,898,334	  	 	 	17.2% 	  
												
	 Ricciardi, Christopher (1)
	 	 	1,472,175	  	 	 	–	  	 	 	1,472,175	  	 	 	–	  	 	 	1,472,175	  	 	 	–	  	 	 	1,472,175	  	 	 	7.4% 	  	 	 	–	  	 	 	1,472,175	  	 	 	6.5% 	  
												
	 McEntee, Jay
	 	 	573,445	  	 	 	–	  	 	 	573,445	  	 	 	–	  	 	 	573,445	  	 	 	–	  	 	 	573,445	  	 	 	2.9% 	  	 	 	–	  	 	 	573,445	  	 	 	2.5% 	  
												
	 Pooler, Joseph
	 	 	117,895	  	 	 	50,000	  	 	 	167,895	  	 	 	–	  	 	 	167,895	  	 	 	–	  	 	 	167,895	  	 	 	0.8% 	  	 	 	–	  	 	 	167,895	  	 	 	0.7% 	  
												
	 Listman, Doug
	 	 	49,616	  	 	 	30,000	  	 	 	79,616	  	 	 	–	  	 	 	79,616	  	 	 	–	  	 	 	79,616	  	 	 	0.4% 	  	 	 	–	  	 	 	79,616	  	 	 	0.4% 	  
												
	 Fink, Rachael
	 	 	18,392	  	 	 	–	  	 	 	18,392	  	 	 	–	  	 	 	18,392	  	 	 	–	  	 	 	18,392	  	 	 	0.1% 	  	 	 	–	  	 	 	18,392	  	 	 	0.1% 	  
												
	 Beach, Walter
	 	 	105,731	  	 	 	19,231	  	 	 	124,962	  	 	 	–	  	 	 	124,962	  	 	 	–	  	 	 	124,962	  	 	 	0.6% 	  	 	 	–	  	 	 	124,962	  	 	 	0.6% 	  
												
	 Bennett, Rodney
	 	 	61,412	  	 	 	19,231	  	 	 	80,643	  	 	 	–	  	 	 	80,643	  	 	 	–	  	 	 	80,643	  	 	 	0.4% 	  	 	 	–	  	 	 	80,643	  	 	 	0.4% 	  
												
	 Costello, Thomas
	 	 	62,922	  	 	 	19,231	  	 	 	82,153	  	 	 	–	  	 	 	82,153	  	 	 	–	  	 	 	82,153	  	 	 	0.4% 	  	 	 	–	  	 	 	82,153	  	 	 	0.4% 	  
												
	 Dawson, G. Steven
	 	 	76,931	  	 	 	19,231	  	 	 	96,162	  	 	 	–	  	 	 	96,162	  	 	 	–	  	 	 	96,162	  	 	 	0.5% 	  	 	 	–	  	 	 	96,162	  	 	 	0.4% 	  
												
	 Donovan, Joseph
	 	 	57,578	  	 	 	19,231	  	 	 	76,809	  	 	 	–	  	 	 	76,809	  	 	 	–	  	 	 	76,809	  	 	 	0.4% 	  	 	 	–	  	 	 	76,809	  	 	 	0.3% 	  
												
	 Haraburda, Jack
	 	 	62,722	  	 	 	19,231	  	 	 	81,953	  	 	 	–	  	 	 	81,953	  	 	 	–	  	 	 	81,953	  	 	 	0.4% 	  	 	 	–	  	 	 	81,953	  	 	 	0.4% 	  
												
	 Ullom, Lance
	 	 	83,072	  	 	 	19,231	  	 	 	102,303	  	 	 	–	  	 	 	102,303	  	 	 	–	  	 	 	102,303	  	 	 	0.5% 	  	 	 	–	  	 	 	102,303	  	 	 	0.5% 	  
												
	 Wolcott, Charles
	 	 	65,662	  	 	 	19,231	  	 	 	84,893	  	 	 	–	  	 	 	84,893	  	 	 	–	  	 	 	84,893	  	 	 	0.4% 	  	 	 	–	  	 	 	84,893	  	 	 	0.4% 	  
												
	 Subin, Neil S.
	 	 	123,627	  	 	 	19,231	  	 	 	142,858	  	 	 	–	  	 	 	142,858	  	 	 	–	  	 	 	142,858	  	 	 	0.7% 	  	 	 	–	  	 	 	142,858	  	 	 	0.6% 	  
												
	 Public and Other
	 	 	8,050,690	  	 	 	299,013	  	 	 	8,349,703	  	 	 	–	  	 	 	8,349,703	  	 	 	–	  	 	 	8,349,703	  	 	 	41.8% 	  	 	 	–	  	 	 	8,349,703	  	 	 	36.8% 	  
		 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 
												
	 TOTAL:
	 	 	11,485,012	  	 	 	752,092	  	 	 	12,237,104	  	 	 	4,983,557	  	 	 	17,220,661	  	 	 	2,749,167	  	 	 	19,969,828	  	 	 	100.0% 	  	 	 	2,749,167	  	 	 	22,718,995	  	 	 	100.0% 	  
		 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

 Note: The pro forma beneficial ownership table in this Schedule 5.3 excludes the
following securities, which do not have voting rights at the IFMI, Inc. level: 
  

																	
	 	  	Vested
  IFMI, LLC 
 
Units (i)	 	  	Unvested
Restricted
  IFMI, LLC  
Units	 	  	Unvested
Restricted
Units of
   IFMI, Inc.   	 	  	             Total	 
					
	 Koster, Linda
	  	 	72,088 	  	  	 	– 	  	  	 	– 	  	  	 	72,088	  
					
	 Ricciardi, Christopher
	  	 	223,520 	  	  	 	– 	  	  	 	– 	  	  	 	223,520	  
					
	 Ricciardi, Stephanie
	  	 	44,925 	  	  	 	– 	  	  	 	– 	  	  	 	44,925	  
					
	 Burklin, Stephan
	  	 	– 	  	  	 	9,938 	  	  	 	– 	  	  	 	9,938	  
					
	 Butkevits, Vince
	  	 	– 	  	  	 	74,536 	  	  	 	– 	  	  	 	74,536	  
					
	 DiGennaro, Daniel
	  	 	– 	  	  	 	9,938 	  	  	 	– 	  	  	 	9,938	  
					
	 Ferry, James
	  	 	– 	  	  	 	74,536 	  	  	 	– 	  	  	 	74,536	  
					
	 Jacobs, Michael
	  	 	– 	  	  	 	5,591 	  	  	 	– 	  	  	 	5,591	  
					
	 Lukas, JoAnn
	  	 	– 	  	  	 	6,212 	  	  	 	– 	  	  	 	6,212	  
					
	 Weaver, Daniel
	  	 	– 	  	  	 	5,591 	  	  	 	– 	  	  	 	5,591	  
					
	 Hohns, Andrew
	  	 	– 	  	  	 	– 	  	  	 	500,000 	  	  	 	500,000	  
					
	 Vernhes, Paul
	  	 	– 	  	  	 	– 	  	  	 	132,450 	  	  	 	132,450	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
					
	 TOTAL:
	  	 	340,533 	  	  	 	186,342 	  	  	 	632,450 	  	  	 	1,159,325	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

 SCHEDULE 5.4 
 SUBSIDIARIES 
 Please see the attached organizational chart for a list of
Subsidiaries and details regarding the Company’s ownership thereof. 
 C&Co/PrinceRidge Holdings LP Profit Units:

  

																	
	 	  	 Vested
	 	  	 Unvested
	 	  	 Total
	 	  	 Percentage
	 
	 Daniel G. Cohen
	  	 	6	  	  	 	–	  	  	 	6	  	  	 	0.00%	  
	 Armand Pastine
	  	 	440	  	  	 	–	  	  	 	440	  	  	 	0.16%	  
	 Leland Harrs
	  	 	846	  	  	 	–	  	  	 	846	  	  	 	0.31%	  
	 John McNicholas
	  	 	1,924	  	  	 	–	  	  	 	1,924	  	  	 	0.71%	  
	 Paul Pasqua
	  	 	133	  	  	 	–	  	  	 	133	  	  	 	0.05%	  
	 IFMI, Inc.
	  	 	268,283	  	  	 	–	  	  	 	268,283	  	  	 	98.50%	  
	 James Holmes
	  	 	–	  	  	 	234	  	  	 	234	  	  	 	0.09%	  
	 Renault Pelletier
	  	 	–	  	  	 	335	  	  	 	335	  	  	 	0.12%	  
	 Sophia Teng
	  	 	–	  	  	 	167	  	  	 	167	  	  	 	0.06%	  
	 TOTAL:
	  	 	271,632	  	  	 	736	  	  	 	272,368	  	  	 	100.00%	  

  
 C&Co/PrinceRidge Holdings LP Equity Units:

  

																	
	 	  	 Vested
	 	  	 Unvested
	 	  	 Total
	 	  	 Percentage
	 
	 Daniel G. Cohen
	  	 	6	  	  	 	–	  	  	 	6	  	  	 	0.00%	  
	 Armand Pastine
	  	 	440	  	  	 	–	  	  	 	440	  	  	 	0.16%	  
	 Leland Harrs
	  	 	846	  	  	 	–	  	  	 	846	  	  	 	0.31%	  
	 John McNicholas
	  	 	1,924	  	  	 	–	  	  	 	1,924	  	  	 	0.71%	  
	 Paul Pasqua
	  	 	133	  	  	 	–	  	  	 	133	  	  	 	0.05%	  
	 IFMI, Inc.
	  	 	267,153	  	  	 	–	  	  	 	267,153	  	  	 	98.49%	  
	 James Holmes
	  	 	–	  	  	 	234	  	  	 	234	  	  	 	0.09%	  
	 Renault Pelletier
	  	 	–	  	  	 	335	  	  	 	335	  	  	 	0.12%	  
	 Sophia Teng
	  	 	–	  	  	 	167	  	  	 	167	  	  	 	0.06%	  
	 TOTAL:
	  	 	270,502	  	  	 	736	  	  	 	271,238	  	  	 	100.00%	  

  
 3 

 SCHEDULE 5.10 
 TITLE TO ASSETS 
  

			
	 Balance Sheet Category

 
	  	 Description
  

	 1.  Receivables from brokers,
dealers, and clearing agencies
	  	 The Company’s clearing arrangements may restrict its
ability to transfer these receivables. These are not Encumbered, but may be restricted as to transfer.
  

	 2.  Investments - trading
	  	
This serves as collateral for the Company’s margin loan with its clearing agent. Therefore, this would be considered
Encumbered.
  

	
3.  Receivables under resale agreements
	  	 The collateral the Company
has for these loans is re-pledged to the Company’s counterparty under its repurchase agreement. Therefore, the collateral may be restricted as to transfer and may be considered Encumbered.

 

	
4.  Other Assets - Equity Method Affiliations
	  	 In order to transfer the
Company’s investment in Star Asia Japan Special Situations LP, the Company would need the consent of Star Asia Partners Ltd., the fund’s general partner, which cannot be unreasonably withheld. The Company owns approximately 33% of Star
Asia Partners Ltd.
  

  

	 	—	 	 CIT Communications Finance Corporation has filed a UCC financing statement evidencing a security interest in certain assets of JVB Financial Group,
L.L.C. 

  

	 	—	 	 PrinceRidge has filed a UCC financing statement evidencing a security interest in all of IFMI, LLC’s interests in its capital accounts in, and
units of, both PrinceRidge and C&Co/PrinceRidge Partners LLC (formerly known as PrinceRidge Partners LLC). 

  
 4 

 SCHEDULE 5.13 
 TAX MATTERS 
  

																					
	FEDERAL NOL ROLLFORWARD
	   Year
  

 
	  	12/31/2008
($)	  	 Loss        /
(Income)
2009

($)
	  	12/31/2009
($)	  	 Loss        /
(Income)
2010

($)
	  	 12/31/2010

($)
	  	 Loss        /
(Income)
2011

($)
	  	12/31/2011
($)	  	 Loss        /
(Income)
2012

($)
	  	12/31/2012
($)	  	 Expiration  
  

 

	   2008
	  	44,593,542	  		  	44,593,542	  		  	44,593,542	  		  	44,593,542	  	(2,778,919)	  	41,814,623	  	2028  
	   2009
	  		  	6,999,151	  	  6,999,151	  		  	  6,999,151	  		  	  6,999,151	  		  	  6,999,151	  	2029  
	   2010
	  		  		  	            --	  	16,240,310	  	16,240,310	  		  	16,240,310	  		  	16,240,310	  	2030  
	   2011
	  		  		  	            --	  		  	            --	  	20,997,598	  	20,997,598	  		  	20,997,598	  	2031  
	   2012
	  		  		  	            --	  		  	            --	  		  	            --	  		  	            --	  	
	   TOTAL:
	  	44,593,542	  	6,999,151	  	51,592,693	  	16,240,310	  	67,833,003	  	20,997,598	  	88,830,601	  	(2,778,919)	  	86,051,682	  	

 Note: 2012 is currently estimated in good faith and is subject to future adjustment. The Company expects
to file its return by September 15, 2013. 
  
  

																					
	FEDERAL NCL ROLLFORWARD
	   Year
  

 
	  	12/31/2008
($)	  	 Loss        /
(Income)
2009

($)
	  	12/31/2009
($)	  	 Loss        /
(Income)
2010

($)
	  	 12/31/2010

($)
	  	 Loss        /
(Income)
2011

($)
	  	12/31/2011
($)	  	 Loss        /
(Income)
2012

($)
	  	12/31/2012
($)	  	 Expiration  
  

 

	   2008
	  	            --	  		  	            --	  		  	            --	  		  	            --	  		  	            --	  	2013  
	   2009
	  		  	34,819,158	  	34,819,158	  		  	34,819,158	  		  	34,819,158	  		  	34,819,158	  	2014  
	   2010
	  		  		  	            --	  	6,432,139	  	  6,432,139	  		  	  6,432,139	  		  	  6,432,139	  	2015  
	   2011
	  		  		  	            --	  		  	            --	  		  	            --	  		  	            --	  	2016  
	   2012
	  		  		  	            --	  		  	            --	  		  	            --	  	17,641,014	  	17,641,014	  	2017  
	   TOTAL:
	  	            --	  	34,819,158	  	34,819,158	  	6,432,139	  	41,251,297	  	            --	  	41,251,297	  	17,641,014	  	58,892,311	  	

 Note: 2012 is currently estimated in good faith and is subject to future adjustment. The Company expects
to file its return by September 15, 2013. 

  
 5 

 SCHEDULE 5.18 
 EMPLOYEE MATTERS 
  

	1.	In addition to the Benefit Plans set forth in the SEC Documents, the Company and its Subsidiaries have the following other such plans, contracts, policies, programs or
arrangements: 

  

	 	•	 	 401(k) Plan 

	 	•	 	 General vacation policy 

	 	•	 	 Health insurance plans 

	 	•	 	 Dental insurance plan 

	 	•	 	 Short & long-term disability plan 

	 	•	 	 NY short-term disability plan 

	 	•	 	 Expat medical, dental, life & long-term disability plans 

	 	•	 	 Supplemental life, STD, LTD, cancer, accident insurance 

	 	•	 	 Flex spending accounts (medical, dependent care, transit, parking) 

	 	•	 	 COBRA benefits 

	 	•	 	 Life & Accidental Death & Dismemberment 

	 	•	 	 NY Disability Benefits Law 

	 	•	 	 Malakoff Mederic Disability 

 Employment & Compensation Agreements 
 Current Employees –
European Capital Markets: 
  

			
	 Arif, Saleem
	  	Broker Dealer, Sales & Trading
	 Caselunghe, Sara
	  	Broker Dealer, Sales
	 Estaun, Sarah
	  	Broker Dealer, Sales
	 Genovart, Jaime
	  	Broker Dealer, Sales
	 Khan, Sherjeel
	  	Broker Dealer, Real Estate Finance
	 Koster, Linda
	  	Broker Dealer, Sales
	 Noonan, Gareth
	  	Broker Dealer, Sales
	 Woergaard, Henrik
	  	Broker Dealer, Sales
	 Thaker, Rajiv
	  	Broker Dealer, Support
	 Cahill, Edward
	  	Broker Dealer, Sales/Trading & Investment Banking
	 Scarlat, Viorel
	  	
		  	Broker Dealer, Investment Banking

 Current Employees – JVB: 

 

			
	 Jim Ferry
	  	CMO Trader
	 Vince Butkevits
	  	CMO Trader
	 Mike Jacobs
	  	CMO Trader
	 J.P. Lauria
	  	CMO Trader
	 Chris Glacken
	  	Pass Through (MBS) Trader
	 Jim Powell
	  	Head Agency Trader

  
 6 

			
	 David Epstein
	  	Agency Trader
	 Kelly Stapleton
	  	Assistant Agency Trader
	 Omelio Armas
	  	Municipal Trader
	 John Hatton
	  	Municipal Trader, Head
	 David Cooper
	  	Municipal Trader
	 Dan Digennaro
	  	Corporate Trader, Head
	 Cameron Caton
	  	Corporate Trader
	 Keith Cronin
	  	Corporate Trader, US Credit & International Trading
	 Dan Weaver
	  	Primary CD Trader
	 Michael Hughes
	  	Managing Director, Head of CD Department
	 Zachary Morris
	  	Assistant CD Trader
	 Tom Brahney
	  	Secondary CD Trader
	 Chris Palmer
	  	Secondary CD Trader,
	 Gordon Kiernan
	  	Treasury Trader, Yield Curve Arbitrage & Hedging
	 Rocco Capoccia
	  	Treasury Trader
	 John Tessar
	  	Structured Products Trader, Head of Structured Products
	 Scott Greenwood
	  	Structured Products Trader
	 David House
	  	Sales Manager
	 James Coulter
	  	Dealer Sales
	 John Borris
	  	Dealer Sales
	 Debbie McNulty
	  	Dealer Sales
	 Vinnie Curcio
	  	Dealer Sales
	 Bill Wetmore
	  	Dealer Sales
	 Jim Rafferty
	  	Dealer Sales
	 Scott Swanson
	  	Dealer Sales
	 Suzanne O’Connell
	  	Dealer Sales
	 Daniel Menscher
	  	Dealer Sales
	 Adam Kerstetter
	  	Advisor Sales
	 Charles Johnson
	  	Advisor Sales
	 Matt Johnson
	  	Advisor Sales
	 Mark McKeever
	  	Advisor Sales
	 Justin Plante
	  	Advisor Sales
	 Harry Fleck
	  	CMBS Trader
	 Lizette Quijano - Martinez
	  	CMBS Trader
	 Brad Cimo
	  	CMO Derivatives Trader
	 Brett Murray
	  	Treasury Trader
	 Jason Jenkins
	  	Treasury Trader
	 Gregg Desort
	  	Treasury Trader
	 Geoff Nash
	  	Institutional Sales
	 Sean Rich
	  	Institutional Sales
	 Joseph Ryan
	  	Institutional Sales
	 Andrew Ahn
	  	Institutional Sales
	 Cary Appel
	  	Institutional Sales / Trader, Fixed Income Arbitrage

  
 7 

			
	 Carmen Marino
	  	Institutional Sales / Manager
	 William Seery
	  	Institutional Sales
	 Stephan Burklin
	  	Chief Operating Officer
	 Katharine Vacca (Katie)
	  	Compliance
	 Joann Lukas
	  	Compliance Officer/HR Manager
	 Jim Barreto
	  	Accounting
	 Joseph Stincic
	  	Accounting
	 Aileen Colucci
	  	Administrative Assistant, Boca Raton
	 Rob Castro
	  	IT
	 Aron Green
	  	IT
	 Giovanny Rozo
	  	IT
	 Jaime Hogan
	  	Marketing
	 Shawn Chen
	  	Risk Management
	 Staci Paul
	  	Operations
	 Staci Raymond
	  	Operations
	 Sandra Brewer
	  	Operations

 Current Employees – PrinceRidge: 

 

			
	 Castelluccio, Joseph
	  	Middle Markets – Management
	 Pastine, Armand
	  	Middle Markets & Rates Group - Management
	 Filipski, Marianne
	  	Middle Markets - Sales
	 Rasel, Jayson
	  	Middle Markets - Sales
	 Wieske, Joe
	  	Middle Markets - Sales
	 Warley, Theodore
	  	Middle Markets - Sales
	 Dillon, Justin
	  	Middle Markets - High Grade Corps - Trading
	 Karlic, Michael
	  	Middle Markets - High Grade Corps - Trading
	 Kinnear, Michael
	  	Middle Markets - High Grade Corps - Trading
	 Korb, David
	  	Middle Markets - High Grade Corps - Trading
	 Books, Aaron
	  	Middle Markets - High Grade Corps - Trading
	 Utter, David
	  	Middle Markets - High Grade Corps - Trading
	 Moogan, Richard
	  	Middle Markets - High Grade Corps - Trading
	 Ford, John
	  	Middle Markets - Municipals - Trading
	 Meehan, James
	  	Middle Markets - Municipals - Trading
	 Lundvall, Mark
	  	Middle Markets - Municipals - Trading
	 Marlin, Dennis
	  	Middle Markets - Municipals - Trading
	 Marlin, Derek
	  	Middle Markets - Municipals - Trading
	 Communiello, Michael
	  	Middle Markets - Preferred - Trading
	 Zawacki, Joseph
	  	Middle Markets - Preferred - Trading
	 Cocco, Stephen
	  	Middle Markets - Structured Notes - Trading
	 Rosciano, Anthony
	  	Middle Markets - Structured Notes - Trading
	 Hansraj, Manie
	  	Middle Markets - Operations Specialist
	 McHugh, Thomas
	  	Rates Group - Repo/Funding - Trading
	 Kelly, Jake
	  	Rates Group - Repo/Funding - Support
	 Anderson, Brian
	  	Rates Group - RMBS Trading - Structured Products - Sales

  
 8 

			
	 Amadeo, Brian
	  	Rates Group - RMBS Trading - Structured Products - Sales
	 Hanlon, Mark
	  	Rates Group - RMBS Trading - Structured Products - Sales
	 Santoro, Lawrence
	  	Rates Group - RMBS Trading - Structured Products - Sales
	 Harvey, Bob
	  	Rates Group - RMBS Trading - Structured Products - MBS Trader
	 Lupin, Michael
	  	Rates Group - RMBS Trading - Structured Products - Agency & MBS
	 Plinio, Anthony
	  	Rates Group - RMBS Trading - Structured Products - Trader
	 Sias, William
	  	Rates Group - RMBS Trading - TBA Sales
	 Fuchs, Robert
	  	Rates Group - RMBS Trading - TBA Sales
	 Perschetz, Kenny
	  	Rates Group - RMBS Trading - Agency - Trading
	 Kissane, Brendan
	  	Rates Group - RMBS Trading - TBA Trading
	 McGovern, Michael
	  	Corporate Credit - Head of Dept.
	 Hurwitz, Steven
	  	Corporate Credit - Research
	 Ziets, Kevin
	  	Corporate Credit - Research
	 Dodd, Stephen
	  	Corporate Credit - Sales
	 Hindenach, James
	  	Corporate Credit - Sales
	 Levine, Peter
	  	Corporate Credit - Sales
	 Marvin, Bradford
	  	Corporate Credit - Sales
	 Schmidt, Stephen
	  	Corporate Credit - Sales
	 Silverman, Jeffrey
	  	Corporate Credit - Sales
	 Vandersnow, Scott
	  	Corporate Credit - Sales
	 Pannuzzo, Brian
	  	Corporate Credit - Trading
	 Connors, Thomas
	  	Structured Products - Sales
	 Pasqua, Paul
	  	CDO / CLO - Trading
	 Bertoni, Jeffrey
	  	CDO / CLO - Sales
	 Kim, Jason
	  	Non-Agency - RMBS Sales & Trading
	 Roth, Lance
	  	Asset-Backed Securities Desk - Origination
	 Soltesz, James
	  	Asset Backed Securities Desk - Trading
	 Videla, Alejandro
	  	Asset Backed Securities Desk - Sales & Structuring
	 Mitrikov, Plamen
	  	Asset Backed Securities Desk - Management
	 D’Agostino, Steve
	  	Asset Backed Securities Desk - Management
	 Dyer, James
	  	Equities - Sales & Trading
	 Parchment, Gerry
	  	Equities - Sales & Trading
	 Gatlin, Brandi
	  	Equities - Sales & Trading
	 Appel, Jeffrey
	  	Equities - Sales & Trading
	 Stamler, Joseph
	  	Equities - Sales & Trading
	 Wald, Ari
	  	Equities - Sales & Trading
	 Harrs, Lee
	  	Corporate Finance - Banking
	 McNicholas, John
	  	Corporate Finance - Banking
	 Stock, Keith
	  	Corporate Finance - Banking
	 Saalwachter, Ric
	  	Corporate Finance - Banking
	 Fischer, Ryan
	  	Corporate Finance - Banking
	 Grady, Michael
	  	Corporate Finance - Banking
	 Farha, Red
	  	Corporate Finance - Banking

  
 9 

			
	 Holmes, James
	  	Corporate Finance - Support
	 Pelletier, Renaud
	  	Corporate Finance - Support
	 Teng, Sophia
	  	Corporate Finance - Support
	 Park, Daniel
	  	Corporate Finance - Support
	 Holman, Bryce
	  	Corporate Finance - Support
	 Brennan, Kevin
	  	Corporate Finance - Support
	 Brining, Ryan
	  	Corporate Finance - Support
	 Fecowicz, Jonathan
	  	Corporate Finance - Support
	 Kerr, Michelle
	  	Corporate Finance - Admin
	 Batalion, David
	  	Equity Capital Markets - Banking
	 Bacchus, Michael
	  	Compliance
	 McCann, Joseph
	  	Executive
	 Tissen, Jayne
	  	HR
	 Cenuser, Vanessa
	  	HR
	 Karayannis, Amy
	  	Legal
	 Silberman, Jeffrey
	  	Legal
	 Cianci, Joseph
	  	Operations
	 Tarnovsky, Jane
	  	Operations

 Current Employees – Other IFMI: 

 

			
	 Addei, Peter
	  	Asset Management, Alesco
	 Creighton, Amy
	  	Asset Management, Alesco
	 Masuyama, Taro
	  	Asset Management, Cohen Asia
	 Poljevka, Frank
	  	Asset Management, Cohen Asia
	 Talton, Brian
	  	Asset Management, Cohen Asia
	 Conreur, Xavier
	  	Asset Management, Paris
	 Ebensperger, Uli
	  	Asset Management, Paris
	 Ghnassia, Nathalie
	  	Asset Management, Paris
	 de Clermont-Tonnerre, Amedee
	  	Asset Management, Paris
	 Vernhes, Paul
	  	Asset Management, Paris
	 Carocci, Massimo
	  	Asset Management, Spain
	 Grasso, Sergio
	  	Asset Management, Spain
	 Kuhnel Torma, Marta
	  	Asset Management, Spain
	 Jimenez Lucas, Gustavo
	  	Asset Management, Spain
	 De Rotaeche Amade, Ana
	  	Asset Management, Spain
	 Ignacio Perea, Jose
	  	Asset Management, Spain
	 Garcia Bartolome, Andres
	  	Asset Management, Spain
	 Rodriguez, Luis
	  	Asset Management, Spain
	 Pasan, Carlos
	  	Asset Management, Spain
	 Rey Herzog, Patricia
	  	Asset Management, Spain
	 Sapone, Domenico
	  	Asset Management, Paris
	 Cohen, Daniel
	  	Management
	 McEntee, Jay
	  	Management
	 Pooler, Joe
	  	Management

  
 10 

			
	 Fink, Rachael
	  	Management/Legal
	 Dobie, Bob
	  	Finance
	 Forrestel, Sean
	  	Finance
	 Listman, Doug
	  	Finance
	 Livewell, Megan
	  	Finance
	 O’Rourke, John
	  	Finance
	 Patel, Manish
	  	Finance
	 Verros, Sophia
	  	Finance
	 Cashman, Milly
	  	Administrative
	 Cuddahy, Jonnell
	  	Administrative
	 DiArenzo, Rich
	  	Operations
	 Noel, Ron
	  	Administrative
	 Weisback, Regina
	  	Administrative
	 Pendlebury, Alan
	  	IT
	 Coger, Theresa
	  	Legal

  
 Former Employees (still being
paid): 
  

			
	 Berkeley, Barry
	  	PrinceRidge, Broker Dealer, Sales & Trading
	 Sussman, Shelly
	  	
European      Capital      Markets,      Broker   
   Dealer,
 Management

  

	2.	In addition to the foregoing Benefit Plans, the Company and its Subsidiaries, upon hiring employees, generally sets forth certain terms of employment in an offer
letter, as may have been amended from time to time. 

  

	3.	Each of the following Benefit Plans has received a favorable opinion letter from the Internal Revenue Service National Office: 

IFMI, Inc. 401(k) Plan (Tradition and Roth Contribution) – favorable determination letter was received May 15, 2012.

  
 11 

 EXHIBIT A 
 NEITHER THIS NOTE NOR THE SHARES ISSUABLE UPON THE CONVERSION HEREOF HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
LAWS OF ANY JURISDICTION. THESE SECURITIES MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM. BY ACQUIRING THIS NOTE, THE HOLDER REPRESENTS THAT THE HOLDER WILL NOT SELL OR OTHERWISE
DISPOSE OF THIS NOTE OR THE SHARES ISSUABLE UPON CONVERSION HEREOF WITHOUT REGISTRATION OR EXEMPTION THEREFROM. 

CONVERTIBLE SENIOR PROMISSORY NOTE 
  

			
	$5,847,501	  	[             ], 2013

 For value received, Institutional Financial Markets, Inc., a Maryland corporation, (together with its successors and
assigns, the “Company”) promises to pay to Mead Park Capital Partners LLC (the “Holder”), the principal amount of $5,847,501, together with all accrued and unpaid interest thereon (the “Outstanding
Amount”). This convertible senior promissory note (the “Note”) has been issued pursuant to that certain Securities Purchase Agreement dated as of May [     ], 2013 by and among the Company,
Mead Park Holdings, LP (“Mead Park”) and the Holder (the “Purchase Agreement”). This Note is subject to the following terms and conditions: 
 1.       Note. 

(a)      Maturity.  The Outstanding Amount shall be due and payable in full on
[            ], 2018 (the “Maturity Date”), unless this Note shall have been earlier converted in accordance with Section 2.1 

(b)      Interest.  Interest shall accrue from the date of this Note on the unpaid
principal amount at a rate equal to eight percent (8%) per annum, computed on the basis of the actual number of days elapsed and a year of 365 days from the date of this Note until the principal amount and all interest accrued thereon are paid
(or converted, as provided in Section 2). Interest shall be payable in cash quarterly on each January 1, April 1, July 1, and September 1 (each, an “Interest Payment Date”) until the Maturity Date,
commencing on the first Interest Payment Date to occur after the Closing under the Purchase Agreement; provided, however, that if no Event of Default has occurred, (i) in the event that dividends of less than Two Cents ($0.02) per share are
paid on the Common Stock in the fiscal quarter prior to any Interest Payment Date, then the Company shall have the option, in its sole discretion, to pay one-half of the interest payable on such Interest Payment Date in cash, in which event the
remaining one-half of the interest otherwise payable on such Interest Payment Date shall accrue and be added to the Outstanding Amount as of such Interest Payment Date; and (ii) in the event that no dividends are paid on the Common Stock in the
fiscal quarter prior to such Interest Payment Date, then the Company shall have the option, in its sole discretion, to make no payment in cash of the interest payable on such Interest Payment Date, in which event all of the interest otherwise
payable on such Interest Payment Date shall accrue and be added to the Outstanding Amount as of such Interest Payment Date; provided, further, that if the Company takes an action permitted under clause (i) or (ii) above, it will provide
written notice to the Holder at least ten (10) days prior to the relevant Interest Payment Date. Such notice shall set forth the amount of interest in cash not paid, as well as the revised Outstanding Amount. Upon the occurrence of any Event of
Default and after any applicable cure period as described in Section 7 and for so long as such Event of Default continues, all principal, interest and other amounts payable under this Note shall bear interest at a rate equal to nine percent
(9%) per annum (the “Default Rate”). 
  

 

	1 	Maturity Date to be five years from the date of issuance of this Note. 

  
 A-1

 (c)      No Prepayment Without Consent. This Note shall not be
prepaid in whole or in part prior to the Maturity Date without the prior written consent of the Holder (which may be granted or withheld in its sole discretion). 
 2.       Conversion.  At any time following the date hereof (including, for the avoidance of the doubt, at any time prior to 5:00 p.m. (ET) on
the business day prior to the Maturity Date), the Holder shall have the right, in the Holder’s sole discretion, to convert all or any part of the Outstanding Amount of this Note (the “Conversion”), without the payment of any
additional consideration therefor, into the number of fully paid and nonassessable shares of the Company’s Common Stock that is determined by dividing (i) the then applicable Outstanding Amount by (ii) $3.00 (the “Conversion
Price”). The Conversion Price is subject to adjustment if the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other
equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of this Note), (ii) subdivides outstanding shares of
Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, (iv) issues by reclassification of shares of Common Stock any shares
of capital stock of the Company or (v) takes any similar action or any action designed to have a similar effect, then in each case the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of
Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon
Conversion shall be proportionately adjusted such that the aggregate Conversion Price of this Note shall remain unchanged. Any adjustment made pursuant to this Section 2 shall become effective immediately after the record date for the
determination of stockholders entitled to participate in such event described in clauses (i) through (v) and shall become effective immediately after the effective date in the case of a subdivision, combination, reclassification or similar
action. Whenever the Conversion Price is adjusted pursuant to this Section 2, the Company shall promptly notify the Holder, in accordance with the Purchase Agreement, of the Conversion Price after such adjustment, any resulting adjustment to
the number of shares of Common Stock issuable upon Conversion and a brief statement of the facts requiring such adjustment. 

  
 A-2

 3.       Mechanics and Effect of Conversion.

 (a)      If the Holder wishes to exercise its right to effect a Conversion, the Holder
shall provide the Company with a written notice of its election. 
 (b)      No fractional shares
will be issued upon conversion of this Note. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall pay to the Holder in cash the unconverted amount that would otherwise be converted into such fractional
share. 
 (c)      In the event that all of this Note is converted pursuant to Section 2,
promptly after such Conversion, the Holder shall surrender this Note, duly endorsed, to the Company and the Note shall thereupon be canceled. At its expense, the Company shall as promptly as practicable (but in no event more than five (5)days after
the Conversion of this Note) issue and deliver to the Holder the number of shares of the Company’s Common Stock to which the Holder is entitled upon such Conversion, together with (i) any accrued interest from the Interest Payment Date
immediately prior to Conversion through the date of Conversion and (ii) if applicable, a check payable to the Holder for any cash amounts payable as described in Section 3(b). 

(d)      Upon issuance of shares of Common Stock in respect of Conversion of the entire Outstanding Amount
in accordance with Section 2, all rights with respect to this Note shall terminate, whether or not this Note has been surrendered for cancellation. The Holder shall be treated for all purposes as the record holder of Common Stock issued upon
Conversion. 
 4.       Covenants of the Company.  The Company
covenants to the Holder that, from the date hereof until all principal, interest and other amounts payable under this Note have been paid in full, the Company shall, except as otherwise agreed in writing by the Holder: 

(a)      take such corporate action as may be necessary from time to time to (i) at all times maintain
an authorized number of shares of Common Stock as is sufficient for issuance of shares of Common Stock upon Conversion of this Note pursuant to Section 2 and (ii) cause the shares of Common Stock issued upon Conversion to be duly
authorized, validly issued, fully paid and non-assessable; 
 (b)      punctually pay the
principal and interest payable on this Note, and any other amount due and payable under this Note in the manner specified in this Note; 
 (c)      give written notice promptly to the Holder of any condition or event that constitutes, or is reasonably expected to constitute, an Event of Default; 

(d)      not avoid or seek to avoid the observance or performance of any of the terms of this Note through
any reorganization, recapitalization, transfer of assets or other voluntary action; and 

(e)      not create or incur any Encumbrance in or on its property or Assets, whether now owned or
hereinafter acquired, or upon any income or revenues or rights therefrom, except: 
  

	 	(i)	Encumbrances existing on the date hereof and previously disclosed to the Holder; 

  
 A-3

	 	(ii)	 Encumbrances for property taxes and assessments or other governmental charges or levies and liens that are not overdue for more than 90 days; or

  

	 	(iii)	Encumbrances of or resulting from any Judgment, the time for appeal or petition for rehearing of which shall not have expired or in respect of which the Company shall
in good faith be prosecuting an appeal or other Proceeding for a review and in respect of which a stay of execution pending such appeal or Proceeding shall have been secured. 

 5.       Form of Payment.  Except as otherwise set forth herein, all payments due hereunder shall be made in lawful money of the United
States of America to such account or at such place as may be designated in writing by the Holder from time to time. Payment shall be credited first to the accrued interest then due and payable and the remainder applied to principal. 

6.       Priorities.  The indebtedness evidenced by this Note and the payment of all
principal, interest and any other amounts payable hereunder is a senior obligation of the Company and shall: (i) be Senior (as hereinafter defined) to, and have priority in right of payment over, all Indebtedness (as hereinafter defined) of the
Company incurred following the date hereof and any subordinated or junior subordinated Indebtedness outstanding as of the date hereof, and (ii) rank pari passu to the notes issued pursuant to the Cohen Purchase Agreement (as defined in the
Purchase Agreement) and any other senior obligations of the Company outstanding as of the date hereof. “Senior” means that, in the event of any default in the payment of the obligations represented by this Note or of any
liquidation, insolvency, bankruptcy, reorganization or similar proceedings relating to the Company, all amounts payable under this Note shall first be paid in full before any payment is made upon any other Indebtedness hereinafter incurred
(including any Indebtedness guaranteed by the Company) or any subordinated or junior subordinated Indebtedness outstanding as of the date hereof, and, in any such event, any payment or distribution of any character which shall be made in respect of
any other Indebtedness of Company shall be paid to the Holder for application to the payment hereof, unless and until the obligations under this Note shall have been paid and satisfied in full. “Indebtedness” means, with respect to a
specified Person: (a) all indebtedness of such Person for borrowed money; (b) all obligations of such Person for the deferred purchase price of property or services (other than current accounts payable and accrued expenses incurred in the
ordinary course of business irrespective of when paid); (c) all obligations of such Person evidenced by bonds, debentures, notes, loan agreements, credit agreements or other similar instruments; (d) all obligations and liabilities of such
Person created or arising under any conditional sales or other title retention agreements with respect to property used and/or acquired by such Person; (e) all capitalized lease obligations of such Person; (f) all aggregate mark-to-market
exposure of such Person under hedging agreements; (g) all obligations in respect of letters of credit (whether drawn or supporting obligations that constitute Indebtedness) and bankers’ acceptances; (h) all obligations referred to in
clauses (a) through (g) of this definition of another Person guaranteed by the specified Person or secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) an Encumbrance
upon property owned by the specified Person, whether or not the specified Person has assumed or become liable for the payment of such Indebtedness. 

  
 A-4

 7.       Events of Default.  An
“Event of Default” shall be deemed to have occurred if: 
 (a)      subject to
the accrual of interest as provided in Section 1(b) hereof, the Company shall fail to pay as and when due any principal or interest hereunder and such nonpayment shall continue uncured for a period of five (5) business days; 

(b)      except for an event described in Section 7(a), the Company fails to perform any covenant or
agreement hereunder, and such failure continues or is not cured within five (5) business days after written notice by the Holder to the Company; 
 (c)      the Company or any significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) (a “Significant Subsidiary”) applies for or
consents to the appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) makes a general assignment for the benefit of itself or any of its creditors, or (iii) commences a
voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect; 

(d)      proceedings for the appointment of a receiver, trustee, liquidator or custodian of the Company or
any Significant Subsidiary, or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to the Company or any Significant Subsidiary, or the
debts thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect are commenced and an order for relief entered or such proceeding is not dismissed or discharged within ninety (90) days of commencement; 

(e)      there is entered against the Company or any Subsidiary a final Judgment for the payment of money
in an aggregate amount exceeding $300,000 and such Judgment shall remain unsatisfied or without a stay in respect thereof for a period of thirty (30) days; 
 (f)      the Company or any Subsidiary shall fail to pay when due any obligation, whether direct or contingent, for Indebtedness exceeding $300,000, or shall breach or
default with respect to any term of any loan agreement, mortgage, indenture or other agreement pursuant to which such obligation for Indebtedness was created or securing such obligation if the effect of such breach or default is to cause, or to
permit the holder or holders of that Indebtedness (or a trustee on behalf of such holder or holders), to cause that Indebtedness to become or be declared due and payable (or redeemable) prior to its stated maturity or the stated maturity of any
underlying obligation, as the case may be; or 
 (g)      a Change in Control shall have occurred.
For purposes of this Note, the term “Change in Control” shall mean any one of the following events: (i) any Person or group (other than the Holder, Mead Park and its or their controlled Affiliates and Principals) is or becomes
a beneficial owner, directly or indirectly, of more than 50% of the aggregate voting power represented by all issued and outstanding capital stock of the Company, (ii) individuals who, on the date hereof, constitute the Board of Directors (the
“Incumbent Directors”) cease for any reason to constitute at least a majority of the Board of Directors; provided that any person becoming a director subsequent to the date hereof whose election or nomination for election was
approved by a majority of the Incumbent Directors then on the Board of Directors (either by a specific vote or by approval of the proxy statement of the relevant party in which such person is named as a nominee for director, without written
objection to such nomination) shall be an Incumbent Director (except that no individuals who were not directors at the time any contested election is reached shall be treated as Incumbent Directors); (iii) the stockholders of the Company
approve a plan of liquidation or dissolution of the Company or a sale of all or substantially all of the Company’s assets; or (iv) the Company has entered into a definitive agreement, the consummation of which would result in the
occurrence of any of the events described in clauses (i) through (iii) of this definition above. 

  
 A-5

 Upon the occurrence or existence of any Event of Default described in Section 6(a),
Section 6(b), Section 6(e), Section 6(f) or Section 6(g) and at any time thereafter during the continuance of such Event of Default, the Holder may, by written notice to the Company, declare the entire unpaid principal amount
outstanding and all interest accrued and unpaid on the Note to be immediately due and payable without presentment, demand, protest or any other notice or demand of any kind. Upon the occurrence or existence of any Event of Default described in
Section 6(c) or Section 6(d), immediately and without notice, the entire unpaid principal amount outstanding and all interest accrued and unpaid on the Note shall automatically become immediately due and payable, without presentment,
demand, protest or any other notice or demand of any kind. Upon the occurrence of any Event of Default and after any applicable cure period as described herein and for so long as such Event of Default continues, all principal, interest and other
amounts payable under this Note shall bear interest at the Default Rate. In addition to the foregoing remedies, upon the occurrence or existence of any Event of Default, the Holder may exercise any other right power or remedy granted to it by this
Note or the Purchase Agreement or otherwise permitted to it by law, either by suit in equity or by action at law, or both. 

8.       Miscellaneous. 
 (a)      This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in
accordance with the laws of the State of New York without regard to its conflicts of law principles or the conflicts of law principles of any other state in either case that would result in the application of the laws of any other state. 

(b)      Any notice or other communication required or permitted to be given hereunder shall be in writing
and given as provided in the Purchase Agreement. 
 (c)      In the event any interest is paid on
this Note which is deemed to be in excess of the then legal maximum rate, then that portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the
principal of this Note. 
 (d)      Amendments to any provision of this Note may be made or
compliance with any term, covenant, agreement, condition or provision set forth in this Note may be waived (either generally or in a particular instance and either retroactively or prospectively) only upon written consent of the Company and the
Holder. Any amendment or waiver effected in accordance herewith shall apply to and be binding upon the Holder, upon each future holder of this Note and upon the Company, whether or not this Note shall have been marked to indicate such amendment or
waiver. No such amendment or waiver shall extend to or affect any obligation not expressly amended or waived or impair any right consequent thereon. 

  
 A-6

 (e)      This Note may not be assigned by any holder (except
that the Holder shall be permitted to assign this Note to Mead Park and Holder’s and Mead Park’s controlled Affiliates and Principals) without the prior written approval of the Company. 

(f)      The Company hereby waives diligence, presentment, protest and demand, notice of protest, notice of
dishonor, notice of nonpayment and any and all other notices and demands in connection with the delivery, acceptance, performance, default or enforcement of this Note. The Company further waives, to the full extent permitted by Law, the right to
plead any and all statutes of limitations as a defense to any demand on this Note. 
 (g)      The
Company agrees to pay all reasonable costs and expenses actually incurred by the Holder in connection with an Event of Default, including without limitation the fees and disbursements of counsel, advisors, consultants, examiners and appraisers for
the Holder, in connection with (i) any enforcement (whether through negotiations, legal process or otherwise) of this Note in connection with such Event of Default, (ii) any workout or restructuring of this Note during the pendency of such
Event of Default and (iii) any bankruptcy case or proceeding of the Company or any appeal thereof. 

(h)      The section and other headings contained in this Note are for reference purposes only and shall
not affect the meaning or interpretation of this Note. 
 (i)      Capitalized terms used herein
and not otherwise defined, shall have the meanings ascribed to them in the Purchase Agreement. 
 Signature page follows

  
 A-7

 IN WITNESS WHEREOF, the Company has caused this Note to be duly executed and delivered by
its authorized officer, as of the date first above written. 
  

			
	INSTITUTIONAL FINANCIAL MARKETS, INC.
		
	By:	 	 

 
			
	Name:	 	 

 
			
	Title:	 	 

 AGREED AND ACKNOWLEDGED: 
 MEAD PARK CAPITAL PARTNERS LLC 
 By: Mead Park Advisors LLC, its investment adviser 

 

					
	By:	 	 	 	

			
	Name:	 	 

			
	Title:	 	 

  
 A-8

 EXHIBIT B 
 REGISTRATION RIGHTS AGREEMENT 
 [See Exhibit 10.3 to Institutional
Financial Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT C 
 SHAREHOLDER RIGHTS PLAN 
 [See Exhibit 4.1 to Institutional Financial
Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT D 
 FORM OF COHEN PURCHASE AGREEMENT 
 [See Exhibit 10.2 to Institutional
Financial Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT E 
 FORM OF EXCHANGE AGREEMENT 
 [See Exhibit 10.4 to Institutional Financial
Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT F 
 FORM OF AMENDED AND RESTATED COHEN EMPLOYMENT AGREEMENT 
 [See Exhibit 10.6
to Institutional Financial Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT G 
 LLC AGREEMENT AMENDMENT 
 [See Exhibit 10.5 to Institutional Financial
Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT H 
 VOTING AGREEMENT 
 THIS VOTING AGREEMENT, dated as of May 9, 2013
(this “Agreement”), is made by
                                         
                (the “Shareholder”) for the benefit of Institutional Financial Markets, Inc., a Maryland corporation (the “Company”),
pursuant to the Securities Purchase Agreement (the “Securities Purchase Agreement”), dated of even date herewith, by and among the Company, Mead Park Holdings, LP, and Mead Park Capital Partners LLC (the “Buyer”).
Capitalized terms used but not defined herein shall have the meanings given to such terms in the Securities Purchase Agreement. 

W I T N E S S E T H: 
 WHEREAS, contemporaneously with the execution and delivery of this Agreement, the Company is entering into the Securities Purchase Agreement, pursuant to which the Company has agreed to sell to Buyer and
Buyer has agreed to purchase from the Company (i) an aggregate of One Million Nine Hundred Forty-Nine Thousand One Hundred Sixty-Seven (1,949,167) newly issued shares (collectively, the “Buyer Common Shares”) of the
Company’s Common Stock, par value $.001 per share (“Common Stock”), for a purchase price of Two Dollars ($2.00) per share, representing an aggregate purchase price of Three Million Eight Hundred Ninety-Eight Thousand Three
Hundred Thirty-Four Dollars ($3,898,334); and (ii) a convertible senior promissory note in the aggregate principal amount of Five Million Eight Hundred Forty-Seven Thousand Five Hundred and One Dollars ($5,847,501) (the “Buyer
Note”); 
 WHEREAS, the Buyer Note is convertible into the “Conversion Shares” as defined in the Securities
Agreement (the “Buyer Conversion Shares”); 
 WHEREAS, contemporaneously with the execution and delivery of
this Agreement, the Company and Daniel G. Cohen are executing and delivering a securities purchase agreement (the “Cohen Purchase Agreement”), pursuant to which the Company has agreed to sell to Mr. Cohen and Mr. Cohen has
agreed to purchase from the Company (i) an aggregate of Eight Hundred Thousand (800,000) newly issued shares (collectively, the “Cohen Common Shares” and, together with the Buyer Common Shares, the “Transaction
Shares”) of the Common Stock, for a purchase price of Two Dollars ($2.00) per share, representing an aggregate purchase price of One Million Six Hundred Thousand Dollars ($1,600,000); and (ii) a convertible senior promissory note in
the aggregate principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000) (the “Cohen Note” and, together with the Buyer Note, the “Notes”); 

WHEREAS, the Cohen Note is convertible into the “Conversion Shares” as defined in the Cohen Purchase Agreement (the
“Cohen Conversion Shares”); 
 WHEREAS, in connection with the transactions contemplated by the Securities
Purchase Agreement and the Cohen Securities Agreement, the issuance of the Transaction Shares, the Buyer Conversion Shares and the Cohen Conversion Shares, and the election of certain directors to the Board of Directors of the Company (the
“Board of Directors”) will be submitted to the Company’s shareholders for approval at the Company’s 2013 annual meeting of shareholders (the “Annual Meeting”), which is anticipated to be held on or about
July 25, 2013; 
 WHEREAS, as an inducement to Buyer to enter into the Securities Purchase Agreement, the Shareholder is
entering into this Agreement; 

  
 H-1

 WHEREAS, as of the date hereof, the Shareholder owns of record, or has the power to vote,
certain of the outstanding voting equity securities of the Company (the “Voting Securities”); and 
 WHEREAS,
with this Agreement, the Shareholder wishes to undertake certain obligations with respect to the Voting Securities of which the Shareholder is the owner of record, or with respect to which the Shareholder has the power to vote, on the Record Date
(as defined below) (such Voting Securities as of such date, the “Total Voting Securities”). 
 NOW, THEREFORE,
in consideration of the foregoing and the mutual representations, warranties, covenants and agreements contained herein, and intending to be legally bound hereby, Shareholder hereby agrees as follows: 

ARTICLE I 

VOTING 

1.1    Agreement to Vote.  Except as otherwise provided in this Agreement and except as prohibited
by applicable Law, the Shareholder agrees that, from and after the date hereof and until the date on which this Agreement is terminated pursuant to Section 3.2, at the Annual Meeting or any other meeting of the shareholders of the Company at
which any of the Transaction Matters (as defined below) are to be voted upon, however called (and including any postponement or adjournment of any such meeting), or in connection with any written consent of the shareholders of the Company with
respect to any of the Transaction Matters, the Shareholder shall: 
 (a)      appear at each such
meeting (in person or by proxy) or otherwise cause all Total Voting Securities owned of record by the Shareholder, or with respect to which the Shareholder has the power to vote, in each case as of the record date used for determining the holders of
voting securities of the Company entitled to vote at such meeting or to deliver such consent (the “Record Date”), to be counted as present thereat for purposes of calculating a quorum; and 

(b)      vote or cause to be voted (in person or by proxy) or deliver a written consent (or cause a
consent to be delivered) covering all Total Voting Securities owned of record by the Shareholder or as to which the Shareholder has the power to vote, in each case as of the Record Date, in favor of: (i) the issuance by the Company of the Buyer
Common Shares and the Buyer Conversion Shares to Buyer; (ii) the issuance by the Company of the Cohen Common Shares and the Cohen Conversion Shares to Daniel G. Cohen; and (iii) the election to the Board of Directors of the nominees for
Director nominated by the Board of Directors in accordance with Section 8.4 of the Securities Purchase Agreement (clauses (i) through (iii) collectively, the “Transaction Matters”). 

1.2    No Inconsistent Agreements.  The Shareholder hereby covenants and agrees that, except as set
forth in this Agreement and except for actions taken in furtherance of this Agreement, the Shareholder has not granted, and shall not grant at any time while this Agreement remains in effect, any proxy, consent or power of attorney with respect to
the Total Voting Securities that would conflict with the provisions of Section 1.1. 

  
 H-2

 1.3    No Other Restrictions.  Except as set forth in
Section 1.1, the Shareholder shall not be restricted from voting in favor of, against or abstaining with respect to any matter presented to the shareholders of the Company. 

ARTICLE II 

REPRESENTATIONS AND WARRANTIES 
 2.1    Representations and Warranties of the Shareholder.  Except as set forth on the signature page hereof, the Shareholder hereby represents and warrants as follows
as of the date hereof: 
 (a)      Authorization; Validity of Agreement;
Necessary Action.  This Agreement has been duly executed and delivered by the Shareholder and constitutes a valid and binding obligation of the Shareholder, enforceable in accordance with its terms (except as enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and general equitable principles). 
 (b)      Ownership.  The Voting Securities set forth below the Shareholder’s name on the signature page hereto are owned of record by the Shareholder or
the Shareholder has the power to vote such Voting Securities, in each case as of the date hereof (such Voting Securities, the “Existing Voting Securities”). The Shareholder’s Existing Voting Securities constitute all voting
equity securities of the Company held of record by the Shareholder or for which voting power is held by the Shareholder as of the date hereof. The Shareholder has sole power to issue instructions with respect to the matters set forth in
Article I hereof, and sole power to agree to all of the matters set forth in this Agreement, in each case with respect to all of the Shareholder’s Existing Voting Securities, with no limitations, qualifications or restrictions on such
rights, subject to applicable federal and state securities laws and the terms of this Agreement. The Shareholder has good title to the Shareholder’s Existing Voting Securities, free and clear of any Encumbrances. 

(c)      No Consents; Conflicts and Violations.  Except for any applicable requirements
of the Securities Exchange Act of 1934, as amended, the execution and delivery of this Agreement by the Shareholder does not, and the performance by the Shareholder of its obligations under this Agreement will not, (i) require any consent,
approval, authorization of or other order of, action by, filing with, or notification to any Governmental Authority; (ii) violate or conflict with or result in the breach of any provision of the organizational documents of the Shareholder;
(iii) cause a violation by the Shareholder of any Law, ordinance or regulation of any Governmental Authority applicable to the Shareholder or by which any of the Existing Voting Securities is bound; or (iv) conflict with, result in any
breach of or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or require payment under, or result in
the creation of any Encumbrance on the properties or assets of the Shareholder pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which the Shareholder is a
party or by which any of the Existing Voting Securities is bound, except, in the case of clauses (i), (iii) and (iv), as could not reasonably be expected, either individually or in the aggregate, to materially impair the ability of the
Shareholder to perform its obligations hereunder or to consummate the transactions contemplated hereby on a timely basis. 

  
 H-3

 ARTICLE III 
 MISCELLANEOUS 
 3.1    Limitation on
Liability.   Notwithstanding anything in this Agreement to the contrary, no party to this Agreement shall have any liability for damages to any other party for any breach or violation of this Agreement unless such breach or violation
was willful or intentional. 
 3.2    Termination.  This Agreement shall terminate upon
the earliest to occur of (i) the date and time of termination of the Securities Purchase Agreement; (ii) the Closing and (iii) the written agreement of the parties hereto and Buyer to terminate this Agreement. Upon such termination,
no party hereto shall have any further obligations or liabilities hereunder; provided, however, that such termination shall not relieve any party from liability for any willful or intentional breach or violation of this Agreement prior to such
termination. 
 3.3    Further Assurances.  From time to time, at the other party’s
request and without further consideration, each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary or desirable to consummate the transactions contemplated by this Agreement.

 3.4    No Ownership Interest.  Nothing contained in this Agreement shall be deemed to
vest in the Company or Buyer any direct or indirect ownership or incident of ownership of or with respect to any Total Voting Securities. All rights, ownership and economic benefits of and relating to the Total Voting Securities shall remain vested
in and belong to the Shareholder. 
 3.5    Notices.  All notices of request, demand and other
communications hereunder shall be addressed to the parties as follows: 
 (a)      if to the
Company, to: 
 Institutional Financial Markets, Inc. 
 Cira Centre 
 2929 Arch Street, 17th Floor 

Philadelphia, Pennsylvania 19104 
 Attn: Joseph W. Pooler, Jr. 
 Facsimile: (215) 701-8280 

E-mail: jpooler@ifmi.com 
 With a copy to: 
 Duane Morris LLP 

30 South 17th Street 
 Philadelphia, Pennsylvania 19103 
 Attn: Darrick M. Mix 

Facsimile: (215) 239-4958 
 Email: dmix@duanemorris.com 

  
 H-4

 (b)      if to the Shareholder, to the address listed next to
the Shareholder’s name on the Shareholder’s signature page hereto, 
 unless the address is changed by the party by
like notice given to the other parties. Notice shall be in writing and shall be deemed delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and properly addressed to the address above, then three
(3) business days after deposit of same in a regularly maintained U.S. Mail receptacle; or (ii) if sent by Federal Express (FedEx), the United Parcel Service (UPS), or another nationally recognized overnight courier service, next business
morning delivery, then one (1) business day after deposit of same with, or in a regularly maintained receptacle of, such overnight courier on or prior to 5:00 p.m., New York City time, on a business day; or (iii) if hand delivered, then
upon hand delivery thereof to the address indicated on or prior to 5:00 p.m., New York City time, on a business day. Any notice hand delivered after 5:00 p.m. New York City time, shall be deemed delivered on the following business day.
Notwithstanding the foregoing, notices, consents, waivers or other communications referred to in this Agreement may be sent by facsimile, e-mail, or other method of delivery, but shall be deemed to have been delivered only when the sending party has
confirmed (by reply e-mail or some other form of written confirmation from the receiving party) that the notice has been received by the other party. 
 3.6    Interpretation.  The words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer
to this Agreement as a whole and not to any particular provision of this Agreement, and section references are to this Agreement unless otherwise specified. The headings contained in this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement. 
 3.7    Entire
Agreement.  This Agreement (including any exhibits hereto) and the Transaction Documents (as defined in the Securities Purchase Agreement) collectively constitute the entire agreement, and supersede all other prior agreements,
understandings, and representations and warranties, both written and oral with respect to the subject matter hereof. 

3.8    Governing Law and Jurisdiction.  This Agreement shall be construed in accordance with the
laws of the State of New York, without regard to the principles of conflicts of laws. The parties further agree that any action between them shall be heard in New York City, New York, and expressly consent to the jurisdiction and venue of the state
and federal courts sitting in New York City, New York, for the adjudication of any civil action asserted pursuant to this Agreement. 

  
 H-5

 3.9    Consent to Jurisdiction.  EACH PARTY HEREBY
IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL COURT LOCATED IN THE STATE OF NEW YORK OR ANY NEW YORK STATE COURT IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING ARISING IN CONNECTION WITH THIS AGREEMENT AND THE TRANSACTION DOCUMENTS
AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY, AND AGREES THAT ANY SUCH ACTION, SUIT OR PROCEEDING SHALL BE BROUGHT ONLY IN SUCH COURT (AND WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS OR ANY OTHER OBJECTION TO VENUE THEREIN);
PROVIDED, HOWEVER, THAT SUCH CONSENT TO JURISDICTION IS SOLELY FOR THE PURPOSE REFERRED TO IN THIS SECTION 3.9 AND SHALL NOT BE DEEMED TO BE A GENERAL SUBMISSION TO THE JURISDICTION OF SAID COURTS OR IN THE STATE OF NEW YORK OTHER THAN
FOR SUCH PURPOSE. 
 3.10    Enforcement.  The Shareholder agrees that in the event that
the Shareholder fails to perform any of the Shareholder’s obligations under this Agreement in accordance with their specific terms, the Company and Buyer will be irreparably harmed and there will be no adequate remedy at Law. It is accordingly
agreed that the Company and Buyer shall be entitled to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity. 

3.11    Amendment.  The parties hereby irrevocably agree that no attempted amendment, modification,
or change of this Agreement shall be valid and effective, unless the parties and Buyer shall unanimously agree in writing to such amendment, modification or change. 
 3.12    Severability.  If any provision of this Agreement is held to be invalid or unenforceable in any respect, then the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall
incorporate such substitute provision in this Agreement. 
 3.13    Assignment; Third Party
Beneficiaries.  Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Company and its successors and permitted assigns. This Agreement is not intended to confer any
rights or remedies hereunder upon any Person other than the Company pursuant to the terms and conditions of the Securities Purchase Agreement, except that Buyer is an express third party beneficiary with full rights to enforce this Agreement,
including Section 3.10, as if it were the Company. 

  
 H-6

 3.14    Shareholder Capacity.  By executing and
delivering this Agreement, the Shareholder makes no agreement or understanding herein in the Shareholder’s capacity or with respect to the Shareholder’s actions as a manager, director, officer or employee of the Company or any of its
Subsidiaries. The Shareholder is signing and entering into this Agreement solely in the Shareholder’s capacity as the record owner of the Shareholder’s Total Voting Securities or in the Shareholder’s capacity as the individual with
voting power with respect to certain Total Voting Securities, and nothing herein shall limit or affect in any way any actions that may be hereafter taken by the Shareholder in the Shareholder’s capacity as an employee, director, officer or
manager of the Company or any of its Subsidiaries or in any other capacity and no such actions shall be deemed to be a breach of this Agreement. Nothing contained in this Agreement shall restrict, limit, prohibit or preclude the Shareholder from
exercising or discharging the Shareholder’s fiduciary duties as a director, officer or manager of the Company or any of its Subsidiaries under applicable Law. Any trustee executing this Agreement is executing this Agreement solely in his or
her fiduciary capacity and shall have no personal liability or obligation under this Agreement. 
 [REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK] 

  
 H-7

 IN WITNESS WHEREOF, the Shareholder has signed this Voting Agreement as of the date first
written above. 
  

					
		 	 SHAREHOLDER:
	  	
		 	  
  
  

 
	  	
		 	 Name:
	  	
		 	 [Title:]
	  	
		 	  
 Total Voting Securities owned by the
Shareholder as of the date hereof:

  

							
		 	 Number of Shares:
	    	  
	  	
		 		    	  
  
  
	  	

  

					
	 Address for Notices:
	 	  
	  	
		 	  

 
	  	
		 	  

 
	  	

 Exceptions to Shareholder’s representations and warranties set forth in ARTICLE II hereof, if any
(please describe in the space provided below): 
  

[Signature Page to Voting Agreement] 

  
 H-8

							
		 		 	 AGREED TO AND ACCEPTED BY:
	 	
				
		 		 	INSTITUTIONAL FINANCIAL MARKETS, INC.	 	

									
					
		 		 	    By:
	 	  
	 	

									
		 		 	 Name:
	 		 	
		 		 	 Title:
	 		 	

  
  
  

[Signature Page to Voting Agreement] 

  
 H-9EX-10.2

 EXHIBIT 10.2 
 SECURITIES PURCHASE AGREEMENT 
 This SECURITIES
PURCHASE AGREEMENT (the “Agreement”) is dated as of the 9th day of May, 2013 (the “Effective Date”), by and between Institutional Financial Markets, Inc., a Maryland corporation (the
“Company”) and Cohen Bros. Financial, LLC, a Delaware limited liability company of which Daniel G. Cohen is the sole member (“Buyer”). 

RECITALS: 
 WHEREAS, Buyer desires to purchase from the Company, and the Company desires to issue and to sell to Buyer, upon the terms and conditions set forth in this Agreement, (i) an aggregate of Eight
Hundred Thousand (800,000) newly issued shares (each, a “Common Share” and, collectively, the “Common Shares”) of the Company’s common stock, $0.001 par value per share (“Common
Stock”), for a purchase price of Two Dollars ($2.00) per Common Share, representing an aggregate purchase price of One Million Six Hundred Thousand Dollars ($1,600,000) (the “Common Stock Purchase Price”); and
(ii) a convertible senior promissory note in the aggregate principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000) (the “Note Purchase Price”), in substantially the form attached hereto as Exhibit
A (the “Note”); 
 WHEREAS, the Company and Buyer are executing and delivering this
Agreement in reliance upon an exemption from registration afforded by the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations promulgated thereunder by the U.S. Securities and Exchange
Commission (the “SEC”); 
 WHEREAS, contemporaneously with the execution and delivery of
this Agreement, the parties hereto are executing and delivering the Registration Rights Agreement attached hereto as Exhibit B (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide
certain registration rights to Buyer and to the Mead Park Buyer (as defined below) under the Securities Act and under applicable state securities Laws; 
 WHEREAS, the Company has approved the shareholder rights plan attached hereto as Exhibit C (the “Shareholder Rights Plan”) to reduce the risk of any limitation of net
operating loss and net capital loss carryforwards and certain other tax benefits under Section 382 of the Internal Revenue Code of 1986, as amended, and the Treasury Regulations promulgated thereunder (the “Code”) and
such plan is effective as of the Effective Date; 
 WHEREAS, contemporaneously with the execution and delivery
of this Agreement, the Company, Mead Park Capital Partners LLC (the “Mead Park Buyer”) and Mead Park Holdings, LP are entering into a securities purchase agreement, pursuant to which the Mead Park Buyer has agreed to purchase from
the Company and the Company has agreed to sell to the Mead Park Buyer (i) One Million Nine Hundred Forty-Nine Thousand One Hundred Sixty-Seven (1,949,167) shares of Common Stock, for a purchase price of Two Dollars ($2.00) per share,
representing an aggregate purchase price of Three Million Eight Hundred Ninety-Eight Thousand Three Hundred Thirty-Four Dollars ($3,898,334) (the “Mead Park Shares”); and (ii) a convertible senior promissory note (the
“Mead Park Note”) in the aggregate principal amount of Five Million Eight Hundred Forty-Seven Thousand Five Hundred and One Dollars ($5,847,501), in the form attached hereto as Exhibit D (the “Mead Park
Purchase Agreement”); 

 WHEREAS, contemporaneously with the execution and delivery of this
Agreement, the Company and Buyer are entering into an exchange agreement providing for the exchange of all of the Institutional Financial Markets, Inc. Series D Voting Non-Convertible Preferred Stock indirectly owned by Buyer for newly issued shares
of Institutional Financial Markets, Inc. Series E Voting Non-Convertible Preferred Stock, in the form attached hereto as Exhibit E (the “Exchange Agreement”); 

WHEREAS, contemporaneously with the execution and delivery of this Agreement, Daniel G. Cohen and the Company are
entering into an amended and restated employment agreement, which is amending and restating the Cohen IFMI Employment Agreement and terminating the Cohen PrinceRidge Employment Agreement (each as defined below), in the form attached hereto as
Exhibit F (the “Amended and Restated Cohen Employment Agreement”); 
 WHEREAS, on
or prior to the Effective Date, each member of IFMI, LLC and the board of managers of IFMI, LLC shall have approved, pursuant to written consents provided to Buyer, the amendment to the IFMI LLC Agreement (as defined below) attached hereto as
Exhibit G (“LLC Agreement Amendment”); and 
 WHEREAS, on or prior to the
Effective Date, the Company and the Voting Agreement Signatories (as defined below), have entered into and delivered to the Mead Park Buyer voting agreements, each attached hereto as Exhibit H (collectively, the “Voting
Agreements”). 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants of the
parties hereinafter expressed and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound, agree as follows: 

ARTICLE I 

RECITALS, EXHIBITS, SCHEDULES 
 The foregoing Recitals are true and correct and, such Recitals, together with the Schedules and Exhibits referred to therein and referred to hereafter, are hereby incorporated into this Agreement by this
reference. 
 ARTICLE II 
 DEFINITIONS 
 Capitalized terms used in this Agreement but
otherwise not defined herein shall have the following meanings: 

2.1      “Affiliate” means, with respect to a Person, any other
Person directly or indirectly controlling, controlled by, or under common control with, such Person at any time during the period for which the determination of affiliation is being made. For purposes of this definition, the terms
“control,” “controlling,” “controlled” and words of similar import, when used in this context, mean, with respect to any Person, the possession, directly or indirectly, of the power to direct, or
cause the direction of, management policies of such Person, whether through the ownership of voting securities, by contract or otherwise. 

  
 2 

 2.2      “Assets”
means all of the properties and assets of the Company or of the Subsidiaries, whether real, personal or mixed, tangible or intangible, wherever located, whether now owned or hereafter acquired. 

2.3      “Board of Directors” means the Board of Directors of the
Company. 
 2.4      “Buyer Fundamental Representations”
means, collectively, the representations and warranties of Buyer contained in Sections 4.1 (Organization; Authority), 4.3 (Investment Purpose), 4.4 (Accredited Buyer Status; Experience of Buyer) and 4.9 (Brokers and Finders). 

2.5      “CCFL” means Cohen & Company Financial Limited
(formerly known as EuroDekania Management LTD) a wholly-owned Subsidiary organized under the laws of the United Kingdom. 
 2.6      “Claims” means any threatened or actual Proceeding, Judgment, settlement, and/or assessment of any nature or kind. 

2.7      “Cohen IFMI Employment Agreement” means the Employment
Agreement, dated February 18, 2010, by and among the Company, IFMI, LLC, and Daniel G. Cohen, as amended by Amendment No. 1, dated December 18, 2012. 

2.8      “Cohen PrinceRidge Employment Agreement”  means
the Executive Agreement, dated May 31, 2011, by and among PrinceRidge, the Company, IFMI, LLC and Daniel G. Cohen and, solely for purposes of Sections 5.5 and 5.6 thereof, C&Co/PrinceRidge Partners LLC (formerly known as PrinceRidge
Partners LLC). 
 2.9      “Company Fundamental
Representations”    means, collectively, the representations and warranties of the Company contained in Sections 5.1 (Organization and Qualification), 5.2 (Authorization; Enforcement; Validity), 5.3 (Capitalization),
5.5 (No Conflicts; Consents and Approvals), 5.6 (Issuance of Securities), 5.8 (Absence of Certain Changes), 5.11 (Compliance with Laws), 5.15 (Acknowledgement Regarding Buyer’s Purchase of the Securities) and 5.16 (Brokerage Fees). 

2.10      “Consent” means any consent, approval, order or
authorization of, or any declaration, qualification, filing or registration with, or any application or report to, or any waiver by, or any other action (whether similar or dissimilar to any of the foregoing) of, by or with, any Person, which is
necessary in order to take a specified action or actions, in a specified manner and/or to achieve a specific result. 
 2.11      “Contract” means any written or oral contract, agreement, order or commitment of any nature whatsoever, including any sales order,
purchase order, lease, sublease, license agreement, services agreement, loan agreement, mortgage, security agreement, guarantee, management contract, employment agreement, consulting agreement, partnership agreement, stockholders agreement, buy-sell
agreement, option, warrant, debenture, subscription, call or put. 

  
 3 

 2.12    “Conversion
Shares”  means the shares of Common Stock issuable upon conversion of the Note. 

2.13    “Convertible IFMI LLC Units”  means units of membership
interest in IFMI, LLC that are redeemable for shares of Common Stock or cash, at the option of the Company, pursuant to the IFMI LLC Agreement (other than any units of membership interest held by the Company). 

2.14    “Current Independent Directors” means the members of the Board
of Directors as of the Effective Date who are considered to be independent directors (as determined in accordance with Section 803 of the NYSE MKT’s Company Guide). 

2.15    “Director” means a member of the Board of Directors. 

2.16    “DRS” means the Direct Registration System maintained by the
transfer agent for the Common Stock. 

2.17    “Encumbrance” means any lien, security interest, pledge,
mortgage, easement, leasehold, assessment, tax, covenant, reservation, conditional sale, prior assignment, or any other encumbrance, claim, burden or charge of any nature whatsoever. 

2.18    “Exchange Act” means the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder. 

2.19    “Family Group” means, with respect to any Person, such Person,
such Person’s sole member, and such Person’s or such sole member’s spouse, parent, sibling and descendants (whether natural or adopted) and any estate, trust, family limited partnership, limited liability company or other entity
wholly owned, directly or indirectly, by such Person or such sole member or such Person’s or sole member’s spouse, parent, sibling and/or descendant that is and remains solely for the benefit of such Person, such sole member and/or such
Person’s or such sole member’s spouse, parent, sibling and/or descendants and any self-directed retirement plan for such individual. 
 2.20    “GAAP” means generally accepted accounting principles in the United States of America as in effect from time to time. 

2.21    “Governmental Authority”  means any foreign, federal, state
or local government, or any political subdivision thereof, or any court, agency or other body, organization, group, stock market or exchange exercising any executive, legislative, judicial, quasi-judicial, regulatory or administrative function of
government. 
 2.22    “IFMI, LLC” means IFMI, LLC, a Delaware
limited liability company and a majority owned Subsidiary. 
 2.23    “IFMI LLC
Agreement” means the Amended and Restated Limited Liability Company Agreement of IFMI, LLC, dated as of December 16, 2009 by and among the Company and the Members (as defined therein) that are signatories thereto, as amended.

  
 4 

 2.24    “Judgment” means
any order, ruling, writ, injunction, fine, citation, award, decree, or any other judgment of any nature whatsoever of any Governmental Authority. 
 2.25    “Knowledge of the Company” or words to that effect means the actual knowledge of any of the following Persons: Joseph W. Pooler, Jr., Douglas
Listman, Rachael Fink, Stephan Burklin and James J. McEntee, III; provided, that for purposes of this definition such Persons shall be deemed to have actual knowledge of facts that would be reasonably expected to come to the attention of such Person
in performing his or her duties in accordance with the Company’s or any relevant Subsidiary’s ordinary management practices. 
 2.26    “Law” means any provision of any law, statute, ordinance, code, constitution, charter, treaty, rule or regulation of any Governmental Authority.

 2.27    “Material Adverse Effect”  means any
circumstance, event, change, development, effect or occurrence that, individually or in the aggregate, (i) is or would reasonably be expected to be materially adverse to the Company’s financial position, results of operations, business,
condition (financial or otherwise) or Assets of the Company and its Subsidiaries, taken as a whole or (ii) would materially impair the ability of the Company to perform its obligations under this Agreement or otherwise materially threaten or
materially impede the consummations of the transactions contemplated herein; provided, however, that in the case of clause (i) only, any circumstance, event, change, development, effect or occurrence that results from any of the following shall
be disregarded in determining whether there has been or would be a “Material Adverse Effect” on the Company (except to the extent that such circumstance, event, change, development, effect or occurrence has a disproportionate adverse
effect on the Company and the Subsidiaries relative to other companies engaged in a similar business as the Company): (A) changes, after the Effective Date, in GAAP; (B) changes, after the Effective Date, in Laws or interpretations thereof
applicable to the Company or the Subsidiaries by any Governmental Authority; (C) general changes in the national or world economy or securities markets generally; (D) changes in the price or trading volume of the Common Stock on the
Trading Market (but not the underlying causes of such changes); or (E) the outbreak or escalation of war or hostilities, any occurrence or threats of terrorist acts or any armed hostilities associated therewith or any national or international
calamity, disaster or emergency or escalation thereof. 
 2.28    “Mead Park
Conversion Shares” means the shares of Common Stock into which the Mead Park Note may be converted. 
 2.29    “Meeting” means any meeting of the stockholders of the Company at which the election of Directors is to be voted upon, however called (and
including any postponement or adjournment of any such meeting) and any written consent of the stockholders of the Company with respect to the election of Directors. 

2.30    “Obligation” means any debt, liability or obligation of any
nature whatsoever, whether secured, unsecured, recourse, nonrecourse, liquidated, unliquidated, accrued, absolute, fixed, contingent, ascertained, unascertained, known, unknown or obligations under executory Contracts. 

  
 5 

 2.31    “Permit” means any
license, permit, approval, waiver, order or authorization granted, issued or approved by any Governmental Authority. 
 2.32    “Person” means any individual, sole proprietorship, joint venture, partnership, company, corporation, association, cooperation, trust, estate,
Governmental Authority, or any other entity of any nature whatsoever. 

2.33    “PrinceRidge” means C&Co/PrinceRidge Holdings LP (formerly known
as PrinceRidge Holdings LP), an indirect Subsidiary. 

2.34    “Principal” of any Person means, at the time of determination, each
principal, partner or member of such Person, any spouse or child of each principal, partner or member, and any trust for the benefit of each principal, partner or member or each such principal’s, partner’s or member’s spouse or lineal
descendants. 
 2.35    “Proceeding” means any demand, claim, suit,
action, litigation, investigation, audit, study, arbitration, administrative hearing, or any other proceeding of any nature whatsoever. 
 2.36    “Sandler O’Neill” means Sandler O’Neill & Partners, L.P., the independent financial advisor to the Special Committee. 

2.37    “Securities” means, together, the Common Shares and the Note.

 2.38    “Shell Company” means an issuer that meets the
description of a shell company as defined under Rule 144. 
 2.39    “Significant
Subsidiary” means each of the significant subsidiaries (as such term is defined in Rule 1-02(w) of Regulation S-X) of the Company, as set forth in the Company’s SEC Documents. 

2.40    “Special Committee” means the special committee of independent
directors of the Board of Directors formed in connection with the transactions contemplated by this Agreement and the Transaction Documents. 
 2.41    “Subsidiary” means each subsidiary of the Company. 
 2.42    “Tax” means (i) any foreign, federal, state or local income, profits, gross receipts, franchise, sales, use, occupancy, general property, real
property, personal property, intangible property, transfer, excise, accumulated earnings, unemployment compensation, social security, withholding taxes, payroll taxes, or any other tax of any nature whatsoever, (ii) any foreign, federal, state
or local organization fee, qualification fee, annual report fee, filing fee, occupation fee, or assessment, or (iii) any deficiency, interest or penalty imposed with respect to any of the foregoing. 

2.43    “Tax Return” means any tax return, filing, declaration, information
statement or other form or document required to be filed in connection with or with respect to any Tax. 

  
 6 

 2.44    “Trading Market” means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange or the OTC Bulletin Board (or any successors to any of the foregoing). 

2.45    “Transaction Documents” means (i) any documents or instruments
to be executed by the Company, Buyer, Mead Park Holdings, LP, the Mead Park Buyer, and IFMI, LLC in connection with this Agreement, including the Note, and the Registration Rights Agreement; and (ii) the Voting Agreements, together, in each
case, with all modifications, amendments, extensions, future advances, renewals, and substitutions thereof and thereto. 
 2.46    “Voting Agreement Signatories” means, collectively, Daniel G. Cohen, Christopher Ricciardi, Stephanie Ricciardi, The Ricciardi Family Foundation, James
J. McEntee, III, Joseph W. Pooler, Jr., Doug Listman, Rachael Fink, Walter Beach, Rodney E. Bennett, Thomas P. Costello, G. Steven Dawson, Joseph M. Donovan, Jack Haraburda, Lance Ullom, Charles W. Wolcott and Neil S. Subin. 

In addition, the following terms shall have the respective meanings ascribed to them in the corresponding Sections:

  

			
	Term	  	 Section
	2013 Annual Meeting of Stockholders	  	  Section 6.7

	8-K Filing	  	  Section 6.5

	Agreement	  	  Preamble

	Amended and Restated Cohen Employment Agreement	  	  Recitals

	Articles of Incorporation	  	  Section 5.1

	Benefit Plan	  	  Section 5.18

	Buyer	  	  Preamble

	Buyer Indemnified Parties	  	  Section 9.1

	Bylaws	  	  Section 5.1

	Closing	  	  Section 3.2

	Closing Date	  	  Section 3.2

	Code	  	  Recitals

	Common Share(s)	  	 Recitals

	Common Stock	  	  Recitals

	Common Stock Purchase Price	  	  Recitals

	Company	  	  Preamble

	Company Indemnified Parties	  	  Section 9.2

	Company Proxy Statement	  	  Section 6.7

	Effective Date	  	  Preamble

	Employees	  	  Section 5.18

	ERISA	  	  Section 5.18

	ERISA Plans	  	  Section 5.18

	Exchange Agreement	  	  Recitals

	Investment Company Act	  	  Section 5.17

	Financial Statements	  	  Section 5.7

  
 7 

			
	Term	    	Section
	 LLC Agreement Amendment
	    	 Recitals

	 Listing Application
	    	 Section 6.6

	 Mead Park Buyer
	    	 Preamble

	 Mead Park Note
	    	 Recitals

	 Mead Park Purchase Agreement
	    	 Recitals

	 Mead Park Shares
	    	 Recitals

	 Minority Board Representative
	    	 Section 6.8(a)

	 New Security
	    	 Section 6.9(a)

	 Note
	    	 Recitals

	 Note Purchase Price
	    	 Recitals

	 Pension Plan
	    	 Section 5.18

	 Registration Rights Agreement
	    	 Recitals

	 Rule 144
	    	 Section 5.21

	 Rule 144 Certificate
	    	 Section 6.2(b)ii

	 SEC
	    	 Recitals

	 SEC Documents
	    	 Section 5.7

	 Securities Act
	    	 Recitals

	 Securities Being Sold
	    	 Section 6.2(b)ii

	 Share Reserve
	    	 Section 6.4

	 Shareholder Rights Plan
	    	 Recitals

	 Stockholder Proposal
	    	 Section 6.7

	 Transaction Deadline
	    	 Section 10.1(b)ii

	 Voting Agreements
	    	 Recitals

 ARTICLE III 
 PURCHASE AND SALE OF SECURITIES 

3.1      Purchase and Sale of Securities.  Subject to the satisfaction (or
waiver) of the terms and conditions of this Agreement, on the Closing Date, (i) Buyer agrees to purchase the Securities; and (ii) the Company agrees to sell and to issue to Buyer the Securities for the aggregate amount of the Common Stock
Purchase Price and the Note Purchase Price. 

3.2      Closing.    The closing (the
“Closing”) of the transactions contemplated hereby will occur at the offices of Duane Morris LLP, 30 South 17th Street, Philadelphia, Pennsylvania, commencing at 9:00 a.m. local time on the second (2nd) business day after the satisfaction or waiver of all
conditions in Article VII and Article VIII (other than conditions with respect to actions that the respective parties hereto will take at the Closing), or at such other location and on such other date as the parties mutually determine (the
“Closing Date”). 
 3.3      Form of Payment; Delivery
of Securities.  Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, on the Closing Date, (i) Buyer shall deliver to the Company the Common Stock Purchase Price and the Note Purchase Price, in the
form of wire transfers of immediately available U.S. funds; and (ii) the Company shall deliver to Buyer the Securities, duly executed on behalf of the Company, together with any other documents required to be delivered pursuant to this
Agreement. 

  
 8 

 ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES OF BUYER 
 Buyer represents
and warrants to the Company that: 
 4.1      Organization;
Authority. Buyer is duly organized, validly existing under the laws of the jurisdiction of its organization with the requisite limited liability company power and authority to enter into and to consummate the transactions contemplated by
this Agreement and by each of the Transaction Documents to which Buyer is a party and otherwise to carry out its obligations hereunder and thereunder. The execution, delivery and performance by Buyer of this Agreement and of each of the Transaction
Documents to which Buyer is a party have been duly authorized by all necessary limited liability company action, on the part of Buyer. Each of this Agreement and the Transaction Documents to which Buyer is a party has been (or upon delivery will
have been) duly executed by Buyer, and, when delivered by Buyer in accordance with the terms hereof and thereof, will constitute the valid and legally binding obligation of Buyer, enforceable against it in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles
of general application. 
 4.2      No
Conflicts.    The execution, delivery and performance by Buyer of this Agreement and the Transaction Documents to which Buyer is a party and the consummation by Buyer of the transactions contemplated hereby and thereby will
not (i) result in a violation of the organizational documents of Buyer, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any Contract, indenture or instrument to which Buyer is a party, or (iii) result in a violation of any Law, rule, regulation, order, judgment or decree (including federal and state
securities Laws) applicable to Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material
adverse effect on the ability of Buyer to perform its obligations hereunder. 

4.3      Investment Purpose.  Buyer understands that the Securities are
not, and the Conversion Shares will not be, registered under the Securities Act or any applicable state securities Laws (subject to the Registration Rights Agreement). Buyer is acquiring the Securities and, upon exercise of the Note (if applicable),
will acquire the Conversion Shares issuable upon exercise thereof, as principal for its own account for investment only and not with a view to or for the purpose of distributing or reselling such Securities or Conversion Shares (if applicable) or
any part thereof in violation of the Securities Act or any applicable state securities Laws. Buyer does not presently have any agreement, plan or understanding, directly or indirectly, with any Person to distribute or effect any distribution of any
of the Securities or the Conversion Shares (if applicable) (or any securities which are derivatives thereof) to or through any person or entity; Buyer is not a registered broker-dealer under Section 15 of the Exchange Act or an entity engaged
in a business that would require it to be so registered as a broker-dealer. 

4.4      Accredited Buyer Status; Experience of Buyer. At the time Buyer was
offered the Securities, it was, on each date on which it acquires Securities it will be, and on each date on which it exercises the Note (if applicable) it will be, an “accredited investor” as defined in Rule 501(a) under the Securities
Act. Buyer, either alone or together with its representatives (if any), has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the
Securities, and has so evaluated the merits and risks of such investment. Buyer acknowledges that it can bear the economic risk and complete loss of its investment in the Securities. 

  
 9 

 4.5      Residency. Buyer has its
principal place of business in the State of New York. 
 4.6      Reliance on
Exemptions. Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities Laws and that the Company is relying upon
the truth and accuracy of, and Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of
Buyer to acquire the Securities. 

4.7      Information.    Buyer and its advisors have been
furnished with all materials relating to the business, finances and operations of the Company and information Buyer deemed material to making an informed investment decision regarding its purchase of the Securities, which have been requested by
Buyer. Buyer and its advisors have been afforded with the opportunity to ask questions of the Company and its management. Buyer has sought such accounting, legal, tax and other professional advice as it has considered necessary to make an informed
investment decision with respect to its acquisition of the Securities. 

4.8      Restrictions on Transferability.  Buyer understands that because
the Securities have not have been registered under the Securities Act, Buyer cannot dispose of any or all of the Securities unless such Securities are subsequently registered under the Securities Act or exemptions from registration are available.
Buyer acknowledges and understands that, except as provided in the Registration Rights Agreement, it has no registration rights. By reason of these restrictions, Buyer understands that it may be required to hold the Securities for an indefinite
period of time. Buyer understands that each certificate or other instrument representing the Securities and the Conversion Shares will bear appropriate legends reflecting the foregoing as well as state “blue sky” legends. In addition,
appropriate transfer restrictions will be affixed to any notation in the DRS for any Securities or Conversion Shares. 
 4.9      Brokers and Finders.    Buyer has not employed any Person, or incurred any liability, for any financial advisory, brokerage or
finder’s fee or commission, and no broker or finder has acted directly or indirectly for Buyer, in connection with the transactions contemplated by this Agreement and the Transactions Documents. 

4.10    Independent Investment Decision.  Buyer has evaluated, independently of the
Company, the merits of its decision to purchase the Securities pursuant to this Agreement and the Transaction Documents. Buyer understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Buyer in
connection with the purchase of the Securities constitutes legal, tax or investment advice. 

  
 10 

 ARTICLE V 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 Except as
set forth and disclosed in the disclosure schedule attached to this Agreement and made a part hereof or as set forth in the SEC Documents (excluding any risk factor disclosures contained in such documents under the heading “Risk Factors”
and any disclosure of risks included in any “forward-looking statements” disclaimer or other statements, in each case, that are predictive or forward-looking in nature), the Company hereby makes the following representations and warranties
to Buyer: 
 5.1      Organization and Qualification.  The
Company is an entity duly incorporated, validly existing and in good standing under the laws of the State of Maryland, with the requisite power and authority to own or lease and use its properties and Assets and to carry on its business as currently
conducted and as currently proposed to be conducted. The Company is not in violation of any of the provisions of the Articles of Incorporation or the Bylaws. The Company is duly qualified to conduct business and is in good standing as a foreign
corporation in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, and no Proceeding has been instituted, is pending, or, to the Knowledge of the Company, is threatened in any such jurisdiction revoking, limiting or
curtailing or seeking to revoke, limit or curtail such power and authority or qualification. The Company has furnished or made available to Buyer true, complete and correct copies of: (A) the Company’s Articles of Incorporation, as amended
and as in effect on the Effective Date (the “Articles of Incorporation”); and (B) the Company’s Bylaws, as in effect on the Effective Date (the “Bylaws”). 

5.2      Authorization; Enforcement; Validity.  The Company has the
requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and by each of the Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and
thereunder. The execution, delivery and performance by the Company of this Agreement and of each of the Transaction Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby (including, but not
limited to, the issuance, sale and delivery of the Securities and the reservation for issuance and the subsequent issuance of the Conversion Shares upon exercise of the Note) have been duly authorized by all necessary corporate action on the part of
the Company, and, other than the approval by the Company’s stockholders of the Stockholder Proposal, no further corporate action is required by the Company, the Board of Directors or its stockholders in connection herewith and therewith. Each
of this Agreement and the Transaction Documents to which the Company is a party has been (or upon delivery will have been) duly and validly executed by the Company and is, or when delivered in accordance with the terms hereof will constitute, the
legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application. The Board of Directors has resolved that the transactions contemplated by this Agreement and
the Transaction Documents are in the best interests of stockholders of the Company. 

  
 11 

 5.3      Capitalization.  The
authorized capital stock of the Company consists of: (a) 100,000,000 shares of Common Stock, of which 12,237,104 shares of Common Stock are issued and outstanding as of the Effective Date; (b) 10,000,000 shares of Preferred Stock, par
value $0.001 per share, all of which are designated as Series C Junior Participating Preferred Stock, none of which are issued or outstanding as of the Effective Date; and (c) 50,000,000 shares of Preferred Stock, par value $0.001 per share, of
which 4,983,557 shares are designated as Series E Voting Non-Convertible Preferred Stock, all of which are issued and outstanding as of the Effective Date. All outstanding shares of Common Stock and Series E Voting Non-Convertible Preferred Stock
have been duly authorized, validly issued and are fully paid and nonassessable. The Common Stock is currently quoted on the NYSE MKT under the trading symbol “IFMI,” and the Company has maintained all requirements on its part for the
continuation of such quotation. No shares of Common Stock are subject to preemptive rights or any other similar rights. Except as contemplated hereby and as set forth on Schedule 5.3 hereto, as of the Effective Date: (i) there are no
outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company, or Contracts, commitments,
understandings or arrangements by which the Company is or may become bound to issue additional shares of capital stock of the Company, or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities or rights convertible into, any shares of capital stock of the Company; (ii) there are no outstanding debt securities, notes, credit agreements, credit facilities or other Contracts or instruments evidencing indebtedness of the
Company, or by which the Company is or may become bound; (iii) there are no agreements or arrangements under which the Company is obligated to register the sale of any of its securities under the Securities Act (except pursuant to the
Registration Rights Agreement); (iv) there are no financing statements securing any obligations of the Company; (v) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by this
Agreement or any related agreement or the consummation of the transactions described herein or therein; and (vi) there are no outstanding securities or instruments of the Company which contain any redemption or similar provisions, and there are
no Contracts by which the Company is or may become bound to redeem a security of the Company. Schedule 5.3 attached hereto contains a pro forma beneficial ownership table for the Company giving effect to the transactions contemplated by this
Agreement and the other Transaction Documents. 

5.4      Subsidiaries.  Except as set forth on Schedule 5.4 hereto, the
Company has no other Subsidiaries and all shares of the outstanding capital stock of each Subsidiary are owned directly or indirectly by the Company. All of such shares so owned by the Company are duly authorized, validly issued and are fully paid
and nonassessable, and are owned by it free and clear of any Encumbrance with respect thereto. Each Significant Subsidiary is an entity duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and has
the requisite power and authority to own or lease and use its properties and Assets and to carry on its business as currently conducted and as currently proposed to be conducted, in each case except as would not reasonably be expected to have a
Material Adverse Effect on the Company. Except as set forth on Schedule 5.4 hereto, the Company does not own beneficially, directly or indirectly, more than five percent (5%) of any class of equity securities or similar interests of any
organization, and is not, directly or indirectly, a partner in any partnership or party to any joint venture. Except as set forth on Schedule 5.4 hereto, no equity security of any Subsidiary is or may be required to be issued by reason of any
option, warrant, scrip, right to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of such Subsidiary, and there are no Contracts, commitments,
understandings or arrangements by which any Subsidiary is or may become bound to issue additional shares of its capital stock, or any option, warrant, scrip, right to subscribe to, call or commitment of any character whatsoever relating to, or
securities or rights convertible into, any shares of its capital stock. 

  
 12 

 5.5      No Conflicts; Consents and
Approvals.  The execution, delivery and performance of this Agreement and the Transaction Documents, and the consummation of the transactions contemplated hereby and thereby, including the issuance, sale and delivery of any of the
Securities and the Conversion Shares, and compliance by the Company with any provisions of the Transaction Documents will not: (i) constitute or result in a violation of or conflict with the Articles of Incorporation, Bylaws, or any other
organizational or governing documents of Company or any Subsidiary; (ii) constitute or result in a violation of, or a default or breach under (either immediately, upon notice, upon lapse of time, or both), or conflicts with, or gives to any
other Person any rights of termination, amendment, acceleration or cancellation of, any provision of any Contract, indenture or instrument to which Company or any Subsidiary is a party or by which it may be bound, or to which the Company or any
Subsidiary or any of their Assets or properties may be bound (other than immaterial contracts relating to back office operations, systems and facilities or similar matters); (iii) constitute a violation of, or a default or breach under (either
immediately, upon notice, upon lapse of time, or both), or conflicts with, any Judgment; (iv) assuming that, in connection with the transactions contemplated hereby, the parties hereto timely make all of the filings required by applicable state
securities Laws and under the applicable rules and regulations of the Trading Market constitute a violation of, or conflict with, any Law, rule, regulation, order, judgment or decree (including federal and state securities Laws); or (v) result
in the loss or adverse modification of, or the imposition of any fine, penalty or other Encumbrance with respect to, any Permit granted or issued to, or otherwise held by or for the use of, the Company or any Subsidiary or any of the their Assets or
properties; except, in the case of clause (v), for such violations, defaults, breaches, conflicts, losses, modifications or impositions that have not had and would not reasonably be expected to have a Material Adverse Effect. The Company is not in
default or breach (and no event has occurred which with notice or lapse of time or both could put the Company in default or breach) under, and the Company has not taken any action or failed to take any action that would give to any other Person any
rights of termination, amendment, acceleration or cancellation of, any material Contract to which the Company is a party or by which any property or Assets of the Company are bound or affected. Except with respect to the SEC and the Trading Market
and as specifically contemplated by this Agreement or the Transaction Documents, the Company is not required to obtain any Consent of, from, or with any Governmental Authority, or any other Person, and no expiration or termination of any statutory
waiting period is necessary, in order for the Company to execute, deliver or perform any of its obligations under this Agreement and the Transaction Documents in accordance with the terms hereof or thereof, or to issue, sell and deliver the
Securities and the Conversion Shares in accordance with the terms hereof and thereof. All Consents which the Company is required to obtain pursuant to the immediately preceding sentence have been obtained or effected on or prior to the Effective
Date or will be obtained or effected on or prior to Closing or as otherwise required under the rules and regulations of the applicable Governmental Authority. 

  
 13 

 5.6      Issuance of
Securities.  The Securities to be issued pursuant to this Agreement have been duly authorized by all necessary corporate action of the Company and, upon issuance in accordance with the terms hereof, the Common Shares, the Note and the
Conversion Shares, as applicable, shall be duly and validly issued, fully paid and non-assessable, and free from all Encumbrances with respect to the issue thereof, and, assuming the accuracy of the representations and warranties of Buyer set forth
in Article IV above, will be issued in compliance with all applicable United States federal and state securities Laws. 
 5.7      Listing and Maintenance Requirements; SEC Documents; Financial Statements.  The Company’s Common Stock is registered pursuant to
Section 12(b) of the Exchange Act, and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act, nor has the Company received any notification
that the SEC is contemplating terminating such registration. The Company has filed all reports, schedules, forms, statements and other documents, together with any amendments thereto, required to be filed by it with the SEC under the Exchange Act
(all of the foregoing filed within the two (2) years preceding the Effective Date and all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference therein, being hereinafter referred to as
the “SEC Documents”). The Company is current with its filing obligations under the Exchange Act and there are no outstanding comments from the SEC with respect to any report, schedule, form, statement and other document
required to be filed by it with the SEC under the Exchange Act. The Company represents and warrants that true and complete copies of the SEC Documents are available on the SEC’s website (www.sec.gov) at no charge. As of their respective dates,
the SEC Documents complied in all material respects with the applicable requirements of the Exchange Act, and none of the SEC Documents, at the time they were filed with or furnished to the SEC, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. No executive officer of the Company has failed in any
respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act of 2002. To the Knowledge of the Company as of the Effective Date, there are no facts or circumstances that would prevent its current
Chief Executive Officer and Chief Financial Officer from giving the certifications and attestations required pursuant to Rules 13a-14 and 15d-14 under the Exchange Act, without qualification, with respect to the Quarterly Report on Form 10-Q for the
fiscal quarter ended March 31, 2013. As of their respective dates, the financial statements of the Company included in the SEC Documents (collectively, the “Financial Statements”) (i) have been prepared from the
books and records of the Company and the Subsidiaries, (ii) complied in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (iii) have been prepared in
accordance with GAAP, consistently applied during the periods involved and (iv) fairly present in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations
and comprehensive income/loss, changes in equity and cash flows for the periods then ended, subject, in the case of unaudited statements, to the absence of notes and normal year-end audit adjustments. 

  
 14 

 5.8      Absence of Certain
Changes.  Except as otherwise disclosed to Buyer in writing on or prior to the date hereof, since the date upon which the last of the SEC Documents was filed with the SEC, there has been no event or circumstance of any nature
whatsoever that has resulted in, or would reasonably be expected to result in, a Material Adverse Effect. 

5.9      Absence of Litigation; No Undisclosed Liabilities.  Except as
otherwise disclosed to Buyer in writing on or prior to the date hereof or as would not reasonably be expected to have a Material Adverse Effect, (i) there is no Proceeding before or by any Governmental Authority or any other Person, pending, or
to the Knowledge of the Company, threatened or contemplated by, against or affecting the Company or any Subsidiary, or their Assets; and (ii) there are no outstanding Judgments against or affecting the Company, any Subsidiary, or their Assets.
There are no obligations that are not appropriately reflected or reserved against in the financial statements described in Section 5.7 to the extent required to be so reflected or reserved against in accordance with GAAP, except for
(i) liabilities that have arisen since December 31, 2012 in the ordinary course of business consistent with past practice and (ii) liabilities that have not had and would not reasonably be expected to have a Material Adverse Effect.

 5.10    Title to Assets.  Except as set forth on Schedule 5.10 hereto,
the Company or a Significant Subsidiary has good and marketable title to, or a valid leasehold interest in, all of its Assets which are material to the business and operations of the Company and the Significant Subsidiaries as presently conducted,
free and clear of all Encumbrances or restrictions on the transfer or use of same. Except as would not have a Material Adverse Effect, the Company’s Assets are in good operating condition and repair, ordinary wear and tear excepted. 

5.11    Compliance with Laws.  The Company and the Subsidiaries (i) are in
material compliance with all applicable Laws and Judgments; (ii) to the Knowledge of the Company, have all material Permits and such Permits are in full force and effect and no material suspension or cancellation of any of them is threatened;
and (iii) to the Knowledge of the Company, are not under investigation with respect to, and have not been threatened to be charged with or given notice of, any material violation of all applicable Laws and Judgments. 

5.12    No Directed Selling Efforts or General Solicitation.  Neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has conducted any “general solicitation” or “general advertising” (as those terms are used in Regulation D promulgated under the Securities Act) in
connection with the offer or sale of any of the Securities. 

  
 15 

 5.13    Tax Matters.  The Company and
each of its Affiliates has made and timely filed all United States federal income Tax Returns and all foreign income Tax Returns and all other material Tax Returns required to be filed by it, and each such Tax Return has been prepared in material
compliance with all applicable Laws, and all such Tax Returns are true and accurate in all material respects. Except and only to the extent that the Company or any of its Affiliates, as the case may be, has set aside on its books provisions
reasonably adequate for the payment of all unpaid and unreported Taxes, the Company and each of its Affiliates has timely paid all Taxes shown or determined to be due on such Tax Returns, except those being contested in good faith, and the Company
and each of its Affiliates has set aside on its books provision reasonably adequate for the payment of all Taxes for periods subsequent to the periods to which such Tax Returns apply. There are no unpaid Taxes of the Company or any of its Affiliates
in any material amount claimed to be due by the taxing authority of any jurisdiction, and, to the Knowledge of the Company, no basis for any such claim. The Company and each of its Affiliates has withheld and paid all Taxes to the appropriate
Governmental Authority required to have been withheld and paid in connection with amounts paid or owing to any Person. There is no Proceeding or Claim for refund now in progress, pending or threatened against or with respect to the Company or any of
its Affiliates, in each case, regarding Taxes. Neither the Company nor any of its Affiliates has waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency, in each case,
that is still in effect, or has pending a request for any such extension or waiver. Neither the Company nor any of its Affiliates has entered into any “listed transaction” within the meaning of Treasury Regulations section 1.6011-4(b)(2).
Neither the Company nor any of its Affiliates has liability for the Taxes of any person other than the Company or any of its Affiliates under Treasury Regulations section 1.1502-6 (or any similar provision of state, local or foreign law). Neither
the Company nor any of its Affiliates is party to, bound by or has any obligation under any Tax allocation, Tax sharing, Tax indemnity or similar agreement, arrangement or understanding (other than any agreement, arrangement or understanding solely
among the Company and its Affiliates). Neither the Company nor any of its Affiliates is currently subject to a section 382 limitation, as defined in section 382 of the Code, with respect to any of its Tax attributes. The representation made in the
previous sentence will be true immediately after the end of the Closing Date. The aggregate amount of the net operating loss carryovers for United States federal income tax purposes of the Company and its Affiliates as of December 31, 2011
equals or exceeds $88,830,601 and as of December 31, 2012, as currently estimated in good faith by the Company (but subject to future adjustment), equals or exceeds $86,051,682, and Schedule 5.13 attached hereto sets forth the dates on which
such net operating loss carryforwards expire. The aggregate amount of the net capital loss carryovers for United States federal income tax purposes of the Company and its Affiliates as of December 31, 2011 equals or exceeds $41,251,297 and as
of December 31, 2012, as currently estimated in good faith by the Company (but subject to future adjustment), equals or exceeds $58,892,311, and Schedule 5.13 attached hereto sets forth the dates on which such net capital loss carryforwards
expire. 
 5.14    Internal Accounting Controls.    The Company
maintains a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as
necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to Assets is permitted only in accordance with management’s general or specific authorization; and
(iv) the recorded accountability for Assets is compared with the existing Assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company (A) has implemented and maintains disclosure controls and
procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that material information relating to the Company, including its consolidated Subsidiaries, is made known to the Chief Executive Officer and the Chief Financial Officer of the
Company by others within those entities, and (B) has disclosed, based on its most recent evaluation prior to the date of this Agreement, to the Company’s outside auditors and the audit committee of the Board of Directors (x) any
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that are reasonably likely to adversely affect the Company’s ability to
record, process, summarize and report financial information, and (y) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls over financial reporting.
Since December 31, 2010, (i) neither the Company nor any Subsidiary nor, to the Knowledge of the Company, any director, officer, employee, auditor, accountant or representative of the Company or any Subsidiary has received, or otherwise
had or obtained knowledge of, any complaint, allegation, assertion or claim that the Company or any Subsidiary has engaged in questionable accounting or auditing practices, and (ii) no attorney representing the Company or any Subsidiary,
whether or not employed by the Company or any Subsidiary, has reported evidence of a material violation of securities laws, breach of fiduciary duty or similar violation by the Company or any of its officers, directors, employees or agents to the
Board of Directors or any committee thereof or to any director or officer of the Company. 

  
 16 

 5.15    Acknowledgment Regarding Buyer’s
Purchase of the Securities. The Company acknowledges and agrees that Buyer is acting solely in the capacity of an “arm’s length” purchaser with respect to this Agreement and the transactions contemplated hereby. The Company
further acknowledges that Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any advice given by Buyer or any of its
representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to Buyer’s purchase of the Securities. The Company further represents to Buyer that the Company’s decision to enter
into this Agreement has been based solely on the independent evaluation by the Company and its representatives. 

5.16    Brokerage Fees.  There is no Person acting on behalf of the Company as
placement agent in connection with the transactions contemplated hereby, and, other than the Special Committee’s retention of Sandler O’Neill, there is no Person acting on behalf of the Company who is entitled to or has any claim for any
financial advisory, brokerage or finder’s fee or commission in connection with the execution of this Agreement or the transactions contemplated hereby. 
 5.17    Investment Company.    The Company is not an “investment company” as defined under the Investment Company Act of 1940, as amended (the
“Investment Company Act”), and the Company does not sponsor any person that is such an investment company. 

  
 17 

 5.18    Employee
Matters.    All benefit and compensation plans, contracts, policies, programs or arrangements covering current or former employees, Directors and consultants of the Company and its Subsidiaries (the
“Employees”), including, but not limited to, “employee benefit plans” within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and employment,
consulting, retirement, pension, severance, termination, change in control, vacation, deferred compensation, stock option, stock purchase, stock appreciation rights, equity based, incentive, bonus, profit sharing, insurance, medical, welfare, fringe
or other benefit plans, contracts, policies, programs or arrangements (the “Benefit Plans”) are listed in this Schedule 5.18 attached hereto, and each Benefit Plan which has received a favorable opinion letter from the Internal
Revenue Service National Office, including any master or prototype plan, has been separately identified. All Benefit Plans are in substantial compliance with ERISA, the Code and other applicable laws. Each Benefit Plan which is subject to ERISA (the
“ERISA Plans”) that is an “employee pension benefit plan” within the meaning of Section 3(2) of ERISA (“Pension Plan”) and that is intended to be qualified under Section 401(a) of the Code, has
received a favorable determination letter from the Internal Revenue Service and, to the Knowledge of the Company, there are no circumstances likely to result in revocation of any such favorable determination letter or the loss of the qualification
of such Pension Plan under Section 401(a) of the Code. Neither the Company nor any Subsidiary has engaged in a transaction with respect to any ERISA Plan that, assuming the taxable period of such transaction expired as of the Effective Date,
could subject the Company or any Subsidiary to a tax or penalty imposed by either Section 4975 of the Code or Section 502(i) of ERISA in an amount which would be material. Neither the Company nor any of the Subsidiaries has incurred or
reasonably expects to incur a material tax or penalty imposed by Section 4980F of the Code or Section 502 of ERISA. Neither the Company, any Subsidiary nor any entity which is considered one employer with the Company under
Section 4001 of ERISA or Section 414 of the Code (x) maintains or contributes to or has within the past six years maintained or contributed to a Pension Plan that is subject to Subtitles C or D of Title IV of ERISA or
(y) maintains or has an obligation to contribute to or has within the past six years maintained or had an obligation to contribute to a multiemployer plan, as defined in Section 3(37) of ERISA. All contributions required to be made under
each Benefit Plan, as of the Effective Date, have been timely made and all obligations in respect of each Benefit Plan have been properly accrued and reflected in the Financial Statements. As of the Effective Date, there is no material pending or,
to the Knowledge of the Company threatened, litigation relating to the Benefit Plans. Neither the Company nor any Subsidiary has any obligations for retiree health and life benefits under any Benefit Plan or collective bargaining agreement. The
Company or its Subsidiaries may amend or terminate any such retiree health and life plan at any time without incurring any liability thereunder other than in respect of claims incurred prior to such amendment or termination. There has been no
amendment to, announcement by the Company or any Subsidiary relating to, or change in participation or coverage under, any Benefit Plan which would increase materially the expense of maintaining such plan above the level of the expense incurred
therefor for the most recent fiscal year. None of the transactions contemplated by this Agreement or the other Transaction Documents, individually or in the aggregate, (i) constitute a “change in control” or “change of
control” (or phrases of similar import) within the meaning of any Benefit Plan, (ii) result in any payment or benefit (including severance, unemployment compensation, “excess parachute payment” (within the meaning of
Section 280G of the Code), forgiveness of indebtedness or otherwise) becoming due to any Employee, the Directors or any consultant of the Company or any Subsidiary under any Benefit Plan, (iii) result in payments under any of the Benefit
Plans which would not be deductible under Section 162(m) of the Code, (iv) increase any compensation or benefits otherwise payable under any Benefit Plan, (v) result in any acceleration of the time of payment or vesting of any such
benefits, (vi) require the funding or increase in the funding of any such benefits, or (vii) result in any limitation on the right of the Company or any Subsidiary to amend, merge, terminate or receive a reversion of assets from any
Benefit Plan or related trust. 
 5.19    Risk Management;
Derivatives.  The Company and the Significant Subsidiaries have in place risk management policies and procedures designed to protect against material risks of the type and in amounts reasonably expected to be incurred by Persons of
similar size and in similar lines of business as the Company and the Significant Subsidiaries. 

  
 18 

 5.20      Foreign Corrupt Practices and
International Trade Sanctions.  To the Knowledge of the Company, neither the Company nor any Subsidiary, nor any of their respective directors, officers, agents, employees or any other persons acting on their behalf (i) has
violated the Foreign Corrupt Practices Act, 15 U.S.C. § 78dd-1 et seq., as amended, or any other similar applicable foreign, federal, or state legal requirement; (ii) has made or provided, or caused to be made or provided, directly or
indirectly, any payment or thing of value to a foreign official, foreign political party, candidate for office or any other person knowing that the person shall pay or offer to pay the foreign official, party or candidate, for the purpose of
influencing a decision, inducing an official to violate their lawful duty, securing any improper advantage, or inducing a foreign official to use their influence to affect a governmental decision; (iii) has paid, accepted or received any
unlawful contributions, payments, expenditures or gifts; (iv) has violated or operated in noncompliance with any export restrictions, money laundering law, anti-terrorism law or regulation, anti-boycott regulations or embargo regulations; or
(v) is currently subject to any United States sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department. 
 5.21      Rule 144.    With a view to making available to Buyer the benefits of Rule 144 promulgated under the Securities Act (“Rule
144”), or any similar rule or regulation of the SEC that may at any time permit Buyer to sell any of the Securities to the public without registration, the Company represents and warrants that: (i) the Company is, and has been for
a period of at least ninety (90) days immediately preceding the Effective Date, subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; (ii) the Company has filed all required reports under Section 13 or
15(d) of the Exchange Act, as applicable, during the twelve (12) months preceding the Closing Date (or for such shorter period that the Company was required to file such reports); and (iii) the Company is not and has not been an issuer
defined as a Shell Company. 
 Buyer acknowledges and agrees that the Company makes no representations or
warranties whatsoever, express or implied, except for those specifically set forth in this Article V, in any certificate delivered hereto or in any other Transaction Document. 
 ARTICLE VI 
 COVENANTS 

6.1        Use of Proceeds.  The proceeds from the purchase and
sale of the Securities shall be used by the Company for general corporate purposes. 

6.2        Affirmative Covenants of the Company.  Following the
Closing, for so long as Buyer, Daniel G. Cohen and its or their controlled Affiliates, Principals and Family Group members collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all
Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock), unless waived in writing by Buyer: 
 (a)      Reporting Status; Listing.  The Company shall (i) file all reports required to be filed under the Securities Act, under the Exchange Act, under
any federal or state securities Laws and regulations applicable to the Company, and under the rules and regulations of the Trading Market; and (ii) comply in all material respects with the Company’s required reporting, filing and other
obligations under the Bylaws or rules of the Trading Market. 

  
 19 

 (b)      Rule 144.  The
Company shall: 
   i.           use its
reasonable best efforts to make, keep and ensure that adequate current public information with respect to the Company, as required in accordance with Rule 144, is publicly available; 

 ii.          furnish to Buyer, promptly upon reasonable request,
such statements, reports, documents or other information as may be reasonably requested by Buyer to permit Buyer to sell any of the Securities or Conversion Shares pursuant to Rule 144 without limitation or restriction; 

iii.         promptly, at the request of Buyer, give the Company’s
transfer agent instructions to the effect that, upon the transfer agent’s receipt from Buyer of a certificate (a “Rule 144 Certificate”) certifying the eligibility for sale under Rule 144 of any portion of the Securities
or Conversion Shares which Buyer proposes to sell (the “Securities Being Sold”), and receipt by the transfer agent of a “Rule 144 Opinion” from the Company or its counsel (or from Buyer and its counsel), the
transfer agent is to effect the transfer of the Securities Being Sold and issue to such transferee(s) thereof the transferred Securities Being Sold. If the transfer agent requires any additional documentation in connection with any proposed transfer
by Buyer of any Securities Being Sold, then the Company shall promptly deliver or cause to be delivered to the transfer agent or to any other Person, all such additional documentation as may be necessary to effectuate the transfer of the Securities
Being Sold and the issuance of an unlegended certificate to any transferee thereof, all at the Company’s expense; and 
 iv.         take such further action as Buyer may reasonably request, all to the extent required from time to time to enable Buyer to sell the Securities or
the Conversion Shares without registration under the Securities Act. 

(c)      Access to Books and Records.  The Company shall afford to Buyer
and its representatives (including officers and employees of Buyer, and counsel, accountants and other professionals retained by Buyer), during normal business hours and upon reasonable notice to the Company, such access to the Company’s books,
records, properties and personnel and to such other information as Buyer (if Buyer is not Daniel G. Cohen) may reasonably request; provided, however, that the Company may withhold such access to Buyer (if Buyer is not Daniel G. Cohen) or any such
representative in the event that Buyer or such representative shall fail to execute a confidentiality agreement in a form reasonably satisfactory to the Company. 

(d)      Efforts.  The Company shall use reasonable best efforts to
prepare and file all necessary documentation, to effect all necessary applications, notices, petitions, filings and other documents, and to obtain all necessary Consents or Permits, or any exemption by, all third parties and Governmental
Authorities, and expiration or termination of any applicable waiting periods, necessary or advisable to consummate the transactions contemplated by this Agreement and the other Transaction Documents and to perform covenants contemplated by this
Agreement and the other Transaction Documents. 
 6.3        Fees and
Expenses.  Each party shall bear its own expenses in connection with the transactions contemplated by this Agreement and the Transaction Documents; provided, however, that in the event that Buyer terminates this Agreement under
Section 10.1(b)i or Section 10.1(e)(i) or the Company terminates this Agreement under Section 10.1(f)(ii), the Company will reimburse Buyer for all out-of-pocket expenses incurred by Buyer and its Affiliates in connection with due
diligence, the negotiation and preparation of this Agreement, the Transaction Documents and the undertaking of the transactions contemplated herein and therein (including fees and expenses of counsel), up to an aggregate maximum amount of Three
Hundred Thousand Dollars ($300,000). 

  
 20 

 6.4      Reservation of
Shares.  The Company shall, at all times, have authorized and reserved for the purpose of issuance, such number of shares of Common Stock as shall be necessary for the issuance of all of the Conversion Shares upon conversion of the
Note (collectively, the “Share Reserve”). If at any time the Share Reserve is insufficient, then the Company shall, as soon as reasonably practicable, take all required measures to implement an increase of the Share Reserve
accordingly. If the Company does not have sufficient authorized and unissued shares of Common Stock available to increase the Share Reserve, then the Company shall call and hold a special meeting of the stockholders of the Company within ninety
(90) business days of such occurrence, for the purpose of increasing the number of shares of Common Stock authorized, and, at any such special meeting, the Company’s management shall recommend to the stockholders to vote in favor of
increasing the number of shares of Common Stock authorized. 

6.5      Disclosure of Transactions and Other Material Information.  The
Company shall, on or before 8:30 a.m., New York City time, on the first (1st) trading day after the date of this Agreement, issue a press release disclosing the material terms of the transactions contemplated by this Agreement and the Transaction Documents. On or before 5:30
p.m., New York City time, on the second
(2nd) business day after the date of this Agreement,
the Company shall file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by this Agreement and by the Transaction Documents in the form required by the Exchange Act (the “8-K
Filing”). None of the Company, its Subsidiaries, or Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated by this Agreement or by the Transaction Documents without the express
written consent of all of the other parties to this Agreement (such consent not to be unreasonably withheld or delayed); provided, however, that the Company shall be entitled, without the prior approval of Buyer, to file the 8-K Filing or other
public disclosure as is required by applicable Law and regulations, subject to providing Buyer with reasonable opportunity to comment thereon. Notwithstanding the foregoing, the Company shall not publicly disclose the name of Buyer or any of its
Affiliates, or include the name of Buyer or any of its Affiliates in any filing with the SEC or any regulatory agency or Trading Market, without the prior consent of Buyer (such consent not to be unreasonably withheld or delayed), except:
(a) as required by federal securities Laws in connection with (x) the 8-K Filing, (y) any registration statement contemplated by the Registration Rights Agreement, or (z) the filing of this Agreement and the final Transaction
Documents with the SEC; and (b) to the extent that such disclosure is required by Law or Trading Market rules and regulations, in which case the Company shall provide Buyer with prior notice of such disclosure permitted under this clause (b).

 6.6      NYSE MKT Listing Application.  Following the
Effective Date and prior to the Closing, the Company shall prepare and file with the NYSE MKT an Additional Listing Application (the “Listing Application”) relating to the Common Shares and the Conversion Shares. 

  
 21 

 6.7        Stockholder Meeting
and Company Proxy Statement. As promptly as reasonably possible following the Effective Date, but in any event within forty-five (45) days of the Effective Date, the Company shall call a meeting of its stockholders (the
“2013 Annual Meeting of Stockholders”) to vote on, among other things, proposals (collectively, the “Stockholder Proposal”) regarding the issuance of the Common Shares, the Conversion Shares, the Mead
Park Shares and the Mead Park Conversion Shares for purposes of Sections 711 and 713 of the NYSE MKT’s Company Guide, as applicable. The Board of Directors shall recommend to the Company’s stockholders that such stockholders approve the
Stockholder Proposal, and shall not modify or withdraw such resolution. In connection with the 2013 Annual Meeting of Stockholders, the Company shall promptly prepare and file with the SEC a Definitive Proxy Statement on Schedule 14A pursuant to
Section 14(a) of the Exchange Act (the “Company Proxy Statement”), shall use its reasonable best efforts to solicit proxies for such stockholder approval and shall use its reasonable best efforts to respond to any
comments of the SEC or its staff and to cause a definitive proxy statement related the 2013 Annual Meeting of Stockholders to be mailed to the Company’s stockholders promptly after clearance by the SEC. The Company shall notify Buyer promptly
of the receipt of any comments from the SEC or its staff with respect to the Company Proxy Statement and of any request by the SEC or its staff for amendments or supplements to such proxy statement or for additional information and shall supply
Buyer with copies of all correspondence between the Company or any of its representatives, on the one hand, and the SEC or its staff, on the other hand, with respect to such proxy statement. If at any time prior to the 2013 Annual Meeting of
Stockholders there shall occur any event that is required to be set forth in an amendment or supplement to the Company Proxy Statement, the Company shall promptly prepare and mail to its stockholders such an amendment or supplement. The Company
agrees promptly to correct any information provided by it or on its behalf for use in the Company Proxy Statement if and to the extent that such information shall have become false or misleading in any material respect, and the Company shall
promptly prepare and mail to its stockholders an amendment or supplement to correct such information to the extent required by applicable Laws. The Company shall consult with Buyer prior to mailing the Company Proxy Statement, or any amendment or
supplement thereto, and provide Buyer with reasonable opportunity to comment thereon. The Board of Directors’ recommendation described in this Section 6.7 shall be included in the Company Proxy Statement. 

6.8        Board Representatives. 

(a)      Minority Board Representative.  Following the Closing, if Buyer,
Daniel G. Cohen and its or their controlled Affiliates, Principals and Family Group members collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and
Convertible IFMI LLC Units as outstanding shares of the Common Stock) as of the record date of a Meeting, then: 
 i.          Buyer shall be entitled to designate one (1) individual (the “Minority Board Representative”) to stand for
election to the Board of Directors at such Meeting; provided, however, that such Minority Board Representative shall have satisfied all of the requirements applicable to the Directors under applicable Law, the Articles of Incorporation, the Bylaws
and any customary director qualification standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing; and 

  
 22 

 ii.          the Board of
Directors shall (i) nominate such Minority Board Representative for election to the Board of Directors at such Meeting; (ii) recommend to the Company’s stockholders the election of the Minority Board Representative at such Meeting;
and (iii) solicit proxies for such Minority Board Representative in connection with such Meeting to the same extent as it does for any of its other nominees to the Board of Directors. 

(b)      Upon any Minority Board Representative’s death, resignation, retirement,
disqualification or removal from office as a Director (including by failure to elect or re-elect), if there is a vacancy on the Board of Directors as a result of such occurrence, then: 

 i.          Buyer shall have the right to designate the
successor for such Minority Board Representative; provided, however, that such successor shall have satisfied all of the requirements applicable to the Directors under applicable Law, the Articles of Incorporation, the Bylaws and any customary
director qualification standards in effect as of the Effective Date and disclosed to Buyer or adopted by the Board of Directors after the Closing; and 
 ii.          the Board of Directors take all necessary actions to fill the vacancy resulting therefrom with such successor. 

(c)      Removal of Board Representatives.  Notwithstanding any other
provision of this Agreement, if Buyer, Daniel G. Cohen and its or their controlled Affiliates, Principals and Family Group members collectively own less than ten percent (10%), then (A) the terms and conditions set forth in Section 6.9(a)
and Section 6.9(b) shall be null and void; and (B) if so requested by the Board of Directors (in its sole discretion), Buyer shall cause the Minority Board Representative or any of its successors designated by Buyer pursuant to
Section 6.9(a) and Section 6.9(b), to resign from his or her position as Director. 

6.9        Gross-Up Rights. 

(a)      Sale of New Securities. After the Closing, for so long as Buyer,
Daniel G. Cohen and its or their controlled Affiliates, Principals and Family Group members collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and
Convertible IFMI LLC Units as outstanding shares of the Common Stock) (before giving effect to any issuances triggering provisions of this Section 6.9), at any time that the Company or IFMI, LLC makes any public or nonpublic offering or sale of
any equity (including the Common Stock, or any preferred stock or restricted stock), or any securities, options or debt that is convertible or exchangeable into equity (including Convertible IFMI LLC Units) or that includes an equity component (such
as, an “equity” kicker) (including any hybrid security) (any such security, a “New Security”) other than (i) pursuant to the granting or exercise of employee stock options or other stock incentives pursuant to
the Company’s stock incentive plans approved by the Board of Directors (so long as the authorized awards under the Company’s stock incentive plans represent less than ten percent (10%) of the outstanding shares of the Company’s
capital stock) or the issuance of capital stock pursuant to any employee stock purchase plan of the Company approved by the Board of Directors or similar plan where stock is being issued or offered to a trust, other entity or otherwise, for the
benefit of any employees, officers or directors of the Company, in each case, in the ordinary course of providing incentive compensation, (ii) issuances of capital stock as full or partial consideration for a merger, acquisition, joint venture,
strategic alliance, license agreement or other similar nonfinancing transaction, (iii) issuances of shares of the Common Stock upon the conversion or exercise of any convertible preferred stock or notes outstanding as of the Effective Date or
issued pursuant to the Transaction Documents, in each case, in accordance with the terms thereof as of the Effective Date); (iv) issuances of rights, stock or other property pursuant to the Shareholder Rights Plan; or (v) issuances of
Convertible IFMI LLC Units pursuant to Section 6.10(x) or (y) of the IFMI LLC Agreement, Buyer shall be afforded the opportunity to acquire from the Company and/or IFMI, LLC for the same price (net of any underwriting discounts or sales
commissions) and on the same terms as New Securities are proposed to be offered to others, up to the amount of New Securities in the aggregate required to enable it to maintain its proportionate equivalent interest in the Company immediately prior
to any such issuance of New Securities (counting for such purposes all Conversion Shares and Convertible IFMI LLC Units as outstanding shares of the Common Stock). 

  
 23 

 (b)      Notice.  In the
event the Company and/or IFMI, LLC proposes to offer or sell New Securities that are subject to Buyer’s rights under Section 6.9(a), the Company and/or IFMI, LLC (as applicable) shall give Buyer written notice of its intention, describing
the price (or range of prices), anticipated amount of securities, timing and other terms upon which the Company and/or IFMI, LLC proposes to offer the same (including, in the case of a registered public offering and to the extent possible, a copy of
the prospectus included in the registration statement filed with respect to such offering), no later than five (5) business days, as the case may be, after the initial filing of a registration statement with the SEC with respect to an
underwritten public offering, after the commencement of marketing with respect to a Rule 144A offering or after the Company and/or IFMI, LLC proposes to pursue any other offering. Buyer shall then have ten (10) business days from the date of
receipt of such a notice to notify the Company and/or IFMI, LLC (as applicable) in writing that it intends to exercise its rights provided in this Section 6.9 and as to the amount of New Securities Buyer desires to purchase, up to the maximum
amount calculated pursuant to Section 6.9(a). Such notice shall constitute a nonbinding indication of interest of Buyer to purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s and/or
IFMI, LLC’s notice to it. The failure of Buyer to respond within such ten (10) business day period shall be deemed to be a waiver of Buyer’s rights under this Section 6.9 only with respect to the offering described in the
applicable notice. The Company shall cause IFMI, LLC to comply with this Section 6.9. 

6.10    Redemption Transactions.  Following the Closing, for so long as Buyer,
Daniel G. Cohen and its or their controlled Affiliates, Principals and Family Group members collectively own ten percent (10%) or more of the outstanding shares of the Common Stock (counting for such purposes all Conversion Shares and
Convertible IFMI LLC Units as outstanding shares of the Common Stock), the Company shall not redeem, recapitalize or repurchase any shares of capital stock of the Company, or rights, options or warrants to purchase shares of capital stock of the
Company, or securities of any type whatsoever that are, or may become, convertible into or exchangeable into or exercisable for capital stock of the Company (except with respect to the Conversion Shares) unless Buyer is given the right to
participate in such redemption, recapitalization, or repurchase in a pro rata manner. 

  
 24 

 6.11      Additional Covenants Prior to
Closing.  Prior to the earlier of the Closing Date and the termination of this Agreement pursuant to Section 10.1, except as expressly provided in this Agreement or as otherwise consented to in writing in advance by Buyer:

 (a)      The Company shall promptly provide Buyer with written notice of the
occurrence of any circumstance, event, change, development or effect occurring after the date hereof and relating to the Company or any Subsidiary of which the Company has Knowledge and which constitutes a Material Adverse Effect or otherwise causes
or renders any of the representations and warranties of the Company or any Subsidiary, as applicable, set forth in this Agreement to be inaccurate. 
 (b)      The Company shall not agree to any amendment, waiver or modification of the Transaction Documents to which Buyer is not a party. 

(c)      The Company will not modify, in any manner, the limited liability company
agreement of IFMI, LLC, other than by the effectiveness of the LLC Agreement Amendment, which amendment shall not be modified in any manner. 
 (d)      The Company shall and shall cause the Subsidiaries to take all actions necessary to ensure that none of the transactions contemplated by this Agreement or the other
Transaction Documents, individually or in the aggregate, shall give rise to a “change in control” or “change of control,” the acceleration of any right, or result in any additional rights, under any Benefit Plan. 

(e)      The Company shall, and shall cause each Subsidiary to conduct its and their
businesses only in the ordinary course of business consistent with past practice and shall use reasonable best efforts to maintain and preserve its and each Subsidiary’s business (including its business organization, Assets, goodwill and
insurance coverage) and preserve business relationships with customers, strategic partners and others having business dealings with it. 
 (f)      Except as required pursuant to any existing written, binding agreements in effect prior to the date of this Agreement, the Company shall not, and shall cause each
Subsidiary to not, take any of the following actions: 

 i.          other than in the ordinary course of business, incur
any indebtedness for borrowed money, assume, guarantee, endorse or otherwise as an accommodation become responsible for the obligations of any other Person or incur any indebtedness of the Company that would be senior in right of payment or any
other respect to the Note; 
 ii.          (A) adjust, split,
combine or reclassify any capital stock of the Company; (B) make, declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase or otherwise acquire, any shares of capital stock or any securities or
obligations convertible into or exchangeable for any shares of the capital stock (except dividends paid by any Subsidiary to the Company or any of the Company’s other wholly-owned Subsidiaries and regular quarterly dividends in an amount not to
exceed $0.02 per share); (C) grant any stock options, stock appreciation rights, performance shares, restricted stock units, restricted shares or other equity-based awards or interests, or grant any Person any right to acquire any shares of
capital stock; or (D) issue, sell or otherwise permit to become outstanding any additional shares of capital stock or securities convertible or exchangeable into, or exercisable for, any shares of its capital stock or any options, warrants, or
other rights of any kind to acquire any shares of capital stock, except pursuant to the exercise of stock options or the settlement of equity compensation awards outstanding as of the Effective Date in accordance with their terms or as otherwise
permitted by this Agreement; 

  
 25 

 iii.          sell,
transfer, mortgage, encumber or otherwise dispose of any of its material properties or Assets to any Person other than a wholly-owned Subsidiary, or cancel, release or assign any indebtedness to any such Person or any Claims held by any such Person,
in each case other than in the ordinary course of business or pursuant to contracts or agreements in force at the date of this Agreement; 
 iv.          except for transactions in the ordinary course of business or pursuant to Contracts or agreements in force at the date of this Agreement or
permitted by this Agreement, make any material investment either by purchase of stock or securities, contributions to capital, property transfers, or purchase of any property or non-investment assets of any other Person other than a wholly-owned
Subsidiary or make any capital expenditure in excess of Two Hundred Thousand Dollars ($200,000); 

 v.          except for transactions in the ordinary course of
business, terminate, materially amend, or waive any material provision of, any material Contract, as the case may be, or make any change in any instrument or agreement governing the terms of any of its securities, or material Contract, other than
normal renewals of Contracts without material adverse changes of terms, or enter into any material Contract; 

vi.          except as required under applicable law or the terms of
any Benefit Plan existing as of the Effective Date, as applicable, (A) enter into, adopt or terminate any employee benefit or compensation plan, program, policy or arrangement for the benefit or welfare of any current or former employee,
officer, director or consultant, (B) amend (whether in writing or through the interpretation of) any employee benefit or compensation plan, program, policy or arrangement for the benefit or welfare of any current or former employee, officer,
director or consultant, (C) materially increase the compensation or benefits payable to any current or former employee, officer, director or consultant (other than in connection with a promotion or change in responsibilities), (D) pay or
award, or commit to pay or award, any bonuses or incentive compensation other than in the ordinary course consistent with past practice, (E) grant or accelerate the vesting of any equity-based awards or other compensation, (F) enter into
any new, or amend any existing, employment, severance, change in control, retention, bonus guarantee, collective bargaining agreement or similar agreement or arrangement, (G) fund any rabbi trust or similar arrangement, (H) terminate the
employment or services of any officer or any employee whose target annual compensation is greater than One Hundred Thousand Dollars ($100,000), other than for cause, or (I) hire any officer, employee, independent contractor or consultant who
has target annual compensation (excluding targeted annual compensation based on commission) greater than One Hundred Thousand Dollars ($100,000); 

  
 26 

 vii.          settle any material Claim, except in the ordinary
course of business or for settlement of a Claim that is settled in an amount and for consideration not in excess of Five Hundred Thousand Dollars ($500,000) and that would not impose any material restriction on the business of the Company or any
Subsidiary; 
 viii.          amend its organizational
documents or its bylaws or comparable governing documents; 

  ix.          other than in prior consultation with Buyer,
materially restructure or materially change its investment securities or derivatives portfolio or its interest rate exposure, through purchases, sales or otherwise, or the manner in which the portfolio is classified or reported or purchase any
security rated below investment grade other than in the ordinary course of business within the capital limits currently in use by the Company; 
    x.          enter into any new line of business; 

  xi.          take any action that, or fail to take any
action the failure of which to be taken, could reasonably be expected to prevent or materially delay the consummation of the transactions contemplated in this Agreement and the Transaction Documents; or 

 xii.          take, offer, propose or authorize any of, or
commit or agree to take any of, the foregoing. 
 6.12    Efforts.  Each of
the parties hereto agrees to use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary to consummate and make effective as promptly as practicable the transactions contemplated
hereby and under the other Transaction Documents and to cooperate with the other parties in connection with the foregoing. Without limiting the generality of the foregoing, the Company shall use its reasonable best efforts to (i) obtain any
required approvals or consents as promptly as practicable, (ii) to lift or rescind as promptly as practicable any injunction or restraining order or other order adversely affecting the ability of the parties hereto to consummate the
transactions contemplated hereby, (iii) to effect all necessary registrations and filings, if any, and (iv) to fulfill all of the conditions to the obligations of the parties to consummate the transactions contemplated by this Agreement
set forth in Article VIII. Without limiting the generality of the foregoing, Buyer shall use its reasonable best efforts to fulfill all of the conditions to the obligations of the parties to consummate the transactions contemplated by this Agreement
set forth in Sections 7.1 and 7.4. 
 ARTICLE VII 
 CONDITIONS PRECEDENT TO THE COMPANY’S OBLIGATIONS TO SELL 
 The obligation of the Company hereunder to issue and to sell the Securities to Buyer at the Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions,
provided that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion: 
 7.1      Buyer’s Execution of Transaction Documents.  Buyer shall have executed the Transaction Documents that require Buyer’s execution, and
delivered such Transaction Documents to the Company. 

  
 27 

 7.2      NYSE MKT Approval of the Listing
of the Common Shares, the Conversion Shares, the Mead Park Shares and the Mead Park Conversion Shares.  Pursuant to the Listing Application, the Common Shares, the Conversion Shares, the Mead Park Shares and the Mead Park Conversion
Shares shall have been approved for listing on the NYSE MKT by the NYSE MKT. 

7.3      Company Stockholder Approval of Contemplated Transactions.  In
connection with the Company Proxy Statement, the Company’s stockholders shall have approved the issuance of the Common Shares, the Conversion Shares, the Mead Park Shares and the Mead Park Conversion Shares. 

7.4      Accuracy of Buyer’s Representations; Compliance with
Covenants.    The representations and warranties of Buyer other than the Buyer Fundamental Representations shall be true and correct in all material respects (except to the extent that any of such representations and
warranties are already qualified as to materiality in Article IV above, in which case, such representations and warranties shall be true and correct in all respects without further qualification) as of the date when made and as of the Closing Date
as though made at that time (except for representations and warranties that speak as of a specific date), the Buyer Fundamental Representations shall be true and correct in all respects (except for de minimis failures) and Buyer shall have
performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by Buyer at or prior to the Closing Date. 

ARTICLE VIII 

CONDITIONS PRECEDENT TO BUYER’S OBLIGATIONS TO PURCHASE 

The obligation of Buyer hereunder to purchase the Securities at the Closing is subject to the satisfaction, at or before
the Closing Date, of each of the following conditions (which conditions shall be deemed satisfied upon the occurrence of the Closing), provided that these conditions are for Buyer’s sole benefit and may be waived by Buyer at any time in its
sole discretion: 
 8.1      Company Execution of the Transaction
Documents.  The Company shall have executed and delivered the Transaction Documents that require the Company’s execution and delivered such Transaction Documents to Buyer and all such Transaction Documents shall have been fully
executed by all other parties thereto (other than Buyer) and remain in full force and effect. 

8.2      NYSE MKT Approval of the Listing of the Common Shares, the Conversion Shares,
the Mead Park Shares and the Mead Park Conversion Shares.  Pursuant to the Listing Application, the Common Shares, the Conversion Shares, the Mead Park Shares and the Mead Park Conversion Shares shall have been approved for listing on
the NYSE MKT by the NYSE MKT. 

  
 28 

 8.3      Company Stockholder Approval of
Contemplated Transactions.  In connection with the Company Proxy Statement, the Company’s stockholders shall have approved the issuance of the Common Shares, the Conversion Shares, the Mead Park Shares and the Mead Park Conversion
Shares. 
 8.4      Composition of the Board of Directors.  The
Board of Directors shall consist of Daniel G. Cohen, Jack DiMaio, Christopher Ricciardi, and five (5) of the Current Independent Directors. In addition, Jack DiMaio shall be Chairman of the Board of Directors, and Daniel G. Cohen shall be
Vice-Chairman of the Board of Directors and President of the Company’s European operations, including the President of CCFL. 
 8.5      Employment Agreements.  The Cohen IFMI Employment Agreement shall have been amended and restated and the Cohen PrinceRidge Employment Agreement
shall have been terminated, in each case, as provided in the Amended and Restated Cohen Employment Agreement, which shall be in full force and effect as of the Closing. 

8.6      Mead Park Purchase Agreement.  The Mead Park Purchase Agreement
shall remain in effect and, simultaneous with the Closing, Mr. Cohen shall purchase from the Company and the Company shall sell to Mr. Cohen (i) the Mead Park Shares, for a purchase price of Two Dollars ($2.00) per share, representing
an aggregate purchase price of Three Million Eight Hundred Ninety-Eight Thousand Three Hundred Thirty-Four Dollars ($3,898,334); and (ii) the Mead Park Note in the aggregate principal amount of Five Million Eight Hundred Forty-Seven Thousand
Five Hundred and One Dollars ($5,847,501), pursuant to the Mead Park Purchase Agreement. 

8.7      Accuracy of Company’s Representations; Compliance with
Covenants.  The representations and warranties of the Company other than the Company Fundamental Representations and the representations set forth in Section 5.13 (Tax Matters) shall be true and correct in all material respects
(except to the extent that any of such representations and warranties are already qualified as to materiality in Article V above, in which case, such representations and warranties shall be true and correct in all respects without further
qualification) as of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date, in which case they shall be true and correct in all material respects as of
such specified date), the Company Fundamental Representations and the representations set forth in Section 5.13 (Tax Matters) shall be true and correct in all respects (except for de minimis failures) and, with respect to any matter disclosed
to Buyer in writing in response to a representation set forth Article V, there shall have been no materially adverse developments that would reasonably be expected to result in a Material Adverse Effect in connection with any such matter. The
Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date.

 8.8      Closing Certificates.  The Company shall have
executed and delivered to Buyer a closing certificate in substance and form reasonably required by Buyer, which closing certificate shall include and attach as exhibits: (i) a true copy of a certificate of good standing evidencing the formation
and good standing of the Company, from the State of Maryland Department of Assessments and Taxation, as of a date within thirty (30) days of the Closing Date; (ii) the Articles of Incorporation; (iii) the Bylaws; and (iv) copies
of the resolutions of the of the Company, consistent with Section 5.2, as adopted by the Board of Directors in a form reasonably acceptable to Buyer, and a senior executive officer of the Company shall have executed and delivered to Buyer a
closing certificate, dated as of the Closing Date, certifying to the effect that the conditions set forth in Section 8.7 have been satisfied. 

  
 29 

8.9        Opinion.  Buyer shall have received from outside
counsel to the Company, a written opinion dated as of the Closing Date that addresses (i) the due incorporation of the Company, (ii) the due authorization and valid issuance of the Common Shares and (iii) the due authorization,
execution and delivery of this Agreement and the Transaction Documents and shall also have received a 10b-5 letter in form and substance reasonably satisfactory to Buyer. 

8.10      Tax Benefits.  Since the date of this Agreement, (i) there
shall have been no material change to any rules under Sections 382, 383 or 384 of the Code that adversely affect the application of Sections 382, 383 or 384 of the Code to any net operating losses, unrealized built-in losses or other tax attributes
of the Company and any Affiliate (if relevant) that exist on or after the Closing Date; and (ii) an Ownership Change (as defined by Section 382(g) of the Code), in Buyer’s reasonable judgment, has not occurred and will not occur as a
result of the transactions contemplated herein. The Shareholder Rights Plan shall be in effect and shall have been in continuous effect since the Effective Date, with the distribution of preferred stock purchase rights occurring promptly thereafter.

 8.11      Articles Supplementary; Designation and Issuance of Series E
Voting Non-Convertible Preferred Stock.  Articles supplementary to the Company’s Articles of Incorporation that provide for the designation of the Series E Voting Non-Convertible Preferred Stock shall have been filed with the
State of Maryland Department of Assessments and Taxation and shall be effective. In accordance with the terms and provisions of the Exchange Agreement, any and all outstanding shares of Series D Voting Non-Convertible Preferred Stock shall have been
exchanged into outstanding shares of Series E Voting Non-Convertible Preferred Stock, which series shall be perpetual, and all such shares of Series E Voting Non-Convertible Preferred Stock shall have been duly authorized, validly issued and shall
be fully paid and nonassessable. 
 8.12      Amendment to IFMI LLC
Agreement.  The LLC Agreement Amendment shall be effective. 

8.13      No Injunctions.  No provision of any applicable Law and no
Judgment shall prohibit the Closing or shall prohibit or restrict Buyer or its Affiliates from owning, voting, converting or exercising any Securities or Conversion Shares in accordance with the terms thereof and no Proceeding shall have been
commenced by a Governmental Authority seeking to effect any of the foregoing. 

  
 30 

 ARTICLE IX 
 INDEMNIFICATION 

9.1      Company’s Obligation to Indemnify.  The Company hereby
agrees to defend, indemnify and hold harmless Buyer and Buyer’s Affiliates and subsidiaries, and its respective directors, officers, partners, employees, agents and representatives, and any Person who controls Buyer, and the successors and
assigns of each of the foregoing (collectively, the “Buyer Indemnified Parties”), to the fullest extent lawful, from and against any and all Claims made, brought or asserted against the Buyer Indemnified Parties, or any one
of them, and the Company hereby agrees to pay or reimburse the Buyer Indemnified Parties for any and all amounts arising out of Claims payable by any of the Buyer Indemnified Parties to any Person, as well as reasonable attorneys’ and
paralegals’ fees and expenses, court costs, settlement amounts, costs of investigation and other similar costs, as a result of, or arising out of, or relating to: (i) any misrepresentation or breach of any representation or warranty made
by the Company in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby; or (ii) any breach of any covenant, agreement or Obligation of the Company contained in this Agreement,
the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the Claims covered hereby, which is permissible under applicable Law. The Company will not be liable to Buyer under this indemnity: (x) for any settlement by Buyer in connection with any
Claim effected without the Company’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed; or (y) to the extent that a Claim is attributable to Buyer’s breach of any of the representations,
warranties, covenants or agreements made by Buyer in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby. Notwithstanding anything to the contrary contained in this
Section 9.1 or anywhere else in this Agreement or in the Transaction Documents, the aggregate amount of indemnification which may be sought, claimed and/or recovered by the Buyer Indemnified Parties (collectively) from the Company pursuant to
this Section 9.1 relating to a breach of a representation or warranty by the Company (other than a breach of the Company Fundamental Representations), excluding the representation and warranty of the Company set forth in clause (ii) of
Section 5.5) shall not, under any circumstances, exceed Ten Million Dollars ($10,000,000). 

9.2      Buyer’s Obligation to Indemnify.  Buyer agrees to defend,
indemnify and hold harmless the Company and each of the Company’s Affiliates and Subsidiaries, and their respective directors, officers, partners, employees, agents and representatives, and the successors and assigns of each of the foregoing
(collectively, the “Company Indemnified Parties”), to the fullest extent lawful, from and against any and all Claims made, brought or asserted against the Company Indemnified Parties, or any one of them, and Buyer hereby
agrees to pay or reimburse the Company Indemnified Parties for any and all amounts arising out of Claims payable by any of the Company Indemnified Parties to any Person, as well as reasonable attorneys’ and paralegals’ fees and expenses,
court costs, settlement amounts, costs of investigation and other similar costs, as a result of, or arising out of, or relating to: (i) any misrepresentation or breach of any representation or warranty made by Buyer in this Agreement, the
Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby or (ii) any breach of any covenant, agreement or Obligation of Buyer contained in this Agreement, the Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby. To the extent that the foregoing undertaking by Buyer may be unenforceable for any reason, Buyer shall make the maximum contribution to the payment and satisfaction of each of the
Claims covered hereby, which is permissible under applicable Law. Buyer will not be liable to the Company under this indemnity: (x) for any settlement by the Company in connection with any Claim effected without Buyer’s prior written
consent, which consent shall not be unreasonably withheld, conditioned or delayed; or (y) to the extent that a Claim is attributable to the Company’s breach of any of the representations, warranties, covenants or agreements made by the
Company in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby. Notwithstanding anything to the contrary contained in this Section 9.2 or anywhere else in this Agreement or
in the Transaction Documents, the aggregate amount of indemnification which may be sought, claimed and/or recovered by the Company Indemnified Parties (collectively) from Buyer pursuant to this Section 9.2 relating to a breach of representation
or warranty made by Buyer (other than a breach of the Buyer Fundamental Representations) shall not, under any circumstances, exceed Three Hundred Thousand Dollars ($300,000). 

  
 31 

 ARTICLE X 
 TERMINATION 

10.1       Termination Events.  This Agreement may be terminated at
any time prior to the Closing: 
  (a)      by the written consent of the
Company and Buyer. 
  (b)      by Buyer with written notice to the Company
if: 
  i.     a material breach of this Agreement has been committed by the
Company and such material breach has not been (i) waived in writing by Buyer, or (ii) cured by the Company to the reasonable satisfaction of Buyer within fifteen (15) days following the Company’s receipt of written notice of such
material breach from Buyer; or 
 ii.     the Closing shall not have occurred on or
before September 30, 2013 (the “Transaction Deadline”), unless such failure shall be due to the failure of Buyer to perform or comply with any of the covenants, agreements or conditions hereof to be performed or complied
with by Buyer prior to the Closing. 
  (c)      by the Company with written
notice to Buyer if: 
  i.     a material breach of this Agreement has been
committed by Buyer and such material breach has not been (i) waived in writing by the Company, or (ii) cured by Buyer to the reasonable satisfaction of the Company within fifteen (15) days following Buyer’s receipt of written
notice of such material breach from the Company; or 
 ii.     the Closing shall not
have occurred on or before the Transaction Deadline, unless such failure shall be due to the failure of the Company to perform or comply with any of the covenants, agreements or conditions hereof to be performed or complied with by the Company prior
to the Closing. 
  (d)      by Buyer or the Company in the event that there
shall be (i) any Law that makes the consummation of the transactions contemplated by this Agreement illegal or otherwise prohibited, or (ii) any Judgment restraining, enjoining or prohibiting any of the transactions contemplated by this
Agreement and such Judgment shall have become final and non-appealable. 

  
 32 

 (e)      (i) by Buyer, if any of the
conditions to Closing set forth in Sections 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.11, or 8.12 are not capable of being satisfied on or before the Transaction Deadline, provided, in each case, that Buyer is not the reason that such condition is not capable
of being satisfied, or (ii) by Buyer, if any of the conditions to Closing set forth in Sections 8.10 or 8.13 are not capable of being satisfied on or before the Transaction Deadline, provided, in each case, that Buyer is not the reason that
such condition is not capable of being satisfied. 
 (f)      (i) by the Company,
if any of the conditions to Closing set forth in Article VII (other than Sections 7.2, 7.3 and 7.4) are not capable of being satisfied on or before the Transaction Deadline, or (ii) by the Company, if any of the conditions to Closing set forth
in Sections 7.2 and 7.3 are not capable of being satisfied on or before the Transaction Deadline, provided, in each case, that the Company is not the reason that such condition is not capable of being satisfied. 

10.2      Effect of Termination. If this Agreement is terminated pursuant to
this Article X, then all further obligations of the parties under or pursuant to this Agreement and under or pursuant to the Transaction Documents (other than Section 6.3, if applicable) shall terminate without further liability of any party to
the other parties; provided that nothing herein shall relieve any party from liability for willful breach of this Agreement of breach of this Agreement prior to any termination thereof. 

ARTICLE XI 

MISCELLANEOUS 
 11.1      Anti-Sandbag Provision.  Notwithstanding anything to the contrary contained in this Agreement, Buyer agrees that no representation or warranty of
the Company in this Agreement shall be deemed to be untrue or incorrect, and the Company shall be deemed not to be in breach thereof, if Buyer or Daniel G. Cohen had knowledge on the Effective Date or the Closing Date, as applicable, that any such
representation or warranty was untrue or incorrect. 

11.2      Interpretation.  In this Agreement, unless the express context
otherwise requires: (i) the words “herein,” “hereof” and “hereunder” and words of similar import refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) references to the
words “Article” or “Section” refer to the respective Articles and Sections of this Agreement, and references to “Exhibit” or “Schedule” refer to the respective Exhibits and Schedules annexed hereto;
(iii) references to a “party” mean a party to this Agreement and include references to such party’s permitted successors and permitted assigns; (iv) references to a “third party” mean a Person not a party to this
Agreement; (v) the terms “dollars” and “$” mean U.S. dollars; (vi) wherever the word “include,” “includes” or “including” is used in this Agreement, it will be deemed to be followed by the
words “without limitation.” 

  
 33 

 11.3    Notices.  All notices of
request, demand and other communications hereunder shall be addressed to the parties as follows: 
  

			
	  If to the Company:
	  	 Institutional Financial Markets, Inc.

Cira Centre
 2929 Arch Street, 17th Floor
 Philadelphia, Pennsylvania
19104
 Attn: Joseph W. Pooler, Jr.

Facsimile: (215) 701-8280
 E-mail: jpooler@ifmi.com
  
 and to:

		
		  	 Institutional Financial Markets, Inc.

1633 Broadway, 28th Floor
 New York, New York 10019
 Attn: Rachael Fink

Facsimile: (866) 543-2907
 E-mail: rfink@ifmi.com

		
	  With a copy to:
	  	 Duane Morris LLP

430 South 17th Street
 Philadelphia, Pennsylvania 19103
 Attn: Darrick M.
Mix
 Facsimile: (215) 239-4958

Email: dmix@duanemorris.com

		
	  If to Buyer:
	  	 At the address on the books and records of the Company.

 unless the address is changed by the party by like notice given to the other parties. Notice shall be in
writing and shall be deemed delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and properly addressed to the address above, then three (3) business days after deposit of same in a regularly maintained
U.S. Mail receptacle; or (ii) if mailed by Federal Express (FedEx), the United Parcel Service (UPS), or another nationally recognized overnight courier service, next business morning delivery, then one (1) business day after deposit of
same in a regularly maintained receptacle of such overnight courier; or (iii) if hand delivered, then upon hand delivery thereof to the address indicated on or prior to 5:00 p.m., New York City time, on a business day. Any notice hand delivered
after 5:00 p.m. New York City time, shall be deemed delivered on the following business day. Notwithstanding the foregoing, notices, consents, waivers or other communications referred to in this Agreement may be sent by facsimile, e-mail, or other
method of delivery, but shall be deemed to have been delivered only when the sending party has confirmed (by reply e-mail or some other form of written confirmation from the receiving party) that the notice has been received by the other party.

 11.4    Entire Agreement.  This Agreement and (i) the Exhibits and
Schedules attached hereto, and (ii) the documents delivered pursuant hereto, including the Transaction Documents, collectively, set forth all the promises, covenants, agreements, conditions and understandings between the parties hereto with
respect to the subject matter hereof and thereof, and supersede all prior and contemporaneous agreements, understandings, inducements or conditions, expressed or implied, oral or written. 

  
 34 

 11.5      Assignment.  No
party hereto may sell or assign this Agreement or any of the Transaction Documents, or any portion thereof or any rights thereunder, either voluntarily or by operation of law, nor delegate any of their respective duties or obligations hereunder or
thereunder, without the prior written consent of all of the other parties to this Agreement, except that Buyer shall be permitted to assign its rights or obligations hereunder to its and Daniel G. Cohen’s controlled Affiliates, Principals and
Family Group members (any such transferee shall be included in the term “Buyer”); provided, that no such assignment shall relieve Buyer of any of its obligations under this Agreement. 

11.6      Binding Effect.  This Agreement shall be binding upon the
parties hereto, their respective successors and permitted assigns. 

11.7      Amendment.  The parties hereby irrevocably agree that no
attempted amendment, modification, or change of this Agreement shall be valid and effective, unless the parties shall unanimously agree in writing to such amendment, modification or change. 

11.8      No Waiver.  No failure or delay by any party in exercising any
right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any provision
of this Agreement shall be effective, unless it is in writing and signed by the party against whom it is asserted, and any such written waiver shall only be applicable to the specific instance to which it relates and shall not be deemed to be a
continuing or future waiver. 
 11.9      Gender and Use of Singular and
Plural.  All pronouns shall be deemed to refer to the masculine, feminine, neuter, singular or plural, as the identity of the party or parties or their personal representatives, successors and assigns may require. 

11.10    Execution.  This Agreement may be executed in one or more counterparts, all
of which taken together shall be deemed and considered one and the same Agreement, and the same shall become effective when counterparts have been signed by each party and each party has delivered its signed counterpart to the other party. In the
event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format file or other similar format file, such signature shall be deemed an original for all purposes and shall create a valid and binding
obligation of the party executing same with the same force and effect as if such facsimile or “.pdf” signature page was an original thereof. 
 11.11    Headings.  The article and section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or
interpretation of the Agreement. 
 11.12    Governing Law.  This Agreement
shall be construed in accordance with the laws of the State of New York, without regard to the principles of conflicts of laws that would result in the application of the laws of another jurisdiction. The parties further agree that any action
between them shall be heard in New York City, New York, and expressly consent to the jurisdiction and venue of the state and federal courts sitting in New York City, New York, for the adjudication of any civil action asserted pursuant to this
Agreement. 

  
 35 

 11.13    Further
Assurances.    The parties hereto will execute and deliver such further instruments and do such further acts and things as may be reasonably required to carry out the intent and purposes of this Agreement and the other
Transaction Documents. 
 11.14    Survival.  The covenants and agreements
made by the Company and Buyer herein shall survive for the duration of any statutes of limitations applicable thereto or until, by their respective terms, they are no longer operative. The representations and warranties made by the Company and Buyer
herein shall survive for a period of eighteen (18) months following the Closing Date, provided, however, that the Company Fundamental Representations and Buyer Fundamental Representations shall survive for a period of three (3) years
following the Closing Date. Notwithstanding the foregoing in this Section 11.14, the representations and warranties contained in Section 5.13 (Tax Matters) shall survive until the expiration of the statute of limitation applicable thereto.

 11.15    Time is of the Essence.  The parties hereby agree that time is
of the essence with respect to performance of each of the parties’ obligations under this Agreement. The parties agree that in the event that any date on which performance is to occur falls on a Saturday, Sunday or state or national holiday,
then the time for such performance shall be extended until the next business day thereafter occurring. 

11.16    Joint Preparation.  The preparation of this Agreement has been a joint
effort of the parties and the resulting documents shall not, solely as a matter of judicial construction, be construed more severely against one of the parties than the other. 

11.17    Severability.  If any provision of this Agreement is held to be invalid or
unenforceable in any respect, then the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable
provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 11.18    No Third Party Beneficiaries.    This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that the provisions of Article IX are intended for the benefit of the Persons referred to in that Article. 

  
 36 

 11.19    WAIVER OF JURY
TRIAL.    EACH OF BUYER AND THE COMPANY, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL, KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES, IRREVOCABLY, THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY
LEGAL PROCEEDING BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT OR ANY OTHER AGREEMENT EXECUTED OR CONTEMPLATED TO BE EXECUTED IN CONJUNCTION WITH THIS AGREEMENT, OR ANY COURSE OF
CONDUCT OR COURSE OF DEALING IN WHICH BUYER AND THE COMPANY ARE ADVERSE PARTIES. THIS PROVISION IS A MATERIAL INDUCEMENT FOR BUYER TO PURCHASE THE SECURITIES. 
 [SIGNATURES ON THE FOLLOWING PAGE] 

  
 37 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be executed as of the date and year first set forth above. 
  

							
		 	 COMPANY:
	 	
		
		 	 INSTITUTIONAL FINANCIAL MARKETS, INC.

		
		 	By:      /s/
Joseph W. Pooler, Jr.                    
		 	Name:	 	Joseph W. Pooler, Jr.	 	
		 	Title:	 	 Executive Vice President, Chief Financial
 Officer and Treasurer

			
	 	 	 BUYER:
	 	 
		
		 	 COHEN BROS. FINANCIAL, LLC

		
		 	By:      /s/ Daniel G.
Cohen                          
		 	Name:	 	Daniel G. Cohen	 	
		 	Title:	 	Managing Member	 	

  
 [Signature page to Securities
Purchase Agreement] 

 DISCLOSURE SCHEDULES 

TO 

SECURITIES PURCHASE AGREEMENT 
 May 9, 2013 
 These Schedules relate to that certain
Securities Purchase Agreement (the “Securities Purchase Agreement”), dated May 9, 2013 by and between Institutional Financial Markets, Inc., a Maryland corporation (“IFMI, Inc.” or the
“Company”), and Cohen Bros. Financial, LLC (“Buyer”). 
 Section
and subsection references in these Schedules are references to the corresponding sections and subsections of the Securities Purchase Agreement and are inserted solely for the sake of convenience. All capitalized terms not otherwise defined shall
have the meanings ascribed to them in the Securities Purchase Agreement. Any matter disclosed in any section of these Schedules shall be deemed disclosed in all other sections of the Schedules to the extent that such disclosure is reasonably
apparent to be applicable to such other sections, notwithstanding the reference to a particular section or subsection. 
 To the extent that any representation or warranty contained in the Securities Purchase Agreement is limited or qualified by the materiality of the matters to which the representation or warranty is given,
the inclusion of any matter in these Schedules does not constitute a determination by Buyer or the Company that such matters are material. Nor in such cases where a representation or warranty is limited or qualified by the materiality of the matters
to which the representation or warranty is given shall the disclosure of any matter in these Schedules imply that any other undisclosed matter having a greater value or significance is material. 

The inclusion in these Schedules of any matter or document shall not constitute any representation, warranty or
undertaking not expressly set forth in the Securities Purchase Agreement nor shall such disclosure be taken as extending the scope of any such representations or warranties. Nothing in these Schedules constitutes an admission of liability or
obligation of Buyer or the Company to any third party, or any admission against Buyer or the Company or the interest of Buyer or the Company. 

  
 1 

 SCHEDULE 5.3 
 CAPITALIZATION 
 (i) 

RESTRICTED IFMI, INC. COMMON STOCK 
  

							
	Recipient	  	 Vesting

Date
	  	 Amount of    

Shares or
 Units
	  	Entity
	 Beach, Walter
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.        

 

	 Bennett, Rodney
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

	 Brahney, Tom
  
	  	 1/13/2014
  
	  	 22,523
  
	  	 IFMI, Inc.
  

	 Burklin, Stephan
  
	  	 1/13/2014
  
	  	 16,216
  
	  	 IFMI, Inc.
  

	 Caton, Cameron
  
	  	 1/13/2014
  
	  	 22,523
  
	  	 IFMI, Inc.
  

	Cohen, Daniel G.	  	 100,000        -
12/31/2013;

100,000        -
 12/31/2014
  
	  	200,000	  	IFMI, Inc.
	 Costello, Thomas
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

	 Curcio, Vincent
  
	  	 1/13/2014
  
	  	 22,523
  
	  	 IFMI, Inc.
  

	 Dawson, G. Steven
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

	 DiGennaro, Daniel
  
	  	 1/13/2014
  
	  	 6,757
  
	  	 IFMI, Inc.
  

	 Donovan, Joseph
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

	 Haraburda, Jack
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

	 Hatton, John
  
	  	 1/13/2014
  
	  	 45,045
  
	  	 IFMI, Inc.
  

	 House, David
  
	  	 1/13/2014
  
	  	 22,523
  
	  	 IFMI, Inc.
  

	 Jacobs, Michael
  
	  	 1/13/2014
  
	  	 17,568
  
	  	 IFMI, Inc.
  

	 Listman, Doug
  
	  	 09/30/2013
  
	  	 30,000
  
	  	 IFMI, Inc.
  

	 Lukas, JoAnn
  
	  	 1/13/2014
  
	  	 4,505
  
	  	 IFMI, Inc.
  

	Pooler, Joseph	  	 32,500          -

12/31/2013;

17,500          -
 12/31/2014
  
	  	50,000	  	IFMI, Inc.
	 Powell, James
  
	  	 6/30/2013
  
	  	 52,788
  
	  	 IFMI, Inc.
  

	 Quijano-Martinez,
Lizette
  
	  	 1/13/2014
  
	  	 33,784
  
	  	 IFMI, Inc.
  

  
 2 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

  

							
	Recipient	  	 Vesting
 Date
	  	 Amount of

Shares or
 Units
	  	Entity            
	 Subin, Neil
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.        

 

	 Tessar, John
  
	  	 12/31/2014    

 
	  	 32,258
  
	  	 IFMI, Inc.
  

	 Ullom, Lance
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

	 Wolcott, Charles
  
	  	 3/4/2014
  
	  	 19,231
  
	  	 IFMI, Inc.
  

		  		  	  
	  	
	TOTAL:	  	 	  	752,092        	  	 
		  		  	  
	  	
	  
 RESTRICTED IFMI, LLC AND IFMI, INC.
UNITS
  

	Recipient	  	 Vesting
 Date
	  	 Amount of

Shares or
 Units
	  	Entity            
	 Burklin, Stephan
  
	  	 1/13/2014
  
	  	 9,938
  
	  	 IFMI, LLC
  

	 Butkevits, Vince
  
	  	 1/13/2014
  
	  	 74,536
  
	  	 IFMI, LLC
  

	 DiGennaro, Daniel
  
	  	 1/13/2014
  
	  	 9,938
  
	  	 IFMI, LLC
  

	 Ferry, James
  
	  	 1/13/2014
  
	  	 74,536
  
	  	 IFMI, LLC
  

	 Jacobs, Michael
  
	  	 1/13/2014      
  
	  	 5,591
  
	  	 IFMI, LLC
  

	 Lukas, JoAnn
  
	  	 1/13/2014
  
	  	 6,212
  
	  	 IFMI, LLC
  

	 Weaver, Daniel
  
	  	 1/13/2014
  
	  	 5,591
  
	  	 IFMI, LLC
  

	Hohns, Andrew	  	 Variable;
based on
performance
thresholds
  
	  	 500,000
  
	  	 IFMI, Inc.
  

	 Vernhes, Paul
  
	  	 3/31/2014
  
	  	 132,450
  
	  	 IFMI, Inc.
  

		  		  	  
	  	
	TOTAL:	  	 	  	818,792        	  	 
		  		  	  
	  	

  
 3 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

 VESTED IFMI, LLC UNITS 

 

											
	Recipient	  	 Vesting
 Date
	  	  	  	  	  	 Amount of  

Shares or
 Units
	  	Entity            
	 Cohen, Daniel G.
  
	  	         N/A

 
	  	 	  	 	  	   4,983,557  

 
	  	 IFMI, LLC
  

	 Koster, Linda
  
	  	 N/A
  
	  	 	  	 	  	 72,088  
  
	  	 IFMI, LLC
  

	 Ricciardi, Christopher
  
	  	 N/A
  
	  	 	  	 	  	 223,520  
  
	  	 IFMI, LLC
  

	 Ricciardi, Stephanie
  
	  	 N/A
  
	  	 	  	 	  	 44,925  
  
	  	 IFMI, LLC
  

		  		  		  		  	  
	  	
	TOTAL:	  	 	  	 	  	 	  	    5,324,090  	  	 
		  		  		  		  	  
	  	

 UNVESTED RESTRICTED PRINCERIDGE UNITS 

 

							
	Recipient	  	 Vesting
 Date
	  	 Amount of

Shares or
 Units
	  	Entity
	 Holmes, James
  
	  	     2/28/2014  

 
	  	             234    

 
	  	 PrinceRidge    
  

	 Pelletier, Renault
  
	  	 2/28/2014  

 
	  	 335    

 
	  	 PrinceRidge
  

	 Teng, Sophia
  
	  	 2/28/2014  
  
	  	 167    

 
	  	 PrinceRidge
  

		  		  	  
	  	
	TOTAL:	  	 	  	736    	  	 
		  		  	  
	  	

 Other Securities / Instruments with Redemptive Features 

The PrinceRidge units not owned by IFMI, LLC; ($532,527 as of March 31, 2013) are subject to redemption by PrinceRidge upon the
withdrawal of limited partners. 
 (ii) 
 Outstanding Debt Securities 
  

	 	1.	$28,125,000 of outstanding par value of junior subordinated notes - Alesco Capital Trust I; 

	 	2.	$20,000,000 of outstanding par value of junior subordinated notes - Sunset Financial Statutory Trust I; and 

	 	3.	$8,121,000 of outstanding par value of 10.50% Contingent Convertible Senior Notes Due 2027 (convertible into common shares at approximately $116.37 per share).

  
 4 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

 Pro Forma Beneficial Ownership Table 

 
  

																																													
	 	 	IFMI, Inc. Common Stock	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	  Common Stock  	 	 	    Restricted    
Stock	 	 	    Total    	 	 	Series
E
Voting Non-
  Convertible  
Preferred
Stock	 	 	  Total Voting  	 	 	Securities
Purchase
  Agreement  	 	 	  Pro Forma  
without
Converts	 	 	  Percentage  	 	 	    Convertible    
Debt (2)	 	 	    Pro Forma    

Assuming
Conversion	 	 	  Percentage  	 
	  
 Cohen, Daniel
G.
	 	 	503,142	  	 	 	200,000	  	 	 	703,142	  	 	 	4,983,557	  	 	 	5,686,699	  	 	 	800,000	  	 	 	6,486,699	  	 	 	32.5% 	  	 	 	800,000	  	 	 	7,286,699	  	 	 	32.1% 	  
	  
 Mead Park
	 	 	–	  	 	 	–	  	 	 	–	  	 	 	–	  	 	 	–	  	 	 	1,949,167	  	 	 	1,949,167	  	 	 	9.8% 	  	 	 	1,949,167	  	 	 	3,898,334	  	 	 	17.2% 	  
	  
 Ricciardi, Christopher
(1)
	 	 	1,472,175	  	 	 	–	  	 	 	1,472,175	  	 	 	–	  	 	 	1,472,175	  	 	 	–	  	 	 	1,472,175	  	 	 	7.4% 	  	 	 	–	  	 	 	1,472,175	  	 	 	6.5% 	  
	  
 McEntee,
Jay
	 	 	573,445	  	 	 	–	  	 	 	573,445	  	 	 	–	  	 	 	573,445	  	 	 	–	  	 	 	573,445	  	 	 	2.9% 	  	 	 	–	  	 	 	573,445	  	 	 	2.5% 	  
	  
 Pooler,
Joseph
	 	 	117,895	  	 	 	50,000	  	 	 	167,895	  	 	 	–	  	 	 	167,895	  	 	 	–	  	 	 	167,895	  	 	 	0.8% 	  	 	 	–	  	 	 	167,895	  	 	 	0.7% 	  
	  
 Listman,
Doug
	 	 	49,616	  	 	 	30,000	  	 	 	79,616	  	 	 	–	  	 	 	79,616	  	 	 	–	  	 	 	79,616	  	 	 	0.4% 	  	 	 	–	  	 	 	79,616	  	 	 	0.4% 	  
	  
 Fink,
Rachael
	 	 	18,392	  	 	 	–	  	 	 	18,392	  	 	 	–	  	 	 	18,392	  	 	 	–	  	 	 	18,392	  	 	 	0.1% 	  	 	 	–	  	 	 	18,392	  	 	 	0.1% 	  
	  
 Beach,
Walter
	 	 	105,731	  	 	 	19,231	  	 	 	124,962	  	 	 	–	  	 	 	124,962	  	 	 	–	  	 	 	124,962	  	 	 	0.6% 	  	 	 	–	  	 	 	124,962	  	 	 	0.6% 	  
	  
 Bennett,
Rodney
	 	 	61,412	  	 	 	19,231	  	 	 	80,643	  	 	 	–	  	 	 	80,643	  	 	 	–	  	 	 	80,643	  	 	 	0.4% 	  	 	 	–	  	 	 	80,643	  	 	 	0.4% 	  
	  
 Costello,
Thomas
	 	 	62,922	  	 	 	19,231	  	 	 	82,153	  	 	 	–	  	 	 	82,153	  	 	 	–	  	 	 	82,153	  	 	 	0.4% 	  	 	 	–	  	 	 	82,153	  	 	 	0.4% 	  
	  
 Dawson, G.
Steven
	 	 	76,931	  	 	 	19,231	  	 	 	96,162	  	 	 	–	  	 	 	96,162	  	 	 	–	  	 	 	96,162	  	 	 	0.5% 	  	 	 	–	  	 	 	96,162	  	 	 	0.4% 	  
	  
 Donovan,
Joseph
	 	 	57,578	  	 	 	19,231	  	 	 	76,809	  	 	 	–	  	 	 	76,809	  	 	 	–	  	 	 	76,809	  	 	 	0.4% 	  	 	 	–	  	 	 	76,809	  	 	 	0.3% 	  
	  
 Haraburda,
Jack
	 	 	62,722	  	 	 	19,231	  	 	 	81,953	  	 	 	–	  	 	 	81,953	  	 	 	–	  	 	 	81,953	  	 	 	0.4% 	  	 	 	–	  	 	 	81,953	  	 	 	0.4% 	  
	  
 Ullom,
Lance
	 	 	83,072	  	 	 	19,231	  	 	 	102,303	  	 	 	–	  	 	 	102,303	  	 	 	–	  	 	 	102,303	  	 	 	0.5% 	  	 	 	–	  	 	 	102,303	  	 	 	0.5% 	  
	  
 Wolcott,
Charles
	 	 	65,662	  	 	 	19,231	  	 	 	84,893	  	 	 	–	  	 	 	84,893	  	 	 	–	  	 	 	84,893	  	 	 	0.4% 	  	 	 	–	  	 	 	84,893	  	 	 	0.4% 	  
	  
 Subin, Neil
S.
	 	 	123,627	  	 	 	19,231	  	 	 	142,858	  	 	 	–	  	 	 	142,858	  	 	 	–	  	 	 	142,858	  	 	 	0.7% 	  	 	 	–	  	 	 	142,858	  	 	 	0.6% 	  
	  
 Public and
Other
	 	 	8,050,690	  	 	 	299,013	  	 	 	8,349,703	  	 	 	–	  	 	 	8,349,703	  	 	 	–	  	 	 	8,349,703	  	 	 	41.8% 	  	 	 	–	  	 	 	8,349,703	  	 	 	36.8% 	  
		 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 
	  

TOTAL:
	 	 	11,485,012	  	 	 	752,092	  	 	 	12,237,104	  	 	 	4,983,557	  	 	 	17,220,661	  	 	 	2,749,167	  	 	 	19,969,828	  	 	 	100.0% 	  	 	 	2,749,167	  	 	 	22,718,995	  	 	 	100.0% 	  
		 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 	 	  
	  
	 

  
 5 

 SCHEDULE 5.3 

CAPITALIZATION CONT’D 
  

 Note: The pro forma beneficial ownership table in this Schedule 5.3 excludes the
following securities, which do not have voting rights at the IFMI, Inc. level: 
  

									
	 	  	 Vested

  IFMI, LLC  
 Units (i)
	  	 Unvested
Restricted

  IFMI, LLC  
 Units
	  	 Unvested
Restricted

Units of

   IFMI, Inc.   
	  	 Total

	  
 Koster, Linda

 
	  	  
 72,088 

 
	  	  
 – 

 
	  	  
 – 

 
	  	  
 72,088

 

	 Ricciardi, Christopher
  
	  	 223,520 
  
	  	 – 
  
	  	 – 
  
	  	 223,520
  

	 Ricciardi, Stephanie
  
	  	 44,925 

 
	  	 – 

 
	  	 – 

 
	  	 44,925

 

	 Burklin, Stephan
  
	  	 – 
  
	  	 9,938 
  
	  	 – 
  
	  	 9,938
  

	 Butkevits, Vince
  
	  	 – 

 
	  	 74,536 

 
	  	 – 

 
	  	 74,536

 

	 DiGennaro, Daniel
  
	  	 – 
  
	  	 9,938 
  
	  	 – 
  
	  	 9,938
  

	 Ferry, James
  
	  	 – 

 
	  	 74,536 

 
	  	 – 

 
	  	 74,536

 

	 Jacobs, Michael
  
	  	 – 
  
	  	 5,591 
  
	  	 – 
  
	  	 5,591
  

	 Lukas, JoAnn
  
	  	 – 

 
	  	 6,212 

 
	  	 – 

 
	  	 6,212

 

	 Weaver, Daniel
  
	  	 – 
  
	  	 5,591 
  
	  	 – 
  
	  	 5,591
  

	 Hohns, Andrew
  
	  	 – 

 
	  	 – 

 
	  	 500,000 

 
	  	 500,000

 

	Vernhes, Paul	  	– 	  	– 	  	132,450 	  	132,450
		  	  
	  	  
	  	  
	  	  

	  
 TOTAL:
	  	      340,533 	  	      186,342 	  	        632,450 	  	     1,159,325
		  	  
	  	  
	  	  
	  	  

  
 6 

 SCHEDULE 5.4 
 SUBSIDIARIES 
 Please see the attached organizational chart for a list of
Subsidiaries and details regarding the Company’s ownership thereof. 
 C&Co/PrinceRidge Holdings LP Profit Units:

  

									
	 	  	 Vested
	  	 Unvested
	  	 Total
	  	 Percentage

	Daniel G. Cohen	  	6	  	–	  	6	  	0.00%
	Armand Pastine	  	440	  	–	  	440	  	0.16%
	Leland Harrs	  	846	  	–	  	846	  	0.31%
	John McNicholas	  	1,924	  	–	  	1,924	  	0.71%
	Paul Pasqua	  	133	  	–	  	133	  	0.05%
	IFMI, Inc.	  	268,283	  	–	  	268,283	  	98.50%
	James Holmes	  	–	  	234	  	234	  	0.09%
	Renault Pelletier	  	–	  	335	  	335	  	0.12%
	Sophia Teng	  	–	  	167	  	167	  	0.06%
	TOTAL:	  	271,632	  	736	  	272,368	  	100.00%

  
 C&Co/PrinceRidge Holdings LP Equity Units: 
  

									
	 	  	 Vested
	  	 Unvested
	  	 Total
	  	 Percentage

	Daniel G. Cohen	  	6	  	–	  	6	  	0.00%
	Armand Pastine	  	440	  	–	  	440	  	0.16%
	Leland Harrs	  	846	  	–	  	846	  	0.31%
	John McNicholas	  	1,924	  	–	  	1,924	  	0.71%
	Paul Pasqua	  	133	  	–	  	133	  	0.05%
	IFMI, Inc.	  	267,153	  	–	  	267,153	  	98.49%
	James Holmes	  	–	  	234	  	234	  	0.09%
	Renault Pelletier	  	–	  	335	  	335	  	0.12%
	Sophia Teng	  	–	  	167	  	167	  	0.06%
	TOTAL:	  	270,502	  	736	  	271,238	  	100.00%

  
 7 

 SCHEDULE 5.10 
 TITLE TO ASSETS 
  

			
	 Balance Sheet Category

 
	 	 Description
  

	
  1.   Receivables from brokers, dealers, and clearing agencies
	 	 The Company’s
clearing arrangements may restrict its ability to transfer these receivables. These are not Encumbered, but may be restricted as to transfer.
  

	
  2.    Investments - trading
	 	 This serves as collateral
for the Company’s margin loan with its clearing agent. Therefore, this would be considered Encumbered.
  

	
  3.    Receivables under resale agreements
	 	 The collateral the Company
has for these loans is re-pledged to the Company’s counterparty under its repurchase agreement. Therefore, the collateral may be restricted as to transfer and may be considered Encumbered.

 

	
  4.    Other Assets - Equity Method Affiliations
	 	 In order to transfer the
Company’s investment in Star Asia Japan Special Situations LP, the Company would need the consent of Star Asia Partners Ltd., the fund’s general partner, which cannot be unreasonably withheld. The Company owns approximately 33% of Star
Asia Partners Ltd.
  

  

	 	—	 	 CIT Communications Finance Corporation has filed a UCC financing statement evidencing a security interest in certain assets of JVB Financial Group,
L.L.C. 

  

	 	—	 	 PrinceRidge has filed a UCC financing statement evidencing a security interest in all of IFMI, LLC’s interests in its capital accounts in, and
units of, both PrinceRidge and C&Co/PrinceRidge Partners LLC (formerly known as PrinceRidge Partners LLC). 

  
 8 

 SCHEDULE 5.13 
 TAX MATTERS 
 FEDERAL NOL ROLLFORWARD 

																																			
	 	  	 	 	  	Loss        /
(Income)	  	 	 	  	Loss        /
(Income)	 	  	 	 	  	Loss        /
(Income)	  	 	 	  	Loss        /
(Income)	 	 	 	  	 	 
	  Year	  	12/31/2008	 	  	2009	  	12/31/2009	 	  	2010	 	  	12/31/2010	 	  	2011	  	12/31/2011	 	  	2012	 	12/31/2012	 	  	Expiration	 
	 	  	($)	 	  	($)	  	($)	 	  	($)	 	  	($)	 	  	($)	  	($)	 	  	($)	 	($)	 	  	 	 
	   2008
	  	 	44,593,542	  	  		  	 	44,593,542	  	  				  	 	44,593,542	  	  		  	 	44,593,542	  	  	(2,778,919)	 	 	41,814,623	  	  	 	2028	  
	  2009	  	 	 	  	6,999,151	  	6,999,151	 	  	 	 	  	6,999,151	 	  	 	  	6,999,151	 	  	 	 	6,999,151	 	  	2029	 
	   2010
	  				  		  	 	--	  	  	 	16,240,310	  	  	 	16,240,310	  	  		  	 	16,240,310	  	  		 	 	16,240,310	  	  	 	2030	  
	  2011	  	 	 	  	 	  	--	 	  	 	 	  	--	 	  	20,997,598	  	20,997,598	 	  	 	 	20,997,598	 	  	2031	 
	   2012
	  				  		  	 	--	  	  				  	 	--	  	  		  	 	--	  	  		 	 	--	  	  			
	  TOTAL:	  	44,593,542	 	  	6,999,151	  	51,592,693	 	  	16,240,310	 	  	67,833,003	 	  	20,997,598	  	88,830,601	 	  	(2,778,919)	 	86,051,682	 	  	 	 

 Note: 2012 is currently estimated in good faith and is subject to future adjustment. The Company expects
to file its return by September 15, 2013. 
  

FEDERAL NCL ROLLFORWARD 

																																					
	 	  	 	 	  	Loss        /
(Income)	  	 	 	  	Loss        /
(Income)	 	  	 	 	  	Loss        /
(Income)	  	 	 	  	Loss        /
(Income)	 	  	 	 	  	 	 
	  Year	  	12/31/2008	 	  	2009	  	12/31/2009	 	  	2010	 	  	12/31/2010	 	  	2011	  	12/31/2011	 	  	2012	 	  	12/31/2012	 	  	Expiration	 
	 	  	($)	 	  	($)	  	($)	 	  	($)	 	  	($)	 	  	($)	  	($)	 	  	($)	 	  	($)	 	  	 	 
	   2008
	  	 	--	  	  		  	 	--	  	  				  	 	--	  	  		  	 	--	  	  				  	 	--	  	  	 	2013	  
	  2009	  	 	 	  	34,819,158	  	34,819,158	 	  	 	 	  	34,819,158	 	  	 	  	34,819,158	 	  	 	 	  	34,819,158	 	  	2014	 
	   2010
	  				  		  	 	--	  	  	 	6,432,139	  	  	 	6,432,139	  	  		  	 	6,432,139	  	  				  	 	6,432,139	  	  	 	2015	  
	  2011	  	 	 	  	 	  	--	 	  	 	 	  	--	 	  	 	  	--	 	  	 	 	  	--	 	  	2016	 
	   2012
	  				  		  	 	--	  	  				  	 	--	  	  		  	 	--	  	  	 	17,641,014	  	  	 	17,641,014	  	  	 	2017	  
	  TOTAL:	  	--	 	  	34,819,158	  	34,819,158	 	  	6,432,139	 	  	41,251,297	 	  	--	  	41,251,297	 	  	17,641,014	 	  	58,892,311	 	  	 	 

 Note: 2012 is currently estimated in good faith and is subject to future adjustment. The Company expects
to file its return by September 15, 2013. 

  
 9 

 SCHEDULE 5.18 
 EMPLOYEE MATTERS 
  

	1.	In addition to the Benefit Plans set forth in the SEC Documents, the Company and its Subsidiaries have the following other such plans, contracts, policies, programs or
arrangements: 

  

	 	—	 	 401(k) Plan 

	 	—	 	 General vacation policy 

	 	—	 	 Health insurance plans 

	 	—	 	 Dental insurance plan 

	 	—	 	 Short & long-term disability plan 

	 	—	 	 NY short-term disability plan 

	 	—	 	 Expat medical, dental, life & long-term disability plans 

	 	—	 	 Supplemental life, STD, LTD, cancer, accident insurance 

	 	—	 	 Flex spending accounts (medical, dependent care, transit, parking) 

	 	—	 	 COBRA benefits 

	 	—	 	 Life & Accidental Death & Dismemberment 

	 	—	 	 NY Disability Benefits Law 

	 	—	 	 Malakoff Mederic Disability 

 Employment & Compensation Agreements 
 Current Employees –
European Capital Markets: 
  

					
	 Arif, Saleem
	  	 Broker Dealer, Sales & Trading
	 	
	 Caselunghe, Sara
	  	 Broker Dealer, Sales
	 	
	 Estaun, Sarah
	  	 Broker Dealer, Sales
	 	
	 Genovart, Jaime
	  	 Broker Dealer, Sales
	 	
	 Khan, Sherjeel
	  	 Broker Dealer, Real Estate Finance
	 	
	 Koster, Linda
	  	 Broker Dealer, Sales
	 	
	 Noonan, Gareth
	  	 Broker Dealer, Sales
	 	
	 Woergaard, Henrik
	  	 Broker Dealer, Sales
	 	
	 Thaker, Rajiv
	  	 Broker Dealer, Support
	 	
	 Cahill, Edward
	  	 Broker Dealer, Sales/Trading & Investment Banking

	 Scarlat, Viorel
  
	  	 Broker Dealer, Investment Banking
	 	

 Current Employees – JVB: 

 

					
	 Jim Ferry
	  	 CMO Trader
	 	
	 Vince Butkevits
	  	 CMO Trader
	 	
	 Mike Jacobs
	  	 CMO Trader
	 	
	 J.P. Lauria
	  	 CMO Trader
	 	
	 Chris Glacken
	  	 Pass Through (MBS) Trader
	 	
	 Jim Powell
	  	 Head Agency Trader
	 	

  
 10 

					
	 David Epstein
	  	 Agency Trader
	 	
	 Kelly Stapleton
	  	 Assistant Agency Trader
	 	
	 Omelio Armas
	  	 Municipal Trader
	 	
	 John Hatton
	  	 Municipal Trader, Head
	 	
	 David Cooper
	  	 Municipal Trader
	 	
	 Dan Digennaro
	  	 Corporate Trader, Head
	 	
	 Cameron Caton
	  	 Corporate Trader
	 	
	 Keith Cronin
	  	 Corporate Trader, US Credit & International Trading

	 Dan Weaver
	  	 Primary CD Trader
	 	
	 Michael Hughes
	  	 Managing Director, Head of CD Department

	 Zachary Morris
	  	 Assistant CD Trader
	 	
	 Tom Brahney
	  	 Secondary CD Trader
	 	
	 Chris Palmer
	  	 Secondary CD Trader,
	 	
	 Gordon Kiernan
	  	 Treasury Trader, Yield Curve Arbitrage & Hedging

	 Rocco Capoccia
	  	 Treasury Trader
	 	
	 John Tessar
	  	 Structured Products Trader, Head of Structured Products

	 Scott Greenwood
	  	 Structured Products Trader
	 	
	 David House
	  	 Sales Manager
	 	
	 James Coulter
	  	 Dealer Sales
	 	
	 John Borris
	  	 Dealer Sales
	 	
	 Debbie McNulty
	  	 Dealer Sales
	 	
	 Vinnie Curcio
	  	 Dealer Sales
	 	
	 Bill Wetmore
	  	 Dealer Sales
	 	
	 Jim Rafferty
	  	 Dealer Sales
	 	
	 Scott Swanson
	  	 Dealer Sales
	 	
	 Suzanne O’Connell
	  	 Dealer Sales
	 	
	 Daniel Menscher
	  	 Dealer Sales
	 	
	 Adam Kerstetter
	  	 Advisor Sales
	 	
	 Charles Johnson
	  	 Advisor Sales
	 	
	 Matt Johnson
	  	 Advisor Sales
	 	
	 Mark McKeever
	  	 Advisor Sales
	 	
	 Justin Plante
	  	 Advisor Sales
	 	
	 Harry Fleck
	  	 CMBS Trader
	 	
	 Lizette Quijano - Martinez
	  	 CMBS Trader
	 	
	 Brad Cimo
	  	 CMO Derivatives Trader
	 	
	 Brett Murray
	  	 Treasury Trader
	 	
	 Jason Jenkins
	  	 Treasury Trader
	 	
	 Gregg Desort
	  	 Treasury Trader
	 	
	 Geoff Nash
	  	 Institutional Sales
	 	
	 Sean Rich
	  	 Institutional Sales
	 	
	 Joseph Ryan
	  	 Institutional Sales
	 	
	 Andrew Ahn
	  	 Institutional Sales
	 	
	 Cary Appel
	  	 Institutional Sales / Trader, Fixed Income Arbitrage

  
 11 

					
	 Carmen Marino
	  	 Institutional Sales / Manager
	 	
	 William Seery
	  	 Institutional Sales
	 	
	 Stephan Burklin
	  	 Chief Operating Officer
	 	
	 Katharine Vacca (Katie)
	  	 Compliance
	 	
	 Joann Lukas
	  	 Compliance Officer/HR Manager
	 	
	 Jim Barreto
	  	 Accounting
	 	
	 Joseph Stincic
	  	 Accounting
	 	
	 Aileen Colucci
	  	 Administrative Assistant, Boca Raton
	 	
	 Rob Castro
	  	 IT
	 	
	 Aron Green
	  	 IT
	 	
	 Giovanny Rozo
	  	 IT
	 	
	 Jaime Hogan
	  	 Marketing
	 	
	 Shawn Chen
	  	 Risk Management
	 	
	 Staci Paul
	  	 Operations
	 	
	 Staci Raymond
	  	 Operations
	 	
	 Sandra Brewer
	  	 Operations
	 	

 Current Employees – PrinceRidge: 

 

					
	 Castelluccio, Joseph
	  	 Middle Markets – Management
	 	
	 Pastine, Armand
	  	 Middle Markets & Rates Group - Management

	 Filipski, Marianne
	  	 Middle Markets - Sales
	 	
	 Rasel, Jayson
	  	 Middle Markets - Sales
	 	
	 Wieske, Joe
	  	 Middle Markets - Sales
	 	
	 Warley, Theodore
	  	 Middle Markets - Sales
	 	
	 Dillon, Justin
	  	 Middle Markets - High Grade Corps - Trading

	 Karlic, Michael
	  	 Middle Markets - High Grade Corps - Trading

	 Kinnear, Michael
	  	 Middle Markets - High Grade Corps - Trading

	 Korb, David
	  	 Middle Markets - High Grade Corps - Trading

	 Books, Aaron
	  	 Middle Markets - High Grade Corps - Trading

	 Utter, David
	  	 Middle Markets - High Grade Corps - Trading

	 Moogan, Richard
	  	 Middle Markets - High Grade Corps - Trading

	 Ford, John
	  	 Middle Markets - Municipals - Trading
	 	
	 Meehan, James
	  	 Middle Markets - Municipals - Trading
	 	
	 Lundvall, Mark
	  	 Middle Markets - Municipals - Trading
	 	
	 Marlin, Dennis
	  	 Middle Markets - Municipals - Trading
	 	
	 Marlin, Derek
	  	 Middle Markets - Municipals - Trading
	 	
	 Communiello, Michael
	  	 Middle Markets - Preferred - Trading
	 	
	 Zawacki, Joseph
	  	 Middle Markets - Preferred - Trading
	 	
	 Cocco, Stephen
	  	 Middle Markets - Structured Notes - Trading

	 Rosciano, Anthony
	  	 Middle Markets - Structured Notes - Trading

	 Hansraj, Manie
	  	 Middle Markets - Operations Specialist
	 	
	 McHugh, Thomas
	  	 Rates Group - Repo/Funding - Trading
	 	
	 Kelly, Jake
	  	 Rates Group - Repo/Funding - Support
	 	
	 Anderson, Brian
	  	 Rates Group - RMBS Trading - Structured Products - Sales

  
 12 

					
	 Amadeo, Brian
	  	 Rates Group - RMBS Trading - Structured Products - Sales

	 Hanlon, Mark
	  	 Rates Group - RMBS Trading - Structured Products - Sales

	 Santoro, Lawrence
	  	 Rates Group - RMBS Trading - Structured Products - Sales

	 Harvey, Bob
	  	 Rates Group - RMBS Trading - Structured Products - MBS Trader

	 Lupin, Michael
	  	 Rates Group - RMBS Trading - Structured Products - Agency & MBS

	 Plinio, Anthony
	  	 Rates Group - RMBS Trading - Structured Products - Trader

	 Sias, William
	  	 Rates Group - RMBS Trading - TBA Sales

	 Fuchs, Robert
	  	 Rates Group - RMBS Trading - TBA Sales

	 Perschetz, Kenny
	  	 Rates Group - RMBS Trading - Agency - Trading

	 Kissane, Brendan
	  	 Rates Group - RMBS Trading - TBA Trading

	 McGovern, Michael
	  	 Corporate Credit - Head of Dept.
	 	
	 Hurwitz, Steven
	  	 Corporate Credit - Research
	 	
	 Ziets, Kevin
	  	 Corporate Credit - Research
	 	
	 Dodd, Stephen
	  	 Corporate Credit - Sales
	 	
	 Hindenach, James
	  	 Corporate Credit - Sales
	 	
	 Levine, Peter
	  	 Corporate Credit - Sales
	 	
	 Marvin, Bradford
	  	 Corporate Credit - Sales
	 	
	 Schmidt, Stephen
	  	 Corporate Credit - Sales
	 	
	 Silverman, Jeffrey
	  	 Corporate Credit - Sales
	 	
	 Vandersnow, Scott
	  	 Corporate Credit - Sales
	 	
	 Pannuzzo, Brian
	  	 Corporate Credit - Trading
	 	
	 Connors, Thomas
	  	 Structured Products - Sales
	 	
	 Pasqua, Paul
	  	 CDO / CLO - Trading
	 	
	 Bertoni, Jeffrey
	  	 CDO / CLO - Sales
	 	
	 Kim, Jason
	  	 Non-Agency - RMBS Sales & Trading
	 	
	 Roth, Lance
	  	 Asset-Backed Securities Desk - Origination

	 Soltesz, James
	  	 Asset Backed Securities Desk - Trading
	 	
	 Videla, Alejandro
	  	 Asset Backed Securities Desk - Sales & Structuring

	 Mitrikov, Plamen
	  	 Asset Backed Securities Desk - Management

	 D’Agostino, Steve
	  	 Asset Backed Securities Desk - Management

	 Dyer, James
	  	 Equities - Sales & Trading
	 	
	 Parchment, Gerry
	  	 Equities - Sales & Trading
	 	
	 Gatlin, Brandi
	  	 Equities - Sales & Trading
	 	
	 Appel, Jeffrey
	  	 Equities - Sales & Trading
	 	
	 Stamler, Joseph
	  	 Equities - Sales & Trading
	 	
	 Wald, Ari
	  	 Equities - Sales & Trading
	 	
	 Harrs, Lee
	  	 Corporate Finance - Banking
	 	
	 McNicholas, John
	  	 Corporate Finance - Banking
	 	
	 Stock, Keith
	  	 Corporate Finance - Banking
	 	
	 Saalwachter, Ric
	  	 Corporate Finance - Banking
	 	
	 Fischer, Ryan
	  	 Corporate Finance - Banking
	 	
	 Grady, Michael
	  	 Corporate Finance - Banking
	 	
	 Farha, Red
	  	 Corporate Finance - Banking
	 	

  
 13 

			
	 Holmes, James
	  	 Corporate Finance - Support

	 Pelletier, Renaud
	  	 Corporate Finance - Support

	 Teng, Sophia
	  	 Corporate Finance - Support

	 Park, Daniel
	  	 Corporate Finance - Support

	 Holman, Bryce
	  	 Corporate Finance - Support

	 Brennan, Kevin
	  	 Corporate Finance - Support

	 Brining, Ryan
	  	 Corporate Finance - Support

	 Fecowicz, Jonathan
	  	 Corporate Finance - Support

	 Kerr, Michelle
	  	 Corporate Finance - Admin

	 Batalion, David
	  	 Equity Capital Markets - Banking

	 Bacchus, Michael
	  	 Compliance

	 McCann, Joseph
	  	 Executive

	 Tissen, Jayne
	  	 HR

	 Cenuser, Vanessa
	  	 HR

	 Karayannis, Amy
	  	 Legal

	 Silberman, Jeffrey
	  	 Legal

	 Cianci, Joseph
	  	 Operations

	 Tarnovsky, Jane
	  	 Operations

 Current Employees – Other IFMI: 

 

			
	 Addei, Peter
	  	 Asset Management, Alesco

	 Creighton, Amy
	  	 Asset Management, Alesco

	 Masuyama, Taro
	  	 Asset Management, Cohen Asia

	 Poljevka, Frank
	  	 Asset Management, Cohen Asia

	 Talton, Brian
	  	 Asset Management, Cohen Asia

	 Conreur, Xavier
	  	 Asset Management, Paris

	 Ebensperger, Uli
	  	 Asset Management, Paris

	 Ghnassia, Nathalie
	  	 Asset Management, Paris

	 de Clermont-Tonnerre, Amedee
	  	 Asset Management, Paris

	 Vernhes, Paul
	  	 Asset Management, Paris

	 Carocci, Massimo
	  	 Asset Management, Spain

	 Grasso, Sergio
	  	 Asset Management, Spain

	 Kuhnel Torma, Marta
	  	 Asset Management, Spain

	 Jimenez Lucas, Gustavo
	  	 Asset Management, Spain

	 De Rotaeche Amade, Ana
	  	 Asset Management, Spain

	 Ignacio Perea, Jose
	  	 Asset Management, Spain

	 Garcia Bartolome, Andres
	  	 Asset Management, Spain

	 Rodriguez, Luis
	  	 Asset Management, Spain

	 Pasan, Carlos
	  	 Asset Management, Spain

	 Rey Herzog, Patricia
	  	 Asset Management, Spain

	 Sapone, Domenico
	  	 Asset Management, Paris

	 Cohen, Daniel
	  	 Management

	 McEntee, Jay
	  	 Management

	 Pooler, Joe
	  	 Management

  
 14 

			
	 Fink, Rachael
	  	 Management/Legal

	 Dobie, Bob
	  	 Finance

	 Forrestel, Sean
	  	 Finance

	 Listman, Doug
	  	 Finance

	 Livewell, Megan
	  	 Finance

	 O’Rourke, John
	  	 Finance

	 Patel, Manish
	  	 Finance

	 Verros, Sophia
	  	 Finance

	 Cashman, Milly
	  	 Administrative

	 Cuddahy, Jonnell
	  	 Administrative

	 DiArenzo, Rich
	  	 Operations

	 Noel, Ron
	  	 Administrative

	 Weisback, Regina
	  	 Administrative

	 Pendlebury, Alan
	  	 IT

	 Coger, Theresa
	  	 Legal

 Former Employees (still being paid): 

 

					
	 Berkeley, Barry
	  	 PrinceRidge, Broker Dealer, Sales & Trading
	  	
	 Sussman, Shelly
	  	 European Capital Markets, Broker Dealer, Management
	  	

  

	2.	In addition to the foregoing Benefit Plans, the Company and its Subsidiaries, upon hiring employees, generally sets forth certain terms of employment in an offer
letter, as may have been amended from time to time. 

  

	3.	Each of the following Benefit Plans has received a favorable opinion letter from the Internal Revenue Service National Office: 

IFMI, Inc. 401(k) Plan (Tradition and Roth Contribution) – favorable determination letter was received May 15, 2012.

  
 15 

 EXHIBIT A 
 NEITHER THIS NOTE NOR THE SHARES ISSUABLE UPON THE CONVERSION HEREOF HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
LAWS OF ANY JURISDICTION. THESE SECURITIES MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM. BY ACQUIRING THIS NOTE, THE HOLDER REPRESENTS THAT THE HOLDER WILL NOT SELL OR OTHERWISE
DISPOSE OF THIS NOTE OR THE SHARES ISSUABLE UPON CONVERSION HEREOF WITHOUT REGISTRATION OR EXEMPTION THEREFROM. 

CONVERTIBLE SENIOR PROMISSORY NOTE 
  

			
	 $2,400,000
	  	[             ], 2013

 For value received, Institutional Financial Markets, Inc., a Maryland corporation, (together with its successors and
assigns, the “Company”) promises to pay to Cohen Bros. Financial, LLC, a Delaware limited liability company of which Daniel G. Cohen is the sole member (the “Holder”), the principal amount of $2,400,000, together
with all accrued and unpaid interest thereon (the “Outstanding Amount”). This convertible senior promissory note (the “Note”) has been issued pursuant to that certain Securities Purchase Agreement dated as of
May [      ], 2013 by and between the Company and the Holder (the “Purchase Agreement”). This Note is subject to the following terms and conditions: 

 

	1.	Note. 

(a)      Maturity.  The Outstanding Amount shall be due and payable in full on
[            ], 2018 (the “Maturity Date”), unless this Note shall have been earlier converted in accordance with Section 2.1 

(b)      Interest.  Interest shall accrue from the date of this Note on the unpaid principal
amount at a rate equal to eight percent (8%) per annum, computed on the basis of the actual number of days elapsed and a year of 365 days from the date of this Note until the principal amount and all interest accrued thereon are paid (or
converted, as provided in Section 2). Interest shall be payable in cash quarterly on each January 1, April 1, July 1, and September 1 (each, an “Interest Payment Date”) until the Maturity Date,
commencing on the first Interest Payment Date to occur after the Closing under the Purchase Agreement; provided, however, that if no Event of Default has occurred, (i) in the event that dividends of less than Two Cents ($0.02) per share are
paid on the Common Stock in the fiscal quarter prior to any Interest Payment Date, then the Company shall have the option, in its sole discretion, to pay one-half of the interest payable on such Interest Payment Date in cash, in which event the
remaining one-half of the interest otherwise payable on such Interest Payment Date shall accrue and be added to the Outstanding Amount as of such Interest Payment Date; and (ii) in the event that no dividends are paid on the Common Stock in the
fiscal quarter prior to such Interest Payment Date, then the Company shall have the option, in its sole discretion, to make no payment in cash of the interest payable on such Interest Payment Date, in which event all of the interest otherwise
payable on such Interest Payment Date shall accrue and be added to the Outstanding Amount as of such Interest Payment Date; provided, further, that if the Company takes an action permitted under clause (i) or (ii) above, it will provide
written notice to the Holder at least ten (10) days prior to the relevant Interest Payment Date. Such notice shall set forth the amount of interest in cash not paid, as well as the revised Outstanding Amount. Upon the occurrence of any Event of
Default and after any applicable cure period as described in Section 7 and for so long as such Event of Default continues, all principal, interest and other amounts payable under this Note shall bear interest at a rate equal to nine percent
(9%) per annum (the “Default Rate”). 
  

 

	1 	Maturity Date to be five years from the date of issuance of this Note. 

  
 A-1

 (c)      No Prepayment Without Consent.  This
Note shall not be prepaid in whole or in part prior to the Maturity Date without the prior written consent of the Holder (which may be granted or withheld in its sole discretion).  
 2.        Conversion.  At any time following the date hereof (including, for the avoidance of the doubt, at any time prior to 5:00 p.m. (ET)
on the business day prior to the Maturity Date), the Holder shall have the right, in the Holder’s sole discretion, to convert all or any part of the Outstanding Amount of this Note (the “Conversion”), without the payment of any
additional consideration therefor, into the number of fully paid and nonassessable shares of the Company’s Common Stock that is determined by dividing (i) the then applicable Outstanding Amount by (ii) $3.00 (the “Conversion
Price”). The Conversion Price is subject to adjustment if the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other
equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of this Note), (ii) subdivides outstanding shares of
Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, (iv) issues by reclassification of shares of Common Stock any shares
of capital stock of the Company or (v) takes any similar action or any action designed to have a similar effect, then in each case the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of
Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon
Conversion shall be proportionately adjusted such that the aggregate Conversion Price of this Note shall remain unchanged. Any adjustment made pursuant to this Section 2 shall become effective immediately after the record date for the
determination of stockholders entitled to participate in such event described in clauses (i) through (v) and shall become effective immediately after the effective date in the case of a subdivision, combination, reclassification or similar
action. Whenever the Conversion Price is adjusted pursuant to this Section 2, the Company shall promptly notify the Holder, in accordance with the Purchase Agreement, of the Conversion Price after such adjustment, any resulting adjustment to
the number of shares of Common Stock issuable upon Conversion and a brief statement of the facts requiring such adjustment.  

3.        Mechanics and Effect of Conversion. 

(a)      If the Holder wishes to exercise its right to effect a Conversion, the Holder shall provide the
Company with a written notice of its election. 

  
 A-2

 (b)      No fractional shares will be issued upon conversion
of this Note. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall pay to the Holder in cash the unconverted amount that would otherwise be converted into such fractional share. 

(c)      In the event that all of this Note is converted pursuant to Section 2, promptly after such
Conversion, the Holder shall surrender this Note, duly endorsed, to the Company and the Note shall thereupon be canceled. At its expense, the Company shall as promptly as practicable (but in no event more than five (5) days after the Conversion
of this Note) issue and deliver to the Holder the number of shares of the Company’s Common Stock to which the Holder is entitled upon such Conversion, together with (i) any accrued interest from the Interest Payment Date immediately prior
to Conversion through the date of Conversion and (ii) if applicable, a check payable to the Holder for any cash amounts payable as described in Section 3(b). 
 (d)      Upon issuance of shares of Common Stock in respect of Conversion of the entire Outstanding Amount in accordance with Section 2, all rights with respect to this
Note shall terminate, whether or not this Note has been surrendered for cancellation. The Holder shall be treated for all purposes as the record holder of Common Stock issued upon Conversion. 
 4.        Covenants of the Company.  The Company covenants to the Holder that, from the date hereof until all principal, interest and other
amounts payable under this Note have been paid in full, the Company shall, except as otherwise agreed in writing by the Holder: 

(a)      take such corporate action as may be necessary from time to time to (i) at all times maintain
an authorized number of shares of Common Stock as is sufficient for issuance of shares of Common Stock upon Conversion of this Note pursuant to Section 2 and (ii) cause the shares of Common Stock issued upon Conversion to be duly
authorized, validly issued, fully paid and non-assessable; 
 (b)      punctually pay the
principal and interest payable on this Note, and any other amount due and payable under this Note in the manner specified in this Note; 
 (c)      give written notice promptly to the Holder of any condition or event that constitutes, or is reasonably expected to constitute, an Event of Default; 

(d)      not avoid or seek to avoid the observance or performance of any of the terms of this Note through
any reorganization, recapitalization, transfer of assets or other voluntary action; and 

(e)      not create or incur any Encumbrance in or on its property or Assets, whether now owned or
hereinafter acquired, or upon any income or revenues or rights therefrom, except: 
  

	 	  (i)	Encumbrances existing on the date hereof and previously disclosed to the Holder; 

 

	 	  (ii)	Encumbrances for property taxes and assessments or other governmental charges or levies and liens that are not overdue for more than 90 days; or

  

	 	  (iii)	Encumbrances of or resulting from any Judgment, the time for appeal or petition for rehearing of which shall not have expired or in respect of which the Company shall
in good faith be prosecuting an appeal or other Proceeding for a review and in respect of which a stay of execution pending such appeal or Proceeding shall have been secured. 

  
 A-3

 5.        Form of Payment.  Except as
otherwise set forth herein, all payments due hereunder shall be made in lawful money of the United States of America to such account or at such place as may be designated in writing by the Holder from time to time. Payment shall be credited first to
the accrued interest then due and payable and the remainder applied to principal.  

6.        Priorities.  The indebtedness evidenced by this Note and the payment of all
principal, interest and any other amounts payable hereunder is a senior obligation of the Company and shall: (i) be Senior (as hereinafter defined) to, and have priority in right of payment over, all Indebtedness (as hereinafter defined) of the
Company incurred following the date hereof and any subordinated or junior subordinated Indebtedness outstanding as of the date hereof, and (ii) rank pari passu to the notes issued pursuant to the Mead Park Purchase Agreement (as defined in the
Purchase Agreement) and any other senior obligations of the Company outstanding as of the date hereof. “Senior” means that, in the event of any default in the payment of the obligations represented by this Note or of any liquidation,
insolvency, bankruptcy, reorganization or similar proceedings relating to the Company, all amounts payable under this Note shall first be paid in full before any payment is made upon any other Indebtedness hereinafter incurred (including any
Indebtedness guaranteed by the Company) or any subordinated or junior subordinated Indebtedness outstanding as of the date hereof, and, in any such event, any payment or distribution of any character which shall be made in respect of any other
Indebtedness of Company shall be paid to the Holder for application to the payment hereof, unless and until the obligations under this Note shall have been paid and satisfied in full. “Indebtedness” means, with respect to a specified
Person: (a) all indebtedness of such Person for borrowed money; (b) all obligations of such Person for the deferred purchase price of property or services (other than current accounts payable and accrued expenses incurred in the ordinary
course of business irrespective of when paid); (c) all obligations of such Person evidenced by bonds, debentures, notes, loan agreements, credit agreements or other similar instruments; (d) all obligations and liabilities of such Person
created or arising under any conditional sales or other title retention agreements with respect to property used and/or acquired by such Person; (e) all capitalized lease obligations of such Person; (f) all aggregate mark-to-market
exposure of such Person under hedging agreements; (g) all obligations in respect of letters of credit (whether drawn or supporting obligations that constitute Indebtedness) and bankers’ acceptances; (h) all obligations referred to in
clauses (a) through (g) of this definition of another Person guaranteed by the specified Person or secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) an Encumbrance
upon property owned by the specified Person, whether or not the specified Person has assumed or become liable for the payment of such Indebtedness. 
 7.        Events of Default.   An “Event of Default” shall be deemed to have occurred if: 

(a)      subject to the accrual of interest as provided in Section 1(b) hereof, the Company shall fail
to pay as and when due any principal or interest hereunder and such nonpayment shall continue uncured for a period of five (5) business days; 

  
 A-4

 (b)      except for an event described in Section 7(a),
the Company fails to perform any covenant or agreement hereunder, and such failure continues or is not cured within five (5) business days after written notice by the Holder to the Company; 

(c)      the Company or any significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation
S-X) (a “Significant Subsidiary”) applies for or consents to the appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) makes a general assignment for the
benefit of itself or any of its creditors, or (iii) commences a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now
or hereafter in effect; 
 (d)      proceedings for the appointment of a receiver, trustee,
liquidator or custodian of the Company or any Significant Subsidiary, or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to the
Company or any Significant Subsidiary, or the debts thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect are commenced and an order for relief entered or such proceeding is not dismissed or discharged within
ninety (90) days of commencement; 
 (e)      there is entered against the Company or any
Subsidiary a final Judgment for the payment of money in an aggregate amount exceeding $300,000 and such Judgment shall remain unsatisfied or without a stay in respect thereof for a period of thirty (30) days; 

(f)      the Company or any Subsidiary shall fail to pay when due any obligation, whether direct or
contingent, for Indebtedness exceeding $300,000, or shall breach or default with respect to any term of any loan agreement, mortgage, indenture or other agreement pursuant to which such obligation for Indebtedness was created or securing such
obligation if the effect of such breach or default is to cause, or to permit the holder or holders of that Indebtedness (or a trustee on behalf of such holder or holders), to cause that Indebtedness to become or be declared due and payable (or
redeemable) prior to its stated maturity or the stated maturity of any underlying obligation, as the case may be; or 

(g)      a Change in Control shall have occurred. For purposes of this Note, the term “Change in
Control” shall mean any one of the following events: (i) any Person or group (other than the Holder, Daniel G. Cohen and its or their controlled Affiliates and Principals and members of Daniel G. Cohen’s Family Group (as defined
in the Purchase Agreement)) is or becomes a beneficial owner, directly or indirectly, of more than 50% of the aggregate voting power represented by all issued and outstanding capital stock of the Company, (ii) individuals who, on the date
hereof, constitute the Board of Directors (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board of Directors; provided that any person becoming a director subsequent to the date hereof whose
election or nomination for election was approved by a majority of the Incumbent Directors then on the Board of Directors (either by a specific vote or by approval of the proxy statement of the relevant party in which such person is named as a
nominee for director, without written objection to such nomination) shall be an Incumbent Director (except that no individuals who were not directors at the time any contested election is reached shall be treated as Incumbent Directors);
(iii) the stockholders of the Company approve a plan of liquidation or dissolution of the Company or a sale of all or substantially all of the Company’s assets; or (iv) the Company has entered into a definitive agreement, the
consummation of which would result in the occurrence of any of the events described in clauses (i) through (iii) of this definition above. 

  
 A-5

 Upon the occurrence or existence of any Event of Default described in Section 6(a),
Section 6(b), Section 6(e), Section 6(f) or Section 6(g) and at any time thereafter during the continuance of such Event of Default, the Holder may, by written notice to the Company, declare the entire unpaid principal amount
outstanding and all interest accrued and unpaid on the Note to be immediately due and payable without presentment, demand, protest or any other notice or demand of any kind. Upon the occurrence or existence of any Event of Default described in
Section 6(c) or Section 6(d), immediately and without notice, the entire unpaid principal amount outstanding and all interest accrued and unpaid on the Note shall automatically become immediately due and payable, without presentment,
demand, protest or any other notice or demand of any kind. Upon the occurrence of any Event of Default and after any applicable cure period as described herein and for so long as such Event of Default continues, all principal, interest and other
amounts payable under this Note shall bear interest at the Default Rate. In addition to the foregoing remedies, upon the occurrence or existence of any Event of Default, the Holder may exercise any other right power or remedy granted to it by this
Note or the Purchase Agreement or otherwise permitted to it by law, either by suit in equity or by action at law, or both. 
  

	8.	Miscellaneous. 

(a)      This Note and all acts and transactions pursuant hereto and the rights and obligations of the
parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of New York without regard to its conflicts of law principles or the conflicts of law principles of any other state in either case that would result
in the application of the laws of any other state. 
 (b)      Any notice or other communication
required or permitted to be given hereunder shall be in writing and given as provided in the Purchase Agreement. 

(c)      In the event any interest is paid on this Note which is deemed to be in excess of the then legal
maximum rate, then that portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of this Note. 

(d)      Amendments to any provision of this Note may be made or compliance with any term, covenant,
agreement, condition or provision set forth in this Note may be waived (either generally or in a particular instance and either retroactively or prospectively) only upon written consent of the Company and the Holder. Any amendment or waiver effected
in accordance herewith shall apply to and be binding upon the Holder, upon each future holder of this Note and upon the Company, whether or not this Note shall have been marked to indicate such amendment or waiver. No such amendment or waiver shall
extend to or affect any obligation not expressly amended or waived or impair any right consequent thereon. 

  
 A-6

 (e)      This Note may not be assigned by any holder (except
that the Holder shall be permitted to assign this Note to Holder’s controlled Affiliates and Principals and members of Daniel G. Cohen’s Family Group (as defined in the Purchase Agreement) without the prior written approval of the Company.

 (f)      The Company hereby waives diligence, presentment, protest and demand, notice of
protest, notice of dishonor, notice of nonpayment and any and all other notices and demands in connection with the delivery, acceptance, performance, default or enforcement of this Note. The Company further waives, to the full extent permitted by
Law, the right to plead any and all statutes of limitations as a defense to any demand on this Note. 

(g)      The Company agrees to pay all reasonable costs and expenses actually incurred by the Holder in
connection with an Event of Default, including without limitation the fees and disbursements of counsel, advisors, consultants, examiners and appraisers for the Holder, in connection with (i) any enforcement (whether through negotiations, legal
process or otherwise) of this Note in connection with such Event of Default, (ii) any workout or restructuring of this Note during the pendency of such Event of Default and (iii) any bankruptcy case or proceeding of the Company or any
appeal thereof. 
 (h)      The section and other headings contained in this Note are for
reference purposes only and shall not affect the meaning or interpretation of this Note. 

(i)       Capitalized terms used herein and not otherwise defined, shall have the meanings ascribed to
them in the Purchase Agreement. 
 Signature page follows 

  
 A-7

 IN WITNESS WHEREOF, the Company has caused this Note to be duly executed and
delivered by its authorized officer, as of the date first above written. 
  

							
		 		 	INSTITUTIONAL FINANCIAL MARKETS, INC.
				
		 		 	By:	 	  

 
			
	Name:	 	  

 

			
	Title:	 	  

  

					
	AGREED AND ACKNOWLEDGED:	  	
		
	Cohen Bros. Financial, LLC	  	
			
	By:	 	  
	  	

					
	Name:	 	Daniel G. Cohen	  	
	Title:	 	Managing Member	  	

  
 A-8

 EXHIBIT B 
 REGISTRATION RIGHTS AGREEMENT 
 [See Exhibit 10.3 to Institutional
Financial Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT C 
 SHAREHOLDER RIGHTS PLAN 
 [See Exhibit 4.1 to Institutional Financial
Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT D 
 FORM OF MEAD PARK PURCHASE AGREEMENT 
 [See Exhibit 10.1 to Institutional
Financial Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT E 
 FORM OF EXCHANGE AGREEMENT 
 [See Exhibit 10.4 to Institutional Financial
Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT F 
 FORM OF AMENDED AND RESTATED COHEN EMPLOYMENT AGREEMENT 
 [See Exhibit 10.6
to Institutional Financial Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT G 
 LLC AGREEMENT AMENDMENT 
 [See Exhibit 10.5 to Institutional Financial
Markets, Inc.’s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on May 13, 2013.] 

 EXHIBIT H 
 VOTING AGREEMENT 
 THIS VOTING AGREEMENT, dated as of May 9, 2013
(this “Agreement”), is made by
                                         
                (the “Shareholder”) for the benefit of Institutional Financial Markets, Inc., a Maryland corporation (the “Company”),
pursuant to the Securities Purchase Agreement (the “Securities Purchase Agreement”), dated of even date herewith, by and among the Company, Mead Park Holdings, LP, and Mead Park Capital Partners LLC (the “Buyer”).
Capitalized terms used but not defined herein shall have the meanings given to such terms in the Securities Purchase Agreement. 

W I T N E S S E T H: 
 WHEREAS, contemporaneously with the execution and delivery of this Agreement, the Company is entering into the Securities Purchase Agreement, pursuant to which the Company has agreed to sell to Buyer and
Buyer has agreed to purchase from the Company (i) an aggregate of One Million Nine Hundred Forty-Nine Thousand One Hundred Sixty-Seven (1,949,167) newly issued shares (collectively, the “Buyer Common Shares”) of the
Company’s Common Stock, par value $.001 per share (“Common Stock”), for a purchase price of Two Dollars ($2.00) per share, representing an aggregate purchase price of Three Million Eight Hundred Ninety-Eight Thousand Three
Hundred Thirty-Four Dollars ($3,898,334); and (ii) a convertible senior promissory note in the aggregate principal amount of Five Million Eight Hundred Forty-Seven Thousand Five Hundred and One Dollars ($5,847,501) (the “Buyer
Note”); 
 WHEREAS, the Buyer Note is convertible into the “Conversion Shares” as defined in the Securities
Agreement (the “Buyer Conversion Shares”); 
 WHEREAS, contemporaneously with the execution and delivery of
this Agreement, the Company and Daniel G. Cohen are executing and delivering a securities purchase agreement (the “Cohen Purchase Agreement”), pursuant to which the Company has agreed to sell to Mr. Cohen and Mr. Cohen has
agreed to purchase from the Company (i) an aggregate of Eight Hundred Thousand (800,000) newly issued shares (collectively, the “Cohen Common Shares” and, together with the Buyer Common Shares, the “Transaction
Shares”) of the Common Stock, for a purchase price of Two Dollars ($2.00) per share, representing an aggregate purchase price of One Million Six Hundred Thousand Dollars ($1,600,000); and (ii) a convertible senior promissory note in
the aggregate principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000) (the “Cohen Note” and, together with the Buyer Note, the “Notes”); 

WHEREAS, the Cohen Note is convertible into the “Conversion Shares” as defined in the Cohen Purchase Agreement (the
“Cohen Conversion Shares”); 
 WHEREAS, in connection with the transactions contemplated by the Securities
Purchase Agreement and the Cohen Securities Agreement, the issuance of the Transaction Shares, the Buyer Conversion Shares and the Cohen Conversion Shares, and the election of certain directors to the Board of Directors of the Company (the
“Board of Directors”) will be submitted to the Company’s shareholders for approval at the Company’s 2013 annual meeting of shareholders (the “Annual Meeting”), which is anticipated to be held on or about
July 25, 2013; 
 WHEREAS, as an inducement to Buyer to enter into the Securities Purchase Agreement, the Shareholder is
entering into this Agreement; 

  
 H-1

 WHEREAS, as of the date hereof, the Shareholder owns of record, or has the power to vote,
certain of the outstanding voting equity securities of the Company (the “Voting Securities”); and 
 WHEREAS,
with this Agreement, the Shareholder wishes to undertake certain obligations with respect to the Voting Securities of which the Shareholder is the owner of record, or with respect to which the Shareholder has the power to vote, on the Record Date
(as defined below) (such Voting Securities as of such date, the “Total Voting Securities”). 
 NOW, THEREFORE,
in consideration of the foregoing and the mutual representations, warranties, covenants and agreements contained herein, and intending to be legally bound hereby, Shareholder hereby agrees as follows: 

ARTICLE I 

VOTING 

1.1    Agreement to Vote.  Except as otherwise provided in this Agreement and except as prohibited
by applicable Law, the Shareholder agrees that, from and after the date hereof and until the date on which this Agreement is terminated pursuant to Section 3.2, at the Annual Meeting or any other meeting of the shareholders of the Company at
which any of the Transaction Matters (as defined below) are to be voted upon, however called (and including any postponement or adjournment of any such meeting), or in connection with any written consent of the shareholders of the Company with
respect to any of the Transaction Matters, the Shareholder shall: 
 (a)      appear at each such
meeting (in person or by proxy) or otherwise cause all Total Voting Securities owned of record by the Shareholder, or with respect to which the Shareholder has the power to vote, in each case as of the record date used for determining the holders of
voting securities of the Company entitled to vote at such meeting or to deliver such consent (the “Record Date”), to be counted as present thereat for purposes of calculating a quorum; and 

(b)      vote or cause to be voted (in person or by proxy) or deliver a written consent (or cause a
consent to be delivered) covering all Total Voting Securities owned of record by the Shareholder or as to which the Shareholder has the power to vote, in each case as of the Record Date, in favor of: (i) the issuance by the Company of the Buyer
Common Shares and the Buyer Conversion Shares to Buyer; (ii) the issuance by the Company of the Cohen Common Shares and the Cohen Conversion Shares to Daniel G. Cohen; and (iii) the election to the Board of Directors of the nominees for
Director nominated by the Board of Directors in accordance with Section 8.4 of the Securities Purchase Agreement (clauses (i) through (iii) collectively, the “Transaction Matters”). 

1.2    No Inconsistent Agreements.  The Shareholder hereby covenants and agrees that, except as set
forth in this Agreement and except for actions taken in furtherance of this Agreement, the Shareholder has not granted, and shall not grant at any time while this Agreement remains in effect, any proxy, consent or power of attorney with respect to
the Total Voting Securities that would conflict with the provisions of Section 1.1. 

  
 H-2

 1.3    No Other Restrictions.  Except as set forth in
Section 1.1, the Shareholder shall not be restricted from voting in favor of, against or abstaining with respect to any matter presented to the shareholders of the Company. 

ARTICLE II 

REPRESENTATIONS AND WARRANTIES 
 2.1    Representations and Warranties of the Shareholder.  Except as set forth on the signature page hereof, the Shareholder hereby represents and warrants as follows
as of the date hereof: 
 (a)       Authorization; Validity of Agreement; Necessary
Action.  This Agreement has been duly executed and delivered by the Shareholder and constitutes a valid and binding obligation of the Shareholder, enforceable in accordance with its terms (except as enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and general equitable principles). 
 (b)      Ownership.  The Voting Securities set forth below the Shareholder’s name on the signature page hereto are owned of record by the Shareholder or
the Shareholder has the power to vote such Voting Securities, in each case as of the date hereof (such Voting Securities, the “Existing Voting Securities”). The Shareholder’s Existing Voting Securities constitute all voting
equity securities of the Company held of record by the Shareholder or for which voting power is held by the Shareholder as of the date hereof. The Shareholder has sole power to issue instructions with respect to the matters set forth in
Article I hereof, and sole power to agree to all of the matters set forth in this Agreement, in each case with respect to all of the Shareholder’s Existing Voting Securities, with no limitations, qualifications or restrictions on such
rights, subject to applicable federal and state securities laws and the terms of this Agreement. The Shareholder has good title to the Shareholder’s Existing Voting Securities, free and clear of any Encumbrances. 

(c)      No Consents; Conflicts and Violations.  Except for any applicable requirements
of the Securities Exchange Act of 1934, as amended, the execution and delivery of this Agreement by the Shareholder does not, and the performance by the Shareholder of its obligations under this Agreement will not, (i) require any consent,
approval, authorization of or other order of, action by, filing with, or notification to any Governmental Authority; (ii) violate or conflict with or result in the breach of any provision of the organizational documents of the Shareholder;
(iii) cause a violation by the Shareholder of any Law, ordinance or regulation of any Governmental Authority applicable to the Shareholder or by which any of the Existing Voting Securities is bound; or (iv) conflict with, result in any
breach of or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or require payment under, or result in
the creation of any Encumbrance on the properties or assets of the Shareholder pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which the Shareholder is a
party or by which any of the Existing Voting Securities is bound, except, in the case of clauses (i), (iii) and (iv), as could not reasonably be expected, either individually or in the aggregate, to materially impair the ability of the
Shareholder to perform its obligations hereunder or to consummate the transactions contemplated hereby on a timely basis. 

  
 H-3

 ARTICLE III 
 MISCELLANEOUS 
 3.1    Limitation on
Liability.  Notwithstanding anything in this Agreement to the contrary, no party to this Agreement shall have any liability for damages to any other party for any breach or violation of this Agreement unless such breach or violation
was willful or intentional. 
 3.2    Termination.  This Agreement shall terminate upon
the earliest to occur of (i) the date and time of termination of the Securities Purchase Agreement; (ii) the Closing and (iii) the written agreement of the parties hereto and Buyer to terminate this Agreement. Upon such termination,
no party hereto shall have any further obligations or liabilities hereunder; provided, however, that such termination shall not relieve any party from liability for any willful or intentional breach or violation of this Agreement prior to such
termination. 
 3.3    Further Assurances.  From time to time, at the other party’s
request and without further consideration, each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary or desirable to consummate the transactions contemplated by this Agreement.

 3.4    No Ownership Interest.  Nothing contained in this Agreement shall be deemed to
vest in the Company or Buyer any direct or indirect ownership or incident of ownership of or with respect to any Total Voting Securities. All rights, ownership and economic benefits of and relating to the Total Voting Securities shall remain vested
in and belong to the Shareholder. 
 3.5    Notices. All notices of request, demand and other
communications hereunder shall be addressed to the parties as follows: 
  

			
	 (a)
	    	 if to the Company, to:

		    	  
 Institutional Financial Markets, Inc.

Cira Centre
 2929
Arch Street, 17th Floor
 Philadelphia, Pennsylvania 19104

Attn: Joseph W. Pooler, Jr.
 Facsimile: (215) 701-8280
 E-mail: jpooler@ifmi.com

 
 With a copy to:

 
 Duane Morris LLP

30 South 17th Street
 Philadelphia, Pennsylvania 19103
 Attn: Darrick M. Mix

Facsimile: (215) 239-4958
 Email: dmix@duanemorris.com

  
 H-4

 (b)      if to the Shareholder, to the address listed next to
the Shareholder’s name on the Shareholder’s signature page hereto, 
 unless the address is changed by the party by
like notice given to the other parties. Notice shall be in writing and shall be deemed delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and properly addressed to the address above, then three
(3) business days after deposit of same in a regularly maintained U.S. Mail receptacle; or (ii) if sent by Federal Express (FedEx), the United Parcel Service (UPS), or another nationally recognized overnight courier service, next business
morning delivery, then one (1) business day after deposit of same with, or in a regularly maintained receptacle of, such overnight courier on or prior to 5:00 p.m., New York City time, on a business day; or (iii) if hand delivered, then
upon hand delivery thereof to the address indicated on or prior to 5:00 p.m., New York City time, on a business day. Any notice hand delivered after 5:00 p.m. New York City time, shall be deemed delivered on the following business day.
Notwithstanding the foregoing, notices, consents, waivers or other communications referred to in this Agreement may be sent by facsimile, e-mail, or other method of delivery, but shall be deemed to have been delivered only when the sending party has
confirmed (by reply e-mail or some other form of written confirmation from the receiving party) that the notice has been received by the other party. 
 3.6    Interpretation.  The words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer
to this Agreement as a whole and not to any particular provision of this Agreement, and section references are to this Agreement unless otherwise specified. The headings contained in this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement. 
 3.7    Entire
Agreement.  This Agreement (including any exhibits hereto) and the Transaction Documents (as defined in the Securities Purchase Agreement) collectively constitute the entire agreement, and supersede all other prior agreements,
understandings, and representations and warranties, both written and oral with respect to the subject matter hereof. 

3.8    Governing Law and Jurisdiction.  This Agreement shall be construed in accordance with the
laws of the State of New York, without regard to the principles of conflicts of laws. The parties further agree that any action between them shall be heard in New York City, New York, and expressly consent to the jurisdiction and venue of the state
and federal courts sitting in New York City, New York, for the adjudication of any civil action asserted pursuant to this Agreement. 

  
 H-5

 3.9      Consent to Jurisdiction.  EACH
PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL COURT LOCATED IN THE STATE OF NEW YORK OR ANY NEW YORK STATE COURT IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING ARISING IN CONNECTION WITH THIS AGREEMENT AND THE
TRANSACTION DOCUMENTS AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY, AND AGREES THAT ANY SUCH ACTION, SUIT OR PROCEEDING SHALL BE BROUGHT ONLY IN SUCH COURT (AND WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS OR ANY OTHER OBJECTION TO
VENUE THEREIN); PROVIDED, HOWEVER, THAT SUCH CONSENT TO JURISDICTION IS SOLELY FOR THE PURPOSE REFERRED TO IN THIS SECTION 3.9 AND SHALL NOT BE DEEMED TO BE A GENERAL SUBMISSION TO THE JURISDICTION OF SAID COURTS OR IN THE STATE OF NEW
YORK OTHER THAN FOR SUCH PURPOSE. 
 3.10    Enforcement.  The Shareholder agrees that in
the event that the Shareholder fails to perform any of the Shareholder’s obligations under this Agreement in accordance with their specific terms, the Company and Buyer will be irreparably harmed and there will be no adequate remedy at Law. It
is accordingly agreed that the Company and Buyer shall be entitled to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity. 

3.11    Amendment.  The parties hereby irrevocably agree that no attempted amendment, modification,
or change of this Agreement shall be valid and effective, unless the parties and Buyer shall unanimously agree in writing to such amendment, modification or change. 
 3.12    Severability.  If any provision of this Agreement is held to be invalid or unenforceable in any respect, then the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall
incorporate such substitute provision in this Agreement. 
 3.13    Assignment; Third Party
Beneficiaries.  Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Company and its successors and permitted assigns. This Agreement is not intended to confer any
rights or remedies hereunder upon any Person other than the Company pursuant to the terms and conditions of the Securities Purchase Agreement, except that Buyer is an express third party beneficiary with full rights to enforce this Agreement,
including Section 3.10, as if it were the Company. 

  
 H-6

 3.14    Shareholder Capacity.  By executing and
delivering this Agreement, the Shareholder makes no agreement or understanding herein in the Shareholder’s capacity or with respect to the Shareholder’s actions as a manager, director, officer or employee of the Company or any of its
Subsidiaries. The Shareholder is signing and entering into this Agreement solely in the Shareholder’s capacity as the record owner of the Shareholder’s Total Voting Securities or in the Shareholder’s capacity as the individual with
voting power with respect to certain Total Voting Securities, and nothing herein shall limit or affect in any way any actions that may be hereafter taken by the Shareholder in the Shareholder’s capacity as an employee, director, officer or
manager of the Company or any of its Subsidiaries or in any other capacity and no such actions shall be deemed to be a breach of this Agreement. Nothing contained in this Agreement shall restrict, limit, prohibit or preclude the Shareholder from
exercising or discharging the Shareholder’s fiduciary duties as a director, officer or manager of the Company or any of its Subsidiaries under applicable Law. Any trustee executing this Agreement is executing this Agreement solely in his or
her fiduciary capacity and shall have no personal liability or obligation under this Agreement. 
 [REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK] 

  
 H-7

 IN WITNESS WHEREOF, the Shareholder has signed this Voting Agreement as of the date first
written above. 
  

									
		 	SHAREHOLDER:	 		 		 	
			
		 	  
	 	
		 	Name:	 		 		 	
		 	[Title:]	 		 		 	
		 	  
 Total Voting Securities owned by the Shareholder as of
the date hereof:

		 	  
 Number of Shares:
	 	  
  
	 		 	
					
		 		 	  
	 		 	

  
  

									
	Address for Notices:	 	  
	 		 	
					
		 		 	  
	 		 	
					
		 		 	  
	 		 	

  
 Exceptions to Shareholder’s
representations and warranties set forth in ARTICLE II hereof, if any (please describe in the space provided below): 
  

 
 [Signature Page to Voting Agreement] 

  
 H-8

					
		 	AGREED TO AND ACCEPTED BY:	 	
		
		 	INSTITUTIONAL FINANCIAL MARKETS, INC.
			
		 	
By:                             
                                         
  
	 	
		 	 Name:
	 	
		 	 Title:
	 	

  
  
  

 
  
  

[Signature Page to Voting Agreement] 

  
 H-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}]]